{
    "questions": [
        {
            "body": "What is the alternative lengthening of telomeres?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24500201",
                "http://www.ncbi.nlm.nih.gov/pubmed/19154407",
                "http://www.ncbi.nlm.nih.gov/pubmed/28760773",
                "http://www.ncbi.nlm.nih.gov/pubmed/28636942",
                "http://www.ncbi.nlm.nih.gov/pubmed/28082393",
                "http://www.ncbi.nlm.nih.gov/pubmed/26428317",
                "http://www.ncbi.nlm.nih.gov/pubmed/15059879",
                "http://www.ncbi.nlm.nih.gov/pubmed/19095716",
                "http://www.ncbi.nlm.nih.gov/pubmed/11439347",
                "http://www.ncbi.nlm.nih.gov/pubmed/28741530"
            ],
            "id": "5ab908d4fcf456587200001a",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24500201",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 99,
                    "text": "Alternative Lengthening of Telomeres is characterized by reduced compaction of telomeric chromatin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19154407",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 193,
                    "text": "Maintenance of telomeric ends by the telomerase ribonucleoprotein complex or the telomerase-independent alternative lengthening of telomeres is necessary for the immortalization of human cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24500201",
                    "endSection": "abstract",
                    "offsetInBeginSection": 108,
                    "offsetInEndSection": 303,
                    "text": "Previous studies in mouse suggested that loss of heterochromatin marks at telomeres might favor onset of Alternative Lengthening of Telomeres (ALT) pathway, by promoting homologous recombination."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28760773",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 115,
                    "text": "Alternative Lengthening of Telomeres Mediated by Mitotic DNA Synthesis Engages Break-Induced Replication Processes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28760773",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 137,
                    "text": "Alternative lengthening of telomeres (ALT) is a telomerase-independent telomere maintenance mechanism that occurs in a subset of cancers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28636942",
                    "endSection": "abstract",
                    "offsetInBeginSection": 104,
                    "offsetInEndSection": 271,
                    "text": "This is achieved by activating a telomere lengthening mechanism (TLM), either telomerase or alternative lengthening of telomeres, to counter normal telomere attrition."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28082393",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 101,
                    "text": "Alternative lengthening of telomeres can be maintained by preferential elongation of lagging strands."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26428317",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1993,
                    "offsetInEndSection": 2128,
                    "text": "We conclude that alternative lengthening of telomeres is a frequent telomere-maintenance mechanism in cytogenetically complex sarcomas."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15059879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 55,
                    "offsetInEndSection": 277,
                    "text": "In some telomerase-negative tumors, telomeres become lengthened by alternative lengthening of telomeres (ALT), a recombination-mediated DNA replication process in which telomeres use other telomeric DNA as a copy template."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19095716",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 182,
                    "text": "Alternative lengthening of telomeres (ALT) is a telomere length maintenance mechanism based on recombination, where telomeres use other telomeric DNA as a template for DNA synthesis."
                }
            ]
        },
        {
            "body": "Which organ express and secretes the hormone FGF21?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/18467542",
                "http://www.ncbi.nlm.nih.gov/pubmed/9139448",
                "http://www.ncbi.nlm.nih.gov/pubmed/18045786",
                "http://www.ncbi.nlm.nih.gov/pubmed/24432989",
                "http://www.ncbi.nlm.nih.gov/pubmed/27911795",
                "http://www.ncbi.nlm.nih.gov/pubmed/24697521",
                "http://www.ncbi.nlm.nih.gov/pubmed/28844867",
                "http://www.ncbi.nlm.nih.gov/pubmed/19531592",
                "http://www.ncbi.nlm.nih.gov/pubmed/25871519",
                "http://www.ncbi.nlm.nih.gov/pubmed/26915669"
            ],
            "id": "5ad3aa47133db5eb78000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18467542",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 98,
                    "text": "Adipose tissue is a metabolically responsive endocrine organ that secretes a myriad of adipokines."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9139448",
                    "endSection": "abstract",
                    "offsetInBeginSection": 435,
                    "offsetInEndSection": 535,
                    "text": "Heart secretes in blood the peptide compound natriuretic hormone which regulates the sodium balance."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18045786",
                    "endSection": "abstract",
                    "offsetInBeginSection": 347,
                    "offsetInEndSection": 543,
                    "text": "An elementary communication is displayed as a causal link from a cell that secretes a particular hormone to those cells which express the corresponding hormone receptor and respond to the hormone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9139448",
                    "endSection": "abstract",
                    "offsetInBeginSection": 536,
                    "offsetInEndSection": 742,
                    "text": "Recent studies have been demonstrated that the adipose tissue cells adipocytes secrete in blood the peptide hormone leptine which stimulates utilization of lipids from the fat deposits in energy metabolism."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18467542",
                    "endSection": "abstract",
                    "offsetInBeginSection": 790,
                    "offsetInEndSection": 998,
                    "text": "Of the 379 genes robustly regulated by two structurally distinct PPARgamma agonists in the epididymal white adipose tissue (EWAT) of db/db mice, 33 encoded for known secreted proteins, one of which was FGF21."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9139448",
                    "endSection": "abstract",
                    "offsetInBeginSection": 256,
                    "offsetInEndSection": 434,
                    "text": "Further, it has been shown that certain brain structures, hypothalamus in particular, are also endocrine organs which secrete in blood a large number of various peptide hormones."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18467542",
                    "endSection": "abstract",
                    "offsetInBeginSection": 628,
                    "offsetInEndSection": 789,
                    "text": "Here, we report the use of transcriptional profiling to identify genes encoding for secreted proteins the expression of which is regulated by PPARgamma agonists."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18467542",
                    "endSection": "abstract",
                    "offsetInBeginSection": 293,
                    "offsetInEndSection": 458,
                    "text": "The mechanism by which altered gene expression in adipose tissue affects liver and muscle insulin sensitivity (and thus glucose homeostasis) is not fully understood."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18045786",
                    "endSection": "abstract",
                    "offsetInBeginSection": 158,
                    "offsetInEndSection": 283,
                    "text": "cells, tissues and organs) where the hormones are synthesized and secreted, and where the respective receptors are expressed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9139448",
                    "endSection": "abstract",
                    "offsetInBeginSection": 743,
                    "offsetInEndSection": 832,
                    "text": "Leptine is the product obese (ob) gene which is mainly expressed in white adipose tissue."
                }
            ]
        },
        {
            "body": "What is the biological role of Neddylation?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28964913",
                "http://www.ncbi.nlm.nih.gov/pubmed/22805479",
                "http://www.ncbi.nlm.nih.gov/pubmed/23148618",
                "http://www.ncbi.nlm.nih.gov/pubmed/26260793",
                "http://www.ncbi.nlm.nih.gov/pubmed/26679222",
                "http://www.ncbi.nlm.nih.gov/pubmed/24124476",
                "http://www.ncbi.nlm.nih.gov/pubmed/24821572",
                "http://www.ncbi.nlm.nih.gov/pubmed/26895833",
                "http://www.ncbi.nlm.nih.gov/pubmed/27839998",
                "http://www.ncbi.nlm.nih.gov/pubmed/16998474"
            ],
            "id": "5ace3e3f0340b9f058000012",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28964913",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 222,
                    "text": "NEDDylation, a post-translational modification mediated by the conjugation of the ubiquitin-like protein Nedd8 to specific substrates, is an essential biological process that regulates cell cycle progression in eukaryotes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22805479",
                    "endSection": "abstract",
                    "offsetInBeginSection": 237,
                    "offsetInEndSection": 444,
                    "text": "Central to the neddylation pathway is the amyloid precursor protein (APP)-binding protein APP-BP1, which together with Uba3, plays an analogous role to the ubiquitin-activating enzyme E1 in nedd8 activation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23148618",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 143,
                    "text": "The neddylation conjugation pathway has a pivotal role in mediating ubiquitination of proteins and regulation of numerous biological processes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26260793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 170,
                    "text": "Neddylation is a posttranslational modification that controls diverse biological processes by covalently conjugating the ubiquitin-like protein NEDD8 to specific targets."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26679222",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 129,
                    "text": "BACKGROUND\nNeddylation is a reversible post-translational modification that plays a vital role in maintaining cellular machinery."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24124476",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 144,
                    "text": "While neddylation is known to activate cullin (CUL)-RING ubiquitin ligases (CRLs), its role in regulating T cell signaling is poorly understood."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23148618",
                    "endSection": "abstract",
                    "offsetInBeginSection": 518,
                    "offsetInEndSection": 727,
                    "text": "Neddylation, a process mediated by the protein NEDD8, is required for conformational changes of cullins, a scaffolding protein situated in the core of cullin-RING ligases, and regulation of E3 ligase activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26260793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 313,
                    "offsetInEndSection": 497,
                    "text": "Although typical neddylation is known to regulate protein function in many ways, the regulatory mechanisms and biological consequence of atypical neddylation remain largely unexplored."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26260793",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 140,
                    "text": "NEDD8 Ultimate Buster 1 Long (NUB1L) Protein Suppresses Atypical Neddylation and Promotes the Proteasomal Degradation of Misfolded Proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24821572",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "Neddylation, the covalent attachment of ubiquitin-like protein Nedd8, of the Cullin-RING E3 ligase family regulates their ubiquitylation activity."
                }
            ]
        },
        {
            "body": "What is break induced replication?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20643142",
                "http://www.ncbi.nlm.nih.gov/pubmed/18414031",
                "http://www.ncbi.nlm.nih.gov/pubmed/27760120",
                "http://www.ncbi.nlm.nih.gov/pubmed/16888651",
                "http://www.ncbi.nlm.nih.gov/pubmed/18562643",
                "http://www.ncbi.nlm.nih.gov/pubmed/8692957",
                "http://www.ncbi.nlm.nih.gov/pubmed/16756487",
                "http://www.ncbi.nlm.nih.gov/pubmed/8631700",
                "http://www.ncbi.nlm.nih.gov/pubmed/26920759",
                "http://www.ncbi.nlm.nih.gov/pubmed/20516198"
            ],
            "id": "5ab9050bfcf4565872000019",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20643142",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 173,
                    "text": "Even though DNA alkylating agents have been used for many decades in the treatment of cancer, it remains unclear what happens when replication forks encounter alkylated DNA."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18414031",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 57,
                    "text": "Break-induced replication: what is it and what is it for?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27760120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 239,
                    "offsetInEndSection": 411,
                    "text": "How DNA damage induces assembly and execution of a DNA replication complex (break-induced replisome) at telomeres or elsewhere in the mammalian genome is poorly understood."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20643142",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1445,
                    "offsetInEndSection": 1687,
                    "text": "Altogether, our data suggest that N-alkylations formed during exposure to alkylating agents physically block replication fork elongation in mammalian cells, causing formation of replication-associated DNA lesions, likely double-strand breaks."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16888651",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 232,
                    "text": "Molecular studies on double-strand break (DSB) repair in mitosis are usually performed with enzymatically induced DSBs, but spontaneous DSBs might arise because of replication failures, for example when replication encounters nicks."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18562643",
                    "endSection": "abstract",
                    "offsetInBeginSection": 999,
                    "offsetInEndSection": 1140,
                    "text": "Tn7 transposition is not dependent on any known specific pathway of replication fork reactivation as a means of recognizing DNA break repair."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8692957",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 111,
                    "text": "Double-strand break repair in the absence of RAD51 in yeast: a possible role for break-induced DNA replication."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20643142",
                    "endSection": "abstract",
                    "offsetInBeginSection": 579,
                    "offsetInEndSection": 816,
                    "text": "A high dose of 5 mM caffeine, inhibiting most DNA damage signalling, decreases replication rates overall but does not reverse MMS-induced replication inhibition, showing that the replication block is independent of DNA damage signalling."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18414031",
                    "endSection": "abstract",
                    "offsetInBeginSection": 316,
                    "offsetInEndSection": 582,
                    "text": "However, DSBs that arise by replication fork collapse or by erosion of uncapped telomeres have only one free end and are thought to repair by strand invasion into a homologous duplex DNA followed by replication to the chromosome end (break-induced replication, BIR)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16756487",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 254,
                    "text": "When a telomere becomes unprotected or if only one end of a chromosomal double-strand break succeeds in recombining with a template sequence, DNA can be repaired by a recombination-dependent DNA replication process termed break-induced replication (BIR)."
                }
            ]
        },
        {
            "body": "What is a fibrocyte?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22043022",
                "http://www.ncbi.nlm.nih.gov/pubmed/28720095",
                "http://www.ncbi.nlm.nih.gov/pubmed/25429068",
                "http://www.ncbi.nlm.nih.gov/pubmed/24264775",
                "http://www.ncbi.nlm.nih.gov/pubmed/27435108",
                "http://www.ncbi.nlm.nih.gov/pubmed/24752483",
                "http://www.ncbi.nlm.nih.gov/pubmed/26948996",
                "http://www.ncbi.nlm.nih.gov/pubmed/21106092",
                "http://www.ncbi.nlm.nih.gov/pubmed/11390511",
                "http://www.ncbi.nlm.nih.gov/pubmed/19937928"
            ],
            "id": "5ad247720340b9f058000017",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22043022",
                    "endSection": "abstract",
                    "offsetInBeginSection": 288,
                    "offsetInEndSection": 462,
                    "text": "Fibrocyte cultures offer one source of transplantable cells, but determining what fibrocyte types they contain and what phenotype transplanted cells may adopt is problematic."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22043022",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 196,
                    "text": "Spiral ligament fibrocytes function in cochlear homeostasis, maintaining the endocochlear potential by participating in potassium recycling, and fibrocyte degeneration contributes to hearing loss."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28720095",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 187,
                    "text": "Fibrocyte measurement in peripheral blood correlates with number of cultured mature fibrocytes in vitro and is a potential biomarker for interstitial lung disease in Rheumatoid Arthritis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25429068",
                    "endSection": "abstract",
                    "offsetInBeginSection": 107,
                    "offsetInEndSection": 381,
                    "text": "To help form scar tissue, circulating monocytes enter the tissue and differentiate into fibroblast-like cells called fibrocytes, but fibrocyte differentiation is strongly inhibited by the plasma protein serum amyloid P (SAP), and healthy tissues contain very few fibrocytes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24264775",
                    "endSection": "abstract",
                    "offsetInBeginSection": 871,
                    "offsetInEndSection": 1008,
                    "text": "A complex array of cytokines, chemokines and growth factors regulate fibrocyte biology, and these are associated with fibrogenesis in CD."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27435108",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 98,
                    "text": "Periostin regulates fibrocyte function to promote myofibroblast differentiation and lung fibrosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24752483",
                    "endSection": "abstract",
                    "offsetInBeginSection": 852,
                    "offsetInEndSection": 1002,
                    "text": "These observations suggest that IgG-mediated inhibition of fibrocyte differentiation is mediated by Fc\u03b3Rs, with Fc\u03b3RI mediating most of the signaling."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24264775",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1009,
                    "offsetInEndSection": 1209,
                    "text": "The cytokines transforming growth factor \u03b21, connective tissue growth factor and interleukin 13, overexpressed in the strictured Crohn's intestine, promote fibrocyte generation and/or differentiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25429068",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1015,
                    "offsetInEndSection": 1190,
                    "text": "Together, these results suggest that tryptase and thrombin may be an initial trigger to override SAP inhibition of fibrocyte differentiation to initiate scar tissue formation."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26948996",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 87,
                    "text": "Fibrocyte and T cell interactions promote disease pathogenesis in rheumatoid arthritis."
                }
            ]
        },
        {
            "body": "Which cellular functions are affected by lncRNA H19 in the heart?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27027436",
                "http://www.ncbi.nlm.nih.gov/pubmed/27895893",
                "http://www.ncbi.nlm.nih.gov/pubmed/26884465",
                "http://www.ncbi.nlm.nih.gov/pubmed/26089099",
                "http://www.ncbi.nlm.nih.gov/pubmed/27789555",
                "http://www.ncbi.nlm.nih.gov/pubmed/28881833",
                "http://www.ncbi.nlm.nih.gov/pubmed/27247022",
                "http://www.ncbi.nlm.nih.gov/pubmed/27813675",
                "http://www.ncbi.nlm.nih.gov/pubmed/27607135",
                "http://www.ncbi.nlm.nih.gov/pubmed/27317124"
            ],
            "id": "5ac7185f0340b9f058000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27027436",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 173,
                    "text": "OBJECTIVE\nThe long non-coding RNA (lncRNA) gene, H19, has been involving in multiple biological functions, which also plays a vital role in colorectal cancer carcinogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27895893",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1338,
                    "offsetInEndSection": 1643,
                    "text": "CONCLUSION\nDownregulation of H19 promoted cell proliferation and inhibited cell apoptosis during late-stage cardiac differentiation by regulating the negative role of miR-19b in Sox6 expression, which suggested that the manipulation of H19 expression could serve as a potential strategy for heart disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27895893",
                    "endSection": "abstract",
                    "offsetInBeginSection": 115,
                    "offsetInEndSection": 206,
                    "text": "At present, biological functions of H19 in cardiac differentiation is not completely clear."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27027436",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 101,
                    "text": "Association of genetic variants in lncRNA H19 with risk of colorectal cancer in a Chinese population."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26884465",
                    "endSection": "abstract",
                    "offsetInBeginSection": 455,
                    "offsetInEndSection": 711,
                    "text": "H19 overexpression increased the cellular abundance of miR-675, which in turn destabilized and repressed the translation of mRNAs encoding tight junction protein ZO-1 and adherens junction E-cadherin, resulting in the dysfunction of the epithelial barrier."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27027436",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1214,
                    "offsetInEndSection": 1421,
                    "text": "CONCLUSIONS\nOur results provided the evidence that rs2839698 in H19 was associated with elevated risk of colorectal cancer, which may be a potential biomarker for predicting colorectal cancer susceptibility."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26089099",
                    "endSection": "abstract",
                    "offsetInBeginSection": 225,
                    "offsetInEndSection": 388,
                    "text": "The developmentally regulated, imprinted H19 long noncoding RNA (lncRNA) functions to reduce the bioavailability of microRNA let-7 by acting as a molecular sponge."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27789555",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1467,
                    "offsetInEndSection": 1740,
                    "text": "CONCLUSIONS\nThese findings indicate that a dysregulation of DNA methylation in the promoter of H19 during calcific aortic valve disease is associated with a higher expression of this lncRNA, which promotes an osteogenic program by interfering with the expression of NOTCH1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27027436",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1072,
                    "offsetInEndSection": 1211,
                    "text": "Additionally, bioinformatic analysis showed that rs2839698 may change the crucial folding structures and alter the target microRNAs of H19."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28881833",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1350,
                    "offsetInEndSection": 1495,
                    "text": "Thus, these results indicate that lncRNA H19 functions as an important mediator of BMP9 signaling by modulating Notch signaling-targeting miRNAs."
                }
            ]
        },
        {
            "body": "Dinutuximab is used for treatment of which disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28389455",
                "http://www.ncbi.nlm.nih.gov/pubmed/25940913",
                "http://www.ncbi.nlm.nih.gov/pubmed/26791869",
                "http://www.ncbi.nlm.nih.gov/pubmed/28154831",
                "http://www.ncbi.nlm.nih.gov/pubmed/29039999",
                "http://www.ncbi.nlm.nih.gov/pubmed/26917818",
                "http://www.ncbi.nlm.nih.gov/pubmed/26891967",
                "http://www.ncbi.nlm.nih.gov/pubmed/28659916",
                "http://www.ncbi.nlm.nih.gov/pubmed/27485082",
                "http://www.ncbi.nlm.nih.gov/pubmed/25987820"
            ],
            "id": "589a247078275d0c4a000035",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28389455",
                    "endSection": "abstract",
                    "offsetInBeginSection": 186,
                    "offsetInEndSection": 467,
                    "text": "SUMMARY\nDinutuximab (Unituxin, United Therapeutics) is a novel monoclonal antibody recently approved for use in combination with granulocyte- macrophage colony-stimulating factor, interleukin-2, and isotretinoin for the treatment of pediatric patients with high-risk neuroblastoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25940913",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 187,
                    "text": "United Therapeutics Corporation and the National Cancer Institute are developing dinutuximab (Unituxin\u2122; ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26791869",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 176,
                    "text": "PURPOSE\nDinutuximab (Unituxin\u2122; ch14.18), a monoclonal antibody against disialoganglioside, improved survival as part of post-consolidation therapy for high-risk neuroblastoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28389455",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1499,
                    "offsetInEndSection": 1661,
                    "text": "CONCLUSION\nDinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25940913",
                    "endSection": "abstract",
                    "offsetInBeginSection": 491,
                    "offsetInEndSection": 635,
                    "text": "The US FDA has recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma in paediatric patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28154831",
                    "endSection": "abstract",
                    "offsetInBeginSection": 330,
                    "offsetInEndSection": 511,
                    "text": "GD2 is the first ganglioside proven to be an effective target antigen for cancer immunotherapy with the regulatory approval of dinutuximab, a chimeric anti-GD2 therapeutic antibody."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25940913",
                    "endSection": "abstract",
                    "offsetInBeginSection": 798,
                    "offsetInEndSection": 1182,
                    "text": "This article summarizes the milestones in the development of dinutuximab leading to this first approval for use (in combination with granulocyte macrophage colony-stimulating factor, interleukin-2 and 13-cis retinoic acid) in the treatment of paediatric patients with high-risk neuroblastoma who achieve at least partial response to prior first-line multiagent, multimodality therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29039999",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1216,
                    "offsetInEndSection": 1441,
                    "text": "High-risk patients received extensive, multimodal treatment consisting of chemotherapy, surgery, myeloablative chemotherapy with stem cell rescue (transplant), radiation, immunotherapy (dinutuximab), and isotretinoin therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26917818",
                    "endSection": "abstract",
                    "offsetInBeginSection": 939,
                    "offsetInEndSection": 1343,
                    "text": "Dinutuximab is a chimeric, human-murine, anti-GD2 monoclonal antibody approved in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), aldesleukin (interleukin-2 [IL-2]), and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to first-line multiagent, multimodality therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26891967",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 200,
                    "text": "Dinutuximab (ch14.18; Unituxin\u2122) is a chimeric human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma cells."
                }
            ]
        },
        {
            "body": "What is the ChIP-exo method used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27246337",
                "http://www.ncbi.nlm.nih.gov/pubmed/26404150",
                "http://www.ncbi.nlm.nih.gov/pubmed/23026909",
                "http://www.ncbi.nlm.nih.gov/pubmed/24373287",
                "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                "http://www.ncbi.nlm.nih.gov/pubmed/27587683",
                "http://www.ncbi.nlm.nih.gov/pubmed/26518661",
                "http://www.ncbi.nlm.nih.gov/pubmed/25735747",
                "http://www.ncbi.nlm.nih.gov/pubmed/25751057",
                "http://www.ncbi.nlm.nih.gov/pubmed/23980024"
            ],
            "id": "5ac24c9495d0062724000002",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27246337",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 78,
                    "text": "Mapping Protein-DNA Interactions Using ChIP-exo and Illumina-Based Sequencing."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26404150",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 128,
                    "text": "Precise Identification of DNA-Binding Proteins Genomic Location by Exonuclease Coupled Chromatin Immunoprecipitation (ChIP-exo)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23026909",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 110,
                    "text": "ChIP-exo method for identifying genomic location of DNA-binding proteins with near-single-nucleotide accuracy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24373287",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 122,
                    "text": "ChIP-exonuclease (ChIP-exo) is a modified ChIP-seq approach for high resolution mapping of transcription factor DNA sites."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24373287",
                    "endSection": "abstract",
                    "offsetInBeginSection": 567,
                    "offsetInEndSection": 666,
                    "text": "Our Illumina-based ChIP-exo provides high resolution mapping of transcription factor binding sites."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23026909",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 171,
                    "text": "This unit describes the ChIP-exo methodology, which combines chromatin immunoprecipitation (ChIP) with lambda exonuclease digestion followed by high-throughput sequencing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27246337",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1065,
                    "offsetInEndSection": 1264,
                    "text": "In this chapter, we provide a brief commentary on these methodological changes and describe a detailed ChIP-exo method able to generate narrower peaks and greater peak coverage from ChIPped material."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24373287",
                    "endSection": "abstract",
                    "offsetInBeginSection": 123,
                    "offsetInEndSection": 324,
                    "text": "We describe an Illumina-based ChIP-exo method which provides a global improvement of the data quality of estrogen receptor (ER) ChIP and insights into the motif structure for key ER-associated factors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26404150",
                    "endSection": "abstract",
                    "offsetInBeginSection": 870,
                    "offsetInEndSection": 1115,
                    "text": "By doing so, ChIP-exo offers new opportunities for a better characterization of the complex and fascinating architecture that resides in DNA-proteins interactions and provides new insights for the comprehension of important molecular mechanisms."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24373287",
                    "endSection": "abstract",
                    "offsetInBeginSection": 325,
                    "offsetInEndSection": 468,
                    "text": "ChIP-exo of the ER pioneer factor FoxA1 identifies protected DNA with a predictable 8\u00a0bp overhang from the Forkhead motif, which we term mesas."
                }
            ]
        },
        {
            "body": "Where do mitochondrial DNA deletion breakpoints tend to occur?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27084947",
                "http://www.ncbi.nlm.nih.gov/pubmed/15776250",
                "http://www.ncbi.nlm.nih.gov/pubmed/3032452",
                "http://www.ncbi.nlm.nih.gov/pubmed/24958239",
                "http://www.ncbi.nlm.nih.gov/pubmed/15133725",
                "http://www.ncbi.nlm.nih.gov/pubmed/9344670",
                "http://www.ncbi.nlm.nih.gov/pubmed/25193669",
                "http://www.ncbi.nlm.nih.gov/pubmed/23472757",
                "http://www.ncbi.nlm.nih.gov/pubmed/2456798",
                "http://www.ncbi.nlm.nih.gov/pubmed/15379855"
            ],
            "id": "5abc9ecffcf4565872000021",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27084947",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1151,
                    "offsetInEndSection": 1320,
                    "text": "Specifically, (AT)n, (GAA)n and (GAAA)n constitute the most frequent repeats at translocation breakpoints, whereas A-tracts occur preferentially at deletion breakpoints."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15776250",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1034,
                    "offsetInEndSection": 1167,
                    "text": "Although the breakpoints of this 2-Mb deletion are not recurrent, it is conspicuous that one breakpoint is located in the JJAZ1 gene."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27084947",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 115,
                    "text": "Translocation and deletion breakpoints in cancer genomes are associated with potential non-B DNA-forming sequences."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27084947",
                    "endSection": "abstract",
                    "offsetInBeginSection": 892,
                    "offsetInEndSection": 1150,
                    "text": "By analyzing the distribution of PONDS-forming sequences within \u00b1500 bases of 19 947 translocation and 46 365 sequence-characterized deletion breakpoints in cancer genomes, we find significant association between PONDS-forming repeats and cancer breakpoints."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3032452",
                    "endSection": "abstract",
                    "offsetInBeginSection": 454,
                    "offsetInEndSection": 658,
                    "text": "In another deletion the breakpoints are separated by 131 bp of DNA, which we have shown to be transposed from a region 36 kb upstream from the 5' breakpoint where it is present in the inverse orientation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3032452",
                    "endSection": "abstract",
                    "offsetInBeginSection": 277,
                    "offsetInEndSection": 453,
                    "text": "Members of the Alu family of repetitive sequences are frequently found at the breakpoints and we describe a novel deletion due to homologous recombination between such repeats."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24958239",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 166,
                    "text": "SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15776250",
                    "endSection": "abstract",
                    "offsetInBeginSection": 102,
                    "offsetInEndSection": 270,
                    "text": "The two major types of NF1 deletions encompass 1.4-Mb and 1.2-Mb, respectively, and have breakpoints in the NF1 low-copy repeats or in the JJAZ gene and its pseudogene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24958239",
                    "endSection": "abstract",
                    "offsetInBeginSection": 646,
                    "offsetInEndSection": 898,
                    "text": "Further, two of the 17 NF1 deletions with non-recurrent breakpoints, identified in unrelated patients, occur in association with the concomitant insertion of SINE/variable number of tandem repeats/Alu (SVA) retrotransposons at the deletion breakpoints."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15133725",
                    "endSection": "abstract",
                    "offsetInBeginSection": 233,
                    "offsetInEndSection": 474,
                    "text": "This mutation is, unlike other previously reported deletions in tubulopathy patients, not flanked by direct repeat sequences but by palindrome sequences at the deletion breakpoints, suggesting an unusual mechanism for production of deletion."
                }
            ]
        },
        {
            "body": "Name 4 circular RNA molecules associated with carcinogenesis.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16675105",
                "http://www.ncbi.nlm.nih.gov/pubmed/23979421",
                "http://www.ncbi.nlm.nih.gov/pubmed/16676796",
                "http://www.ncbi.nlm.nih.gov/pubmed/23692083",
                "http://www.ncbi.nlm.nih.gov/pubmed/26649774",
                "http://www.ncbi.nlm.nih.gov/pubmed/28970820",
                "http://www.ncbi.nlm.nih.gov/pubmed/26246469",
                "http://www.ncbi.nlm.nih.gov/pubmed/22665269",
                "http://www.ncbi.nlm.nih.gov/pubmed/23761296",
                "http://www.ncbi.nlm.nih.gov/pubmed/28185365"
            ],
            "id": "5ac721230340b9f058000005",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16675105",
                    "endSection": "abstract",
                    "offsetInBeginSection": 768,
                    "offsetInEndSection": 965,
                    "text": "Although, the precise contribution of RNA molecules by themselves and RNA-regulated processes on cancer development is currently unknown, recent data suggest their important role in carcinogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23979421",
                    "endSection": "abstract",
                    "offsetInBeginSection": 339,
                    "offsetInEndSection": 545,
                    "text": "Studies on the recently discovered of EBV-encoded microRNAs (ebv-miRNAs) showed that these small molecules function as post-transcriptional gene regulators and may play a role in the carcinogenesis process."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16675105",
                    "endSection": "abstract",
                    "offsetInBeginSection": 39,
                    "offsetInEndSection": 208,
                    "text": "According to the currently accepted model of carcinogenesis, several consequential mutations in oncogenes or tumor suppressor genes are necessary for cancer development."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23979421",
                    "endSection": "abstract",
                    "offsetInBeginSection": 753,
                    "offsetInEndSection": 838,
                    "text": "The importance of several miR-BARTs in carcinogenesis has recently been demonstrated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16676796",
                    "endSection": "abstract",
                    "offsetInBeginSection": 573,
                    "offsetInEndSection": 797,
                    "text": "In the limits of these specialized \"disbalanses\" the named signal molecules play key role not only on starting \"mitochondrial\" stages of aging process, carcinogenesis and apoptosis, but also on following \"performing\" stages."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23979421",
                    "endSection": "abstract",
                    "offsetInBeginSection": 201,
                    "offsetInEndSection": 338,
                    "text": "Reports have shown that EBV produces several viral oncoproteins, yet their pathological roles in carcinogenesis are not fully elucidated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23692083",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1238,
                    "offsetInEndSection": 1331,
                    "text": "Regucalcin may be a key molecule suppressor protein in cell proliferation and carcinogenesis."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26649774",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "Circular RNA participates in the carcinogenesis and the malignant behavior of cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28970820",
                    "endSection": "abstract",
                    "offsetInBeginSection": 128,
                    "offsetInEndSection": 411,
                    "text": "Accumulating evidence indicates that long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) may play key roles in the carcinogenesis of different cancers; however, little is known about the mechanisms of lncRNAs and circRNAs in the progression and metastasis of cervical cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26246469",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 89,
                    "text": "Altered expression of long noncoding RNAs (lncRNAs) associated with human carcinogenesis."
                }
            ]
        },
        {
            "body": "Which is the enzymatic activity of nardilysin?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/12590613",
                "http://www.ncbi.nlm.nih.gov/pubmed/21151101",
                "http://www.ncbi.nlm.nih.gov/pubmed/10880358",
                "http://www.ncbi.nlm.nih.gov/pubmed/12095415",
                "http://www.ncbi.nlm.nih.gov/pubmed/19935654",
                "http://www.ncbi.nlm.nih.gov/pubmed/27051521",
                "http://www.ncbi.nlm.nih.gov/pubmed/17555553",
                "http://www.ncbi.nlm.nih.gov/pubmed/15544571",
                "http://www.ncbi.nlm.nih.gov/pubmed/16805830",
                "http://www.ncbi.nlm.nih.gov/pubmed/28207963"
            ],
            "id": "5ac138aa95d0062724000001",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12590613",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 47,
                    "text": "Nardilysin cleaves peptides at monobasic sites."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21151101",
                    "endSection": "abstract",
                    "offsetInBeginSection": 191,
                    "offsetInEndSection": 321,
                    "text": "Here we demonstrate that the cytosolic endopeptidases nardilysin and thimet oligopeptidase (TOP) complemented proteasome activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10880358",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 208,
                    "text": "N-arginine (R) dibasic (NRD) convertase (nardilysin; EC 3.4.24.61), a metalloendopeptidase of the M16 family, specifically cleaves peptide substrates at the N-terminus of arginines in dibasic motifs in vitro."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12095415",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 178,
                    "text": "Nardilysin (N-arginine dibasic convertase, or NRDc) is a cytosolic and cell-surface metalloendopeptidase that, in vitro, cleaves substrates upstream of Arg or Lys in basic pairs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12590613",
                    "endSection": "abstract",
                    "offsetInBeginSection": 663,
                    "offsetInEndSection": 740,
                    "text": "Nardilysin also cleaves calcitonin at His-Arg and somatostatin-14 at Cys-Lys."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10880358",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 158,
                    "text": "N-arginine dibasic convertase (nardilysin) isoforms are soluble dibasic-specific metalloendopeptidases that localize in the cytoplasm and at the cell surface."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12590613",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 187,
                    "text": "Nardilysin (N-arginine dibasic convertase, EC 3.4.24.61) was first identified on the basis of its ability to cleave peptides containing an arginine dibasic pair, i.e., Arg-Arg or Arg-Lys."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19935654",
                    "endSection": "abstract",
                    "offsetInBeginSection": 116,
                    "offsetInEndSection": 310,
                    "text": "We found that nardilysin (N-arginine dibasic convertase, also known as Nrd1 and NRDc), a metalloendopeptidase enhancer of protein ectodomain shedding, is a critical regulator of these processes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27051521",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 179,
                    "text": "BACKGROUND\nNRD convertase, also termed Nardilysin, is a Zn(++) metalloendopeptidase that specifically cleaves the N-terminus of arginine and lysine residues into dibasic moieties."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17555553",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "Enhancement of alpha-secretase cleavage of amyloid precursor protein by a metalloendopeptidase nardilysin."
                }
            ]
        },
        {
            "body": "The Mantoux test detects what latent infection/disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20843417",
                "http://www.ncbi.nlm.nih.gov/pubmed/16307510",
                "http://www.ncbi.nlm.nih.gov/pubmed/22086450",
                "http://www.ncbi.nlm.nih.gov/pubmed/28470727",
                "http://www.ncbi.nlm.nih.gov/pubmed/3592920",
                "http://www.ncbi.nlm.nih.gov/pubmed/21987138",
                "http://www.ncbi.nlm.nih.gov/pubmed/14642251",
                "http://www.ncbi.nlm.nih.gov/pubmed/12238571",
                "http://www.ncbi.nlm.nih.gov/pubmed/23128409",
                "http://www.ncbi.nlm.nih.gov/pubmed/17501976"
            ],
            "id": "5ab147edfcf4565872000013",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20843417",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 126,
                    "text": "BACKGROUND\nThe Mantoux tuberculin skin test (TST) is widely used to diagnose latent infection with Mycobacterium tuberculosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16307510",
                    "endSection": "abstract",
                    "offsetInBeginSection": 474,
                    "offsetInEndSection": 657,
                    "text": "Until recently, the 100-year-old tuberculin skin test (Mantoux) has been the only available diagnostic test for latent tuberculosis infection, despite its many well-known limitations."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22086450",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 143,
                    "text": "Comparing the performance of QuantiFERON-TB Gold and Mantoux test in detecting latent tuberculosis infection among Iranian health care workers."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16307510",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 101,
                    "text": "Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28470727",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 276,
                    "text": "Mycobacterium tuberculosis is very rarely found in erythema induratum of Bazin; recently, we found an unusual case with positive acid-fast bacilli and polymerase chain reaction for detecting M.\u00a0tuberculosis in both skin lesions of the extremities and the site of Mantoux test."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3592920",
                    "endSection": "abstract",
                    "offsetInBeginSection": 151,
                    "offsetInEndSection": 359,
                    "text": "Association of familial contamination, phlyctenular Mantoux test, apex infiltrate with a calcified nodule on chest x-ray film and numerous pelvic calcifications on plain films of the abdomen led to diagnosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21987138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 555,
                    "offsetInEndSection": 821,
                    "text": "Assays based on the detection of synthesis of gamma interferon in vitro by peripheral monoclonal cells, stimulated by specific antigens (ESAT-6 and CFP-10), seem to offer better accuracy when compared to the Mantoux test in identifying latent tuberculosis infection."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14642251",
                    "endSection": "abstract",
                    "offsetInBeginSection": 80,
                    "offsetInEndSection": 222,
                    "text": "METHODS\nThe Mantoux tuberculin skin test and serology testing for hepatitis B, hepatitis C, HIV and syphilis were performed in 488 immigrants."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12238571",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 288,
                    "text": "In order to determine the prevalence of latent infection due to Mycobacterium tuberculosis in drug users and to provide centres for drug users with a practical tool for tuberculosis screening, 237 drug users were subjected to the Monotest and, for reference purposes, to the Mantoux test."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16307510",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1036,
                    "offsetInEndSection": 1305,
                    "text": "They are more sensitive than the tuberculin skin test in detecting people with active tuberculosis, and their results correlate more closely with M. tuberculosis exposure risk factors than the tuberculin skin test in people likely to have latent tuberculosis infection."
                }
            ]
        },
        {
            "body": "What is measured with the Proseek panels?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26475405",
                "http://www.ncbi.nlm.nih.gov/pubmed/28930774",
                "http://www.ncbi.nlm.nih.gov/pubmed/29392211",
                "http://www.ncbi.nlm.nih.gov/pubmed/28437237",
                "http://www.ncbi.nlm.nih.gov/pubmed/27383427",
                "http://www.ncbi.nlm.nih.gov/pubmed/19040730",
                "http://www.ncbi.nlm.nih.gov/pubmed/27710869",
                "http://www.ncbi.nlm.nih.gov/pubmed/29050213",
                "http://www.ncbi.nlm.nih.gov/pubmed/28083617",
                "http://www.ncbi.nlm.nih.gov/pubmed/26204497"
            ],
            "id": "5a9d99ac4e03427e73000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26475405",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1057,
                    "offsetInEndSection": 1175,
                    "text": "Laboratory analyses were performed by Proximity Extension Assay (Proseek Multiplex CVD I(96 \u00d7 96)), ELISAs and RT-PCR."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28930774",
                    "endSection": "abstract",
                    "offsetInBeginSection": 738,
                    "offsetInEndSection": 948,
                    "text": "The samples were analyzed with a multiplex proximity extension assay in which 92 inflammation-related proteins were measured simultaneously (Proseek Multiplex Inflammation I; Olink Bioscience, Uppsala, Sweden)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29392211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 366,
                    "offsetInEndSection": 542,
                    "text": "To simultaneously measure 92 inflammatory biomarkers, we used the proximity extension assay with the Proseek Multiplex Inflammation I panel (Olink Bioscience, Uppsala, Sweden)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28437237",
                    "endSection": "abstract",
                    "offsetInBeginSection": 750,
                    "offsetInEndSection": 962,
                    "text": "Blood samples were obtained at baseline (0 hour), 6, 24, and 96 hours post PCI, and stored at -80\u00b0C until they were analyzed by PROSEEK Multiplex CVD and PROSEEK Multiplex INF (Olink Bioscience, Uppsala, Sweden)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27383427",
                    "endSection": "abstract",
                    "offsetInBeginSection": 767,
                    "offsetInEndSection": 929,
                    "text": "In addition to conventional laboratory tests, 92 inflammatory proteins were analysed with a multiplex system (Proseek Multiplex Inflammation I, Olink Bioscience)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19040730",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 44,
                    "text": "ProSeeK: a web server for MLPA probe design."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19040730",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1548,
                    "offsetInEndSection": 1676,
                    "text": "ProSeeK will become a useful tool for all laboratories that are currently using MLPA in their research projects for CNV studies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27710869",
                    "endSection": "abstract",
                    "offsetInBeginSection": 498,
                    "offsetInEndSection": 588,
                    "text": "Samples were analyzed by Mesoscale Discovery, Myriad RBM MAP technology and Olink Proseek."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29050213",
                    "endSection": "abstract",
                    "offsetInBeginSection": 160,
                    "offsetInEndSection": 575,
                    "text": "Using highly-sensitive Proximity Extension ImmunoAssay on 92 cancer biomarkers (Proseek Multiplex, Olink), enhanced serum levels of Adrenomedullin (ADM, Pcorr= .0004), Growth differentiation factor 15 (GDF15, Pcorr= .003), and soluble Major histocompatibility complex class I-related chain A (sMICA, Pcorr= .023), all prosurvival and chemoprotective factors for myeloma cells, were detected in MM comparing to MGUS."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28083617",
                    "endSection": "abstract",
                    "offsetInBeginSection": 543,
                    "offsetInEndSection": 828,
                    "text": "Serum concentrations of 92 inflammation-associated proteins were measured in samples obtained from 80 aHSCT patients 14\u00a0days after transplantation and from 23 healthy control subjects by a novel sensitive proximity extension assay technology using Proseek Multiplex Inflammation I kit."
                }
            ]
        },
        {
            "body": "Is Enlimomab effective for stroke treatment?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/12365824",
                "http://www.ncbi.nlm.nih.gov/pubmed/19849665",
                "http://www.ncbi.nlm.nih.gov/pubmed/9693236",
                "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                "http://www.ncbi.nlm.nih.gov/pubmed/9744839",
                "http://www.ncbi.nlm.nih.gov/pubmed/11692032",
                "http://www.ncbi.nlm.nih.gov/pubmed/20029781",
                "http://www.ncbi.nlm.nih.gov/pubmed/9973515",
                "http://www.ncbi.nlm.nih.gov/pubmed/10096530",
                "http://www.ncbi.nlm.nih.gov/pubmed/12777909"
            ],
            "id": "58ec6eb5eda5a5767200000c",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12365824",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "Anti-leukocyte antibodies: LeukArrest (Hu23F2G) and Enlimomab (R6.5) in acute stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19849665",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1772,
                    "offsetInEndSection": 1933,
                    "text": "Treatment with a murine anti-ICAM-1 antibody (enlimomab) has been investigated in patients with acute ischemic stroke in the Enlimomab Acute Stroke Trial (EAST)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9693236",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 165,
                    "text": "Safety, pharmacokinetics and biological activity of enlimomab (anti-ICAM-1 antibody): an open-label, dose escalation study in patients hospitalized for acute stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1440,
                    "offsetInEndSection": 1635,
                    "text": "CONCLUSIONS\nThe authors conclude that anti-ICAM therapy with enlimomab is not an effective treatment for ischemic stroke in the model studied and, indeed, may significantly worsen stroke outcome."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 91,
                    "text": "Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 134,
                    "offsetInEndSection": 282,
                    "text": "Enlimomab, a murine intercellular adhesion molecule-1 (ICAM-1) antibody, reduces leukocyte adhesion and infarct size in experimental stroke studies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9693236",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1284,
                    "offsetInEndSection": 1504,
                    "text": "CONCLUSIONS\nDoses of enlimomab between 140 and 480 mg administered over 5 days did not increase the risk of adverse events in patients with ischaemic or haemorrhagic stroke during an observation period of 30 +/- 10 days."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9693236",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 156,
                    "text": "BACKGROUND AND PURPOSE\nTo obtain information on the safety, pharmacokinetics and biological activity of enlimomab (anti-ICAM-1 antibody) in stroke patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 387,
                    "offsetInEndSection": 546,
                    "text": "METHODS\nA total of 625 patients with ischemic stroke were randomized to receive either enlimomab (n = 317) or placebo (n = 308) within 6 hours of stroke onset."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9693236",
                    "endSection": "abstract",
                    "offsetInBeginSection": 329,
                    "offsetInEndSection": 498,
                    "text": "A loading dose of enlimomab administered within 24 h of the onset of stroke symptoms was followed by four daily maintenance doses; total doses ranged from 140 to 480 mg."
                }
            ]
        },
        {
            "body": "Are AAV vectors considered for the treatment of retinal dystrophies?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21818300",
                "http://www.ncbi.nlm.nih.gov/pubmed/18414684",
                "http://www.ncbi.nlm.nih.gov/pubmed/27229628",
                "http://www.ncbi.nlm.nih.gov/pubmed/15960597",
                "http://www.ncbi.nlm.nih.gov/pubmed/27416076",
                "http://www.ncbi.nlm.nih.gov/pubmed/24572793",
                "http://www.ncbi.nlm.nih.gov/pubmed/23593201",
                "http://www.ncbi.nlm.nih.gov/pubmed/23150381",
                "http://www.ncbi.nlm.nih.gov/pubmed/22845794",
                "http://www.ncbi.nlm.nih.gov/pubmed/23560080"
            ],
            "id": "5a74acd80384be9551000006",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21818300",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 163,
                    "text": "BACKGROUND\nGene transfer using adeno-associated viral (AAV) vectors has been successfully applied in the retina for the treatment of inherited retinal dystrophies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18414684",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 130,
                    "text": "Vectors derived from adeno-associated virus (AAV) are promising for human gene therapy, including treatment for retinal blindness."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27229628",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 178,
                    "text": "Recombinant adeno-associated virus (AAV) has emerged as a promising vector for retinal gene delivery to restore visual function in certain forms of inherited retinal dystrophies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15960597",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 202,
                    "text": "Recombinant adeno-associated viral (AAV) vectors have become powerful gene delivery tools for the treatment of retinal degeneration in a variety of animal models that mimic corresponding human diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27416076",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 148,
                    "text": "Gene therapy using adeno-associated viral (AAV) vectors for the treatment of retinal degenerations has shown safety and efficacy in clinical trials."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24572793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 283,
                    "text": "Gene therapy with adeno-associated viral (AAV) vectors is limited by AAV cargo capacity that prevents their application to the inherited retinal diseases (IRDs), such as Stargardt disease (STGD) or Usher syndrome type IB (USH1B), which are due to mutations in genes larger than 5\u2009kb."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15960597",
                    "endSection": "abstract",
                    "offsetInBeginSection": 442,
                    "offsetInEndSection": 682,
                    "text": "In the sheltered environment of the retina, AAV vectors are able to maintain high levels of transgene expression in the retinal pigmented epithelium (RPE), photoreceptors, or ganglion cells for long periods of time after a single treatment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23593201",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 125,
                    "text": "Adeno-associated viral vectors (AAV) have been shown to be safe in the treatment of retinal degenerations in clinical trials."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23150381",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 126,
                    "text": "Adeno-associated virus (AAV) vectors are in wide use for in vivo gene transfer for the treatment of inherited retinal disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15960597",
                    "endSection": "abstract",
                    "offsetInBeginSection": 203,
                    "offsetInEndSection": 441,
                    "text": "AAV vectors possess a number of features that render them ideally suited for retinal gene therapy, including a lack of pathogenicity, minimal immunogenicity, and the ability to transduce postmitotic cells in a stable and efficient manner."
                }
            ]
        },
        {
            "body": "Does International Citicoline Trial on acUte Stroke trial supports efficacy of citicoline for stroke treatment?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/12865605",
                "http://www.ncbi.nlm.nih.gov/pubmed/26658924",
                "http://www.ncbi.nlm.nih.gov/pubmed/10582983",
                "http://www.ncbi.nlm.nih.gov/pubmed/22677765",
                "http://www.ncbi.nlm.nih.gov/pubmed/22691567",
                "http://www.ncbi.nlm.nih.gov/pubmed/15686962",
                "http://www.ncbi.nlm.nih.gov/pubmed/21164116",
                "http://www.ncbi.nlm.nih.gov/pubmed/16603447",
                "http://www.ncbi.nlm.nih.gov/pubmed/14702207",
                "http://www.ncbi.nlm.nih.gov/pubmed/27186142"
            ],
            "id": "58ec709aeda5a5767200000e",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12865605",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 164,
                    "text": "BACKGROUND\nCytidine diphosphate choline (citicoline) has been previously shown to have efficacy in reducing the functional impairments associated with acute stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26658924",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 148,
                    "text": "OBJECTIVE\nCiticoline is an endogenous nucleotide that has historically been used to treat stroke, traumatic brain injury, and cognitive dysfunction."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10582983",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 81,
                    "text": "A randomized efficacy trial of citicoline in patients with acute ischemic stroke."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22677765",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 87,
                    "text": "[Neuroprotective treatment with citicoline (ceraxon) in patients with ischemic stroke]."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22691567",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 137,
                    "text": "Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15686962",
                    "endSection": "abstract",
                    "offsetInBeginSection": 232,
                    "offsetInEndSection": 339,
                    "text": "Citicoline is the only neuroprotectant that has proved efficacy in patients with moderate to severe stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21164116",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 131,
                    "text": "Citicoline is a neuroprotectant and neurorestorative drug that is used in the treatment of acute ischemic stroke in some countries."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16603447",
                    "endSection": "abstract",
                    "offsetInBeginSection": 382,
                    "offsetInEndSection": 524,
                    "text": "Citicoline is a neuroprotective agent used clinically to treat for instance Parkinson disease, stroke, Alzheimer's disease and brain ischemia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22691567",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1908,
                    "offsetInEndSection": 2059,
                    "text": "INTERPRETATION\nUnder the circumstances of the ICTUS trial, citicoline is not efficacious in the treatment of moderate-to-severe acute ischaemic stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10582983",
                    "endSection": "abstract",
                    "offsetInBeginSection": 196,
                    "offsetInEndSection": 358,
                    "text": "A previous dose-comparison trial in patients with acute stroke found that 500 mg of citicoline appeared to improve neurological outcome with minimal side effects."
                }
            ]
        },
        {
            "body": "Is human lysyl oxidase-like 2 a glycoprotein?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/18929111",
                "http://www.ncbi.nlm.nih.gov/pubmed/19627254",
                "http://www.ncbi.nlm.nih.gov/pubmed/21954900",
                "http://www.ncbi.nlm.nih.gov/pubmed/23319596",
                "http://www.ncbi.nlm.nih.gov/pubmed/27063404",
                "http://www.ncbi.nlm.nih.gov/pubmed/20306300",
                "http://www.ncbi.nlm.nih.gov/pubmed/26612622",
                "http://www.ncbi.nlm.nih.gov/pubmed/25146937",
                "http://www.ncbi.nlm.nih.gov/pubmed/17018530",
                "http://www.ncbi.nlm.nih.gov/pubmed/14551188"
            ],
            "id": "5ad240f70340b9f058000015",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18929111",
                    "endSection": "abstract",
                    "offsetInBeginSection": 742,
                    "offsetInEndSection": 1309,
                    "text": "The characteristic fibrils, composed of microfibrillar subunits surrounded by an amorphous matrix comprising various glycoconjugates, contain predominantly epitopes of elastic fibers, such as elastin, tropoelastin, amyloid P, vitronectin, and components of elastic microfibrils, such as fibrillin-1, fibulin-2, vitronectin, microfibril-associated glycoprotein (MAGP-1), and latent TGF-beta binding proteins (LTBP-1 and LTBP-2), the proteoglycans syndecan and versican, the extracellular chaperone clusterin, the cross-linking enzyme lysyl oxidase, and other proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18929111",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1310,
                    "offsetInEndSection": 1523,
                    "text": "A recent milestone study showed that two common single nucleotide polymorphisms in the coding region of the lysyl oxidase-like 1 (LOXL1) gene located on chromosome 15 were specifically associated with XFS and XFG."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18929111",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1524,
                    "offsetInEndSection": 1736,
                    "text": "LOXL1 is a member of the lysyl oxidase family of enzymes, which are essential for the formation, stabilization, maintenance, and remodeling of elastic fibers and prevent age-related loss of elasticity of tissues."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18929111",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1737,
                    "offsetInEndSection": 1932,
                    "text": "LOXL1 protein is a major component of exfoliation deposits and appears to play a role in its accumulation and in concomitant elastotic processes in intra- and extraocular tissues of XFS patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19627254",
                    "endSection": "abstract",
                    "offsetInBeginSection": 108,
                    "offsetInEndSection": 220,
                    "text": "Fibulin-4 is an elastic-fibre-associated glycoprotein that is indispensable for elastic-fibre formation in mice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18929111",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 292,
                    "text": "Exfoliation syndrome (XFS) is an age-related, generalized disorder of the extracellular matrix characterized by the production and progressive accumulation of a fibrillar extracellular material in many ocular tissues and is the most common identifiable cause of open-angle glaucoma worldwide."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18929111",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1933,
                    "offsetInEndSection": 2038,
                    "text": "This discovery should open the way to new approaches and directions of therapy for this protein disorder."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21954900",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 233,
                    "text": "A general protease digestion procedure for optimal protein sequence coverage and post-translational modifications analysis of recombinant glycoproteins: application to the characterization of human lysyl oxidase-like 2 glycosylation."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23319596",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 119,
                    "text": "Post-translational modifications of recombinant human lysyl oxidase-like 2 (rhLOXL2) secreted from Drosophila S2 cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21954900",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1382,
                    "offsetInEndSection": 1478,
                    "text": "This method was successfully applied to a novel recombinant protein, human lysyl oxidase-like 2."
                }
            ]
        },
        {
            "body": "Can GDF15 be a biomarker for metformin treatment?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                "http://www.ncbi.nlm.nih.gov/pubmed/25541611",
                "http://www.ncbi.nlm.nih.gov/pubmed/28880265",
                "http://www.ncbi.nlm.nih.gov/pubmed/25446397",
                "http://www.ncbi.nlm.nih.gov/pubmed/27510384",
                "http://www.ncbi.nlm.nih.gov/pubmed/23710769",
                "http://www.ncbi.nlm.nih.gov/pubmed/24179558",
                "http://www.ncbi.nlm.nih.gov/pubmed/24669014",
                "http://www.ncbi.nlm.nih.gov/pubmed/26990020",
                "http://www.ncbi.nlm.nih.gov/pubmed/24088749"
            ],
            "id": "5ad3013d0340b9f058000019",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 863,
                    "offsetInEndSection": 1010,
                    "text": "CONCLUSIONS\nGDF15 levels are a biomarker for the use of metformin in people with dysglycemia, and its concentration reflects the dose of metformin."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 68,
                    "text": "Growth Differentiation Factor 15 as a Novel Biomarker for Metformin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 774,
                    "offsetInEndSection": 860,
                    "text": "A 1.64 ng/mL higher GDF15 level predicted a 188-mg higher metformin dose (P < 0.0001)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 447,
                    "offsetInEndSection": 698,
                    "text": "RESULTS\nGrowth differentiation factor 15 (GDF15) was strongly linked to metformin, such that the odds of metformin use per SD increase in level varied from 3.73 (95% CI 3.40, 4.09) to 3.94 (95% CI 3.59, 4.33) depending on the other included variables."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25541611",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 56,
                    "text": "GDF15 Is a Novel Biomarker for Impaired Fasting Glucose."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25541611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1610,
                    "offsetInEndSection": 1683,
                    "text": "GDF15 may be a novel biomarker for detecting IFG in nondiabetic patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 162,
                    "offsetInEndSection": 374,
                    "text": "RESEARCH DESIGN AND METHODS\nA total of 237 biomarkers were assayed in baseline serum from 8,401 participants (2,317 receiving metformin) in the Outcome Reduction with Initial Glargine Intervention (ORIGIN) trial."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 61,
                    "text": "OBJECTIVE\nMetformin is a commonly used glucose-lowering drug."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 375,
                    "offsetInEndSection": 444,
                    "text": "Regression models were used to identify biomarkers for metformin use."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25541611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 126,
                    "text": "BACKGROUND\nGrowth differentiation factor-15 (GDF15) is a protein that belongs to the transforming growth factor \u03b2 superfamily."
                }
            ]
        },
        {
            "body": "Has rituximab been considered as a treatment for chronic fatigues syndrome? (November 2017)",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28094456",
                "http://www.ncbi.nlm.nih.gov/pubmed/22778751",
                "http://www.ncbi.nlm.nih.gov/pubmed/21918268",
                "http://www.ncbi.nlm.nih.gov/pubmed/11226001",
                "http://www.ncbi.nlm.nih.gov/pubmed/30353902",
                "http://www.ncbi.nlm.nih.gov/pubmed/11320903",
                "http://www.ncbi.nlm.nih.gov/pubmed/27793209",
                "http://www.ncbi.nlm.nih.gov/pubmed/28243993",
                "http://www.ncbi.nlm.nih.gov/pubmed/29668480",
                "http://www.ncbi.nlm.nih.gov/pubmed/28782884"
            ],
            "id": "5aa395fcd6d6b54f79000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28094456",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1430,
                    "offsetInEndSection": 1433,
                    "text": "Am."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28094456",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1446,
                    "offsetInEndSection": 1463,
                    "text": "92:209-217, 2017."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28094456",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1464,
                    "offsetInEndSection": 1494,
                    "text": "\u00a9 2016 Wiley Periodicals, Inc."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28094456",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1434,
                    "offsetInEndSection": 1445,
                    "text": "J. Hematol."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28094456",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 93,
                    "text": "Waldenstr\u00f6m macroglobulinemia: 2017 update on diagnosis, risk stratification, and management."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28094456",
                    "endSection": "abstract",
                    "offsetInBeginSection": 963,
                    "offsetInEndSection": 1050,
                    "text": "The preferred Mayo Clinic nonstudy therapeutic induction is rituximab and bendamustine."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28094456",
                    "endSection": "abstract",
                    "offsetInBeginSection": 750,
                    "offsetInEndSection": 907,
                    "text": "Rituximab-based therapy is used in virtually all U.S. patients with WM and can be combined with bendamustine, an alkylating agent, or a proteosome inhibitor."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28094456",
                    "endSection": "abstract",
                    "offsetInBeginSection": 615,
                    "offsetInEndSection": 749,
                    "text": "Risk-Adapted Therapy: Not all patients who fulfill WM criteria require therapy; these patients can be observed until symptoms develop."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28094456",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1327,
                    "offsetInEndSection": 1429,
                    "text": "Given WM's natural history, reduction of complications will be a priority for future treatment trials."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28094456",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1144,
                    "offsetInEndSection": 1326,
                    "text": "Management of Refractory Disease: Bortezomib, fludarabine, thalidomide, everolimus, ibrutinib, carfilzomib, lenalidomide, and bendamustine have all been shown to have activity in WM."
                }
            ]
        },
        {
            "body": "Does oncogene-induced DNA replication stress inhibit genomic instability?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22410776",
                "http://www.ncbi.nlm.nih.gov/pubmed/23204322",
                "http://www.ncbi.nlm.nih.gov/pubmed/27548226",
                "http://www.ncbi.nlm.nih.gov/pubmed/21149733",
                "http://www.ncbi.nlm.nih.gov/pubmed/25959964",
                "http://www.ncbi.nlm.nih.gov/pubmed/20177397",
                "http://www.ncbi.nlm.nih.gov/pubmed/22465609",
                "http://www.ncbi.nlm.nih.gov/pubmed/28166452",
                "http://www.ncbi.nlm.nih.gov/pubmed/26616915",
                "http://www.ncbi.nlm.nih.gov/pubmed/23643534"
            ],
            "id": "5ab9032afcf4565872000018",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22410776",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "Oncogene-induced replication stress is recognized as the primary cause of accumulation of DNA damage and genome instability in precancerous cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23204322",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 90,
                    "text": "Oncogene-induced DNA replication stress is thought to drive genomic instability in cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22410776",
                    "endSection": "abstract",
                    "offsetInBeginSection": 963,
                    "offsetInEndSection": 1218,
                    "text": "Overall, our findings give insights into the mechanisms protecting replication forks in cells experiencing oncogene-induced replication stress, and identify factors that, when mutated or dysfunctional, may enhance genome instability in precancerous cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22410776",
                    "endSection": "abstract",
                    "offsetInBeginSection": 552,
                    "offsetInEndSection": 754,
                    "text": "Loss of WRN affects cell cycle progression and results in enhanced accumulation of double-strand breaks and instability at common fragile sites in cells experiencing oncogene-induced replication stress."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27548226",
                    "endSection": "abstract",
                    "offsetInBeginSection": 602,
                    "offsetInEndSection": 947,
                    "text": "Although replication stress has been proven to induce genomic instability and tumorigenesis, recent studies have counterintuitively shown that enhancing replicative stress through further loosening of the remaining checkpoints in cancer cells to induce their catastrophic failure of proliferation may provide an alternative therapeutic approach."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21149733",
                    "endSection": "abstract",
                    "offsetInBeginSection": 939,
                    "offsetInEndSection": 1111,
                    "text": "We propose that the loss of L3MBTL1 contributes to the development of 20q(-) hematopoietic malignancies by inducing replicative stress, DNA damage, and genomic instability."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25959964",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1641,
                    "offsetInEndSection": 1756,
                    "text": "Our results demonstrate how oncogene-induced replication stress contributes to genomic instability in human cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20177397",
                    "endSection": "abstract",
                    "offsetInBeginSection": 489,
                    "offsetInEndSection": 846,
                    "text": "Instead, the mutation patterns of the tumour suppressor TP53 (which encodes p53), ataxia telangiectasia mutated (ATM) and cyclin-dependent kinase inhibitor 2A (CDKN2A; which encodes p16INK4A and p14ARF) support the oncogene-induced DNA replication stress model, which attributes genomic instability and TP53 and ATM mutations to oncogene-induced DNA damage."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25959964",
                    "endSection": "abstract",
                    "offsetInBeginSection": 806,
                    "offsetInEndSection": 926,
                    "text": "However, it remains unknown how cyclin E-mediated replication stress promotes genomic instability during carcinogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22465609",
                    "endSection": "abstract",
                    "offsetInBeginSection": 118,
                    "offsetInEndSection": 222,
                    "text": "Recently, in vitro studies have found that oncogene-induced replication stress leads to CFS instability."
                }
            ]
        },
        {
            "body": "Is the petrous bone used in ancient DNA sampling?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                "http://www.ncbi.nlm.nih.gov/pubmed/26086078",
                "http://www.ncbi.nlm.nih.gov/pubmed/27557460",
                "http://www.ncbi.nlm.nih.gov/pubmed/28526291",
                "http://www.ncbi.nlm.nih.gov/pubmed/28129388",
                "http://www.ncbi.nlm.nih.gov/pubmed/11025879",
                "http://www.ncbi.nlm.nih.gov/pubmed/12105791",
                "http://www.ncbi.nlm.nih.gov/pubmed/23739561",
                "http://www.ncbi.nlm.nih.gov/pubmed/23524715",
                "http://www.ncbi.nlm.nih.gov/pubmed/18773469"
            ],
            "id": "5abd3707fcf456587200002d",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 108,
                    "text": "A minimally-invasive method for sampling human petrous bones from the cranial base for ancient DNA analysis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                    "endSection": "abstract",
                    "offsetInBeginSection": 731,
                    "offsetInEndSection": 943,
                    "text": "We assessed this method by comparing the aDNA results from one petrous bone processed using our novel method to its pair, which was processed using established protocols for sampling disarticulated petrous bones."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                    "endSection": "abstract",
                    "offsetInBeginSection": 209,
                    "offsetInEndSection": 495,
                    "text": "The osseous labyrinth inside the petrous bone has been shown to yield higher amounts of endogenous DNA than any other skeletal element; however, accessing this labyrinth in cases of a complete or reconstructed skull involves causing major structural damage to the cranial vault or base."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26086078",
                    "endSection": "abstract",
                    "offsetInBeginSection": 517,
                    "offsetInEndSection": 890,
                    "text": "In this study we investigate whether (a) different parts of the petrous bone of archaeological human specimens give different percentages of endogenous DNA yields, (b) there are significant differences in average DNA read lengths, damage patterns and total DNA concentration, and (c) it is possible to obtain endogenous ancient DNA from petrous bones from hot environments."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                    "endSection": "abstract",
                    "offsetInBeginSection": 944,
                    "offsetInEndSection": 1160,
                    "text": "We show a decrease in endogenous DNA and molecular copy numbers when the drilling method is used; however, we also show that this method produces more endogenous DNA and higher copy numbers than any postcranial bone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26086078",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1092,
                    "offsetInEndSection": 1359,
                    "text": "We obtained shotgun DNA sequences from three distinct areas within the petrous: a spongy part of trabecular bone (part A), the dense part of cortical bone encircling the osseous inner ear, or otic capsule (part B), and the dense part within the otic capsule (part C)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26086078",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 77,
                    "text": "Optimal Ancient DNA Yields from the Inner Ear Part of the Human Petrous Bone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26086078",
                    "endSection": "abstract",
                    "offsetInBeginSection": 341,
                    "offsetInEndSection": 516,
                    "text": "The only skeletal element for which a systematically higher endogenous DNA content compared to other skeletal elements has been shown is the petrous part of the temporal bone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26086078",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1360,
                    "offsetInEndSection": 1714,
                    "text": "Our results confirm that dense bone parts of the petrous bone can provide high endogenous aDNA yields and indicate that endogenous DNA fractions for part C can exceed those obtained for part B by up to 65-fold and those from part A by up to 177-fold, while total endogenous DNA concentrations are up to 126-fold and 109-fold higher for these comparisons."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 208,
                    "text": "Ancient DNA (aDNA) research involves invasive and destructive sampling procedures that are often incompatible with anthropological, anatomical, and bioarcheological analyses requiring intact skeletal remains."
                }
            ]
        },
        {
            "body": "Is recursive splicing more common in short introns?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25970244",
                "http://www.ncbi.nlm.nih.gov/pubmed/25970246",
                "http://www.ncbi.nlm.nih.gov/pubmed/19924226",
                "http://www.ncbi.nlm.nih.gov/pubmed/15802507",
                "http://www.ncbi.nlm.nih.gov/pubmed/27965595",
                "http://www.ncbi.nlm.nih.gov/pubmed/16260721",
                "http://www.ncbi.nlm.nih.gov/pubmed/27490541",
                "http://www.ncbi.nlm.nih.gov/pubmed/12034457",
                "http://www.ncbi.nlm.nih.gov/pubmed/21974994",
                "http://www.ncbi.nlm.nih.gov/pubmed/21445000"
            ],
            "id": "5abc974bfcf456587200001f",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970244",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 160,
                    "text": "Recursive splicing is a process in which large introns are removed in multiple steps by re-splicing at ratchet points--5' splice sites recreated after splicing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970246",
                    "endSection": "abstract",
                    "offsetInBeginSection": 113,
                    "offsetInEndSection": 310,
                    "text": "However, some long Drosophila melanogaster introns contain a cryptic site, known as a recursive splice site (RS-site), that enables a multi-step process of intron removal termed recursive splicing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970244",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1038,
                    "offsetInEndSection": 1226,
                    "text": "Together, these results indicate that recursive splicing is commonly used in Drosophila, occurs in humans, and provides insight into the mechanisms by which some large introns are removed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19924226",
                    "endSection": "abstract",
                    "offsetInBeginSection": 320,
                    "offsetInEndSection": 579,
                    "text": "In invertebrates, especially Drosophila, it has been shown that larger introns can be spliced efficiently through a process known as recursive splicing-a consecutive splicing from the 5'-end at a series of combined donor-acceptor splice sites called RP-sites."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507",
                    "endSection": "abstract",
                    "offsetInBeginSection": 167,
                    "offsetInEndSection": 364,
                    "text": "We present bioinformatic, phylogenetic, and experimental evidence in Drosophila for a mechanism that subdivides many large introns by recursive splicing at nonexonic elements and alternative exons."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970244",
                    "endSection": "abstract",
                    "offsetInBeginSection": 562,
                    "offsetInEndSection": 709,
                    "text": "The sequential nature of recursive splicing was confirmed by identification of lariat introns generated by splicing to and from the ratchet points."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 87,
                    "text": "Subdivision of large introns in Drosophila by recursive splicing at nonexonic elements."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507",
                    "endSection": "abstract",
                    "offsetInBeginSection": 971,
                    "offsetInEndSection": 1253,
                    "text": "Experimental analyses of in vivo processing intermediates and lariat products from four large introns in the unrelated genes kuzbanian, outspread, and Ultrabithorax confirmed that these introns are removed by a series of recursive splicing steps using the predicted nonexonic sites."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970244",
                    "endSection": "abstract",
                    "offsetInBeginSection": 710,
                    "offsetInEndSection": 922,
                    "text": "We also show that recursive splicing is a constitutive process, that depletion of U2AF inhibits recursive splicing, and that the sequence and function of ratchet points are evolutionarily conserved in Drosophila."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27965595",
                    "endSection": "abstract",
                    "offsetInBeginSection": 844,
                    "offsetInEndSection": 1029,
                    "text": "This process, called \"recursive splicing,\" often involves non-canonical splicing elements positioned deep within introns, and different mechanisms for its deployment have been proposed."
                }
            ]
        },
        {
            "body": "Is Lysyl oxidase crosslinking collagen?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/9401",
                "http://www.ncbi.nlm.nih.gov/pubmed/25146937",
                "http://www.ncbi.nlm.nih.gov/pubmed/26918",
                "http://www.ncbi.nlm.nih.gov/pubmed/22528876",
                "http://www.ncbi.nlm.nih.gov/pubmed/28864775",
                "http://www.ncbi.nlm.nih.gov/pubmed/9524359",
                "http://www.ncbi.nlm.nih.gov/pubmed/7546771",
                "http://www.ncbi.nlm.nih.gov/pubmed/4531019",
                "http://www.ncbi.nlm.nih.gov/pubmed/23494965",
                "http://www.ncbi.nlm.nih.gov/pubmed/9402968"
            ],
            "id": "5ac07b67dd95b2cd42000001",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9401",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 23,
                    "text": "Collagen cross-linking."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9401",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 132,
                    "text": "Lysyl oxidase is a specific amine oxidase that catalyzes the formation of aldehyde cross-link intermediates in collagen and elastin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25146937",
                    "endSection": "abstract",
                    "offsetInBeginSection": 154,
                    "offsetInEndSection": 285,
                    "text": "LOXL2 is proposed to function similarly to LOX in the extracellular matrix (ECM) by promoting crosslinking of collagen and elastin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26918",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 65,
                    "text": "Lysyl oxidase catalyzes the crosslinking of collagen and elastin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22528876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 317,
                    "text": "Lysyl oxidase (LOX) family oxidases, LOX and LOXL1-4, oxidize lysine residues in collagens and elastin, resulting in the covalent crosslinking and stabilization of these extracellular matrix (ECM) structural components, thus provide collagen and elastic fibers much of their tensile strength and structural integrity."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28864775",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 137,
                    "text": "Proteolytic processing of lysyl oxidase-like-2 in the extracellular matrix is required for crosslinking of basement membrane collagen IV."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9524359",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 202,
                    "text": "Lysyl oxidase (LO) is a copper-dependent amine oxidase that plays a critical role in the biogenesis of connective tissue matrices by crosslinking the extracellular matrix proteins, collagen and elastin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7546771",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 138,
                    "text": "Lysyl oxidase, a copper-dependent metalloenzyme, plays a central role in crosslinking of collagen and elastin in the extracellular matrix."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9401",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1055,
                    "offsetInEndSection": 1250,
                    "text": "Formation of aldehyde intermediates and cross-links during fibril formation may facilitate the biosynthesis of stable collagen fibrils and contribute to increased fibril tensile strength in vivo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28864775",
                    "endSection": "abstract",
                    "offsetInBeginSection": 974,
                    "offsetInEndSection": 1128,
                    "text": "Together, our data demonstrate that proteolytic processing is an important event that allows LOXL2-mediated crosslinking of basement membrane collagen IV."
                }
            ]
        },
        {
            "body": "Is sternotomy closure done using either a sternal ZipFix\u2122 implant  or conventional steel wire following cardiac surgery?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24771728",
                "http://www.ncbi.nlm.nih.gov/pubmed/20732527",
                "http://www.ncbi.nlm.nih.gov/pubmed/26290838",
                "http://www.ncbi.nlm.nih.gov/pubmed/15658909",
                "http://www.ncbi.nlm.nih.gov/pubmed/15215921",
                "http://www.ncbi.nlm.nih.gov/pubmed/27923485",
                "http://www.ncbi.nlm.nih.gov/pubmed/14726063",
                "http://www.ncbi.nlm.nih.gov/pubmed/28846532",
                "http://www.ncbi.nlm.nih.gov/pubmed/26052962",
                "http://www.ncbi.nlm.nih.gov/pubmed/19592548"
            ],
            "id": "5ab2cdc5fcf4565872000016",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24771728",
                    "endSection": "abstract",
                    "offsetInBeginSection": 83,
                    "offsetInEndSection": 174,
                    "text": "The sternotomy incision is predominantly closed with either steel wire or polyester suture."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20732527",
                    "endSection": "abstract",
                    "offsetInBeginSection": 537,
                    "offsetInEndSection": 686,
                    "text": "METHODS\nIn part A, fresh human cadaver blocks were subjected to midline sternotomy and either conventional wire closure or modified adhesive closure."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26290838",
                    "endSection": "abstract",
                    "offsetInBeginSection": 454,
                    "offsetInEndSection": 692,
                    "text": "METHODS\nData were collected retrospectively on 1,354 patients who underwent sternal closure after major cardiac surgery, using either the multifilament cable wiring system or conventional steel wires between January 2009 and October 2010."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24771728",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 73,
                    "text": "Is steel wire closure of sternotomy better than polyester suture closure?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15658909",
                    "endSection": "abstract",
                    "offsetInBeginSection": 152,
                    "offsetInEndSection": 332,
                    "text": "METHODS\nSixty-four patients scheduled for cardiac surgery were prospectively randomized to undergo sternal closure using either Mersilene tape (n=30) or standard metal wire (n=34)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26290838",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 115,
                    "text": "Multifilament Cable Wire versus Conventional Wire for Sternal Closure in Patients Undergoing Major Cardiac Surgery."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15215921",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 139,
                    "text": "Sternal closure after median sternotomy in the pediatric age group may be accomplished with non-resorbable sutures or stainless steel wire."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27923485",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 132,
                    "text": "OBJECTIVE\nTo evaluate sternal healing, complications, and costs after sternotomy closure with rigid plate fixation or wire cerclage."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15658909",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1121,
                    "offsetInEndSection": 1341,
                    "text": "CONCLUSION\nThis prospective randomized study showed Mersilene tape sternal closure not to be more closely associated with increased complications or patient discomfort due to sternal wound than the standard wire closure."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26290838",
                    "endSection": "abstract",
                    "offsetInBeginSection": 308,
                    "offsetInEndSection": 451,
                    "text": "We aimed to compare conventional steel wiring to multifilament cable fixation for sternal closure in patients undergoing major cardiac surgery."
                }
            ]
        },
        {
            "body": "Is transcription of eRNA bidirectional?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26166704",
                "http://www.ncbi.nlm.nih.gov/pubmed/25588787",
                "http://www.ncbi.nlm.nih.gov/pubmed/23993744",
                "http://www.ncbi.nlm.nih.gov/pubmed/25564661",
                "http://www.ncbi.nlm.nih.gov/pubmed/23728303",
                "http://www.ncbi.nlm.nih.gov/pubmed/24038352",
                "http://www.ncbi.nlm.nih.gov/pubmed/24953189",
                "http://www.ncbi.nlm.nih.gov/pubmed/28225006",
                "http://www.ncbi.nlm.nih.gov/pubmed/21572438",
                "http://www.ncbi.nlm.nih.gov/pubmed/27932455"
            ],
            "id": "5ac24f7595d0062724000003",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26166704",
                    "endSection": "abstract",
                    "offsetInBeginSection": 651,
                    "offsetInEndSection": 1000,
                    "text": "Condensins positively regulate ligand-dependent enhancer activation at least in part by recruiting an E3 ubiquitin ligase, HECTD1, to modulate the binding of enhancer-associated coactivators/corepressors, including p300 and RIP140, permitting full eRNA transcription, formation of enhancer:promoter looping, and the resultant coding gene activation."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25588787",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 110,
                    "text": "Chromatin looping and eRNA transcription precede the transcriptional activation of gene in the \u03b2-globin locus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25588787",
                    "endSection": "abstract",
                    "offsetInBeginSection": 758,
                    "offsetInEndSection": 871,
                    "text": "These results show that chromatin looping and eRNA transcription precedes the transcriptional activation of gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23993744",
                    "endSection": "abstract",
                    "offsetInBeginSection": 115,
                    "offsetInEndSection": 322,
                    "text": "Here, by using genome-wide binding profiling, we show extensive occupancy of transcription factors of myogenesis (MyoD and Myogenin) at extragenic enhancer regions coinciding with RNA synthesis (i.e., eRNA)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25588787",
                    "endSection": "abstract",
                    "offsetInBeginSection": 191,
                    "offsetInEndSection": 519,
                    "text": "To explore the kinetics of enhancer-promoter looping and eRNA transcription during transcriptional activation, we induced the \u03b2-globin locus by chemical treatment and analysed cross-linking frequency between the \u03b2-globin gene and locus control region (LCR) and the amount of eRNAs transcribed on the LCR in a time course manner."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25564661",
                    "endSection": "abstract",
                    "offsetInBeginSection": 747,
                    "offsetInEndSection": 903,
                    "text": "Unexpectedly, genes repressed by TLR4 signaling are also associated with super enhancer domains and accompanied by massive repression of eRNA transcription."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23728303",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1385,
                    "offsetInEndSection": 1586,
                    "text": "These studies provide evidence for a direct role of eRNAs in contributing to enhancer functions and suggest that Rev-Erbs act to suppress gene expression at a distance by repressing eRNA transcription."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24038352",
                    "endSection": "abstract",
                    "offsetInBeginSection": 666,
                    "offsetInEndSection": 752,
                    "text": "However, it remains challenging to link chromatin modifications to eRNA transcription."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24953189",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 129,
                    "text": "A TEAD1/p65 complex regulates the eutherian-conserved MnSOD intronic enhancer, eRNA transcription and the innate immune response."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28225006",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1199,
                    "offsetInEndSection": 1414,
                    "text": "Thus, our data support the view that eRNA dysregulation in HD striatum is a key mechanism leading to altered transcription of striatal neuron identity genes, through reduced recruitment of RNAPII at super-enhancers."
                }
            ]
        },
        {
            "body": "Is the protein pelota a ribosomal rescue factor?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22358840",
                "http://www.ncbi.nlm.nih.gov/pubmed/28213379",
                "http://www.ncbi.nlm.nih.gov/pubmed/27493551",
                "http://www.ncbi.nlm.nih.gov/pubmed/23031510",
                "http://www.ncbi.nlm.nih.gov/pubmed/28115162",
                "http://www.ncbi.nlm.nih.gov/pubmed/20876129",
                "http://www.ncbi.nlm.nih.gov/pubmed/25132172",
                "http://www.ncbi.nlm.nih.gov/pubmed/17889667",
                "http://www.ncbi.nlm.nih.gov/pubmed/8900058",
                "http://www.ncbi.nlm.nih.gov/pubmed/9584085"
            ],
            "id": "5ad35933133db5eb78000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22358840",
                    "endSection": "abstract",
                    "offsetInBeginSection": 430,
                    "offsetInEndSection": 604,
                    "text": "Here we present cryo-electron microscopy reconstructions of eukaryotic and archaeal ribosome recycling complexes containing ABCE1 and the termination factor paralogue Pelota."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28213379",
                    "endSection": "abstract",
                    "offsetInBeginSection": 813,
                    "offsetInEndSection": 952,
                    "text": "Our data suggest that the decay of platelet mRNAs is slowed by the natural loss of the mRNA surveillance and ribosome rescue factor Pelota."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551",
                    "endSection": "abstract",
                    "offsetInBeginSection": 271,
                    "offsetInEndSection": 398,
                    "text": "In eukaryotes, Pelota (Dom34 in yeast) and Hbs1 are responsible for solving general problems of ribosomal stall in translation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22358840",
                    "endSection": "abstract",
                    "offsetInBeginSection": 711,
                    "offsetInEndSection": 969,
                    "text": "Moreover, the iron-sulphur cluster domain of ABCE1 interacts with and stabilizes Pelota in a conformation that reaches towards the peptidyl transferase centre, thus explaining how ABCE1 may stimulate peptide-release activity of canonical termination factors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551",
                    "endSection": "abstract",
                    "offsetInBeginSection": 399,
                    "offsetInEndSection": 521,
                    "text": "In archaea, aPelota and aEF1\u03b1, homologous to Pelota and Hbs1, respectively, are considered to be involved in that process."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23031510",
                    "endSection": "abstract",
                    "offsetInBeginSection": 744,
                    "offsetInEndSection": 821,
                    "text": "In concert with eRF1 or Pelota, ABCE1 dissociates the ribosome into subunits."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28115162",
                    "endSection": "abstract",
                    "offsetInBeginSection": 506,
                    "offsetInEndSection": 830,
                    "text": "In this work, we addressed the question of whether 5'-nonstop-mRNA fragments generated by siRNA cleavage or nonsense-mediated-mRNA decay (NMD) are degraded by the NSD pathway in Drosophila melanogaster cells by knocking down three NSD components, Pelota (a yeast Dom34 homolog), Hbs1 and ABCE1 (a ribosome-recycling factor)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876129",
                    "endSection": "abstract",
                    "offsetInBeginSection": 335,
                    "offsetInEndSection": 539,
                    "text": "Recently, we found that archaeal Pelota (aPelota) associates with archaeal elongation factor 1\u03b1 (aEF1\u03b1) to act in the mRNA surveillance pathway, which accounts for the lack of an Hbs1 ortholog in archaea."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876129",
                    "endSection": "abstract",
                    "offsetInBeginSection": 183,
                    "offsetInEndSection": 334,
                    "text": "In eukaryotes, the protein complex of Pelota (yeast Dom34) and Hbs1 translational GTPase recognizes the stalled ribosome containing the defective mRNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25132172",
                    "endSection": "abstract",
                    "offsetInBeginSection": 411,
                    "offsetInEndSection": 549,
                    "text": "We find that the primary role of the ribosome splitting factors Hbs1, Pelota, and ABCE1 is to permit Listerin access to the nascent chain."
                }
            ]
        },
        {
            "body": "Is CXCL7 a chemokine?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/29038657",
                "http://www.ncbi.nlm.nih.gov/pubmed/28368308",
                "http://www.ncbi.nlm.nih.gov/pubmed/24678812",
                "http://www.ncbi.nlm.nih.gov/pubmed/12193731",
                "http://www.ncbi.nlm.nih.gov/pubmed/22253825",
                "http://www.ncbi.nlm.nih.gov/pubmed/15899984",
                "http://www.ncbi.nlm.nih.gov/pubmed/20022386",
                "http://www.ncbi.nlm.nih.gov/pubmed/15235069",
                "http://www.ncbi.nlm.nih.gov/pubmed/21084802",
                "http://www.ncbi.nlm.nih.gov/pubmed/28245630"
            ],
            "id": "5a9db99ffd02ddc336000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29038657",
                    "endSection": "abstract",
                    "offsetInBeginSection": 148,
                    "offsetInEndSection": 313,
                    "text": "CXCL7 exerts its function by activating the CXC chemokine receptor 2 (CXCR2) receptor and binding sulfated glycosaminoglycans (GAGs) that regulate receptor activity."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28368308",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 111,
                    "text": "Chemokine CXCL7 Heterodimers: Structural Insights, CXCR2 Receptor Function, and Glycosaminoglycan Interactions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29038657",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 147,
                    "text": "Platelet-derived chemokine CXCL7 (also known as NAP-2) plays a crucial role in orchestrating neutrophil recruitment in response to vascular injury."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29038657",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 145,
                    "text": "Platelet-Derived Chemokine CXCL7 Dimer Preferentially Exists in the Glycosaminoglycan-Bound Form: Implications for Neutrophil-Platelet Crosstalk."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24678812",
                    "endSection": "abstract",
                    "offsetInBeginSection": 256,
                    "offsetInEndSection": 380,
                    "text": "CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, and CXCL7 are also ELR+ chemokine members that bind to these receptors, especially CXCR2."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12193731",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 202,
                    "text": "Platelet-derived chemokines CXC chemokine ligand (CXCL)7, connective tissue-activating peptide III, and CXCL4 differentially affect and cross-regulate neutrophil adhesion and transendothelial migration."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28368308",
                    "endSection": "abstract",
                    "offsetInBeginSection": 461,
                    "offsetInEndSection": 802,
                    "text": "Solution nuclear magnetic resonance (NMR) and molecular dynamics characterization of platelet-derived chemokine CXCL7 heterodimerization with chemokines CXCL1, CXCL4, and CXCL8 indicated that packing interactions promote CXCL7-CXCL1 and CXCL7-CXCL4 heterodimers, and electrostatic repulsive interactions disfavor the CXCL7-CXCL8 heterodimer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12193731",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 382,
                    "text": "In this study, we have examined the major platelet-derived CXC chemokines connective tissue-activating peptide III (CTAP-III), its truncation product neutrophil-activating peptide 2 (CXC chemokine ligand 7 (CXCL7)), as well as the structurally related platelet factor 4 (CXCL4) for their impact on neutrophil adhesion to and transmigration through unstimulated vascular endothelium."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22253825",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1191,
                    "offsetInEndSection": 1357,
                    "text": "BM-infiltrating NB cells expressed indeed the proteins encoded by the top-ranked genes, S100A8 and A9 (calprotectin), CD177 and CD3, and secreted the CXCL7 chemokine."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15899984",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 440,
                    "text": "Platelet-derived chemokines, such as regulated on activation, normal T expressed and secreted (RANTES; CC chemokine ligand 5), platelet factor 4 [PF4; CXC chemokine ligand 4 (CXCL4)], and epithelial neutrophil-activating protein 78 (ENA-78; CXCL5), or precursors, such as beta-thromboglobulin, which can be processed to neutrophil-activating protein-2 (NAP-2; CXCL7), may play an important role in monocyte recruitment during atherogenesis."
                }
            ]
        },
        {
            "body": "The TRPM2 gene is associated with development of spontaneous thromboembolism?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16352308",
                "http://www.ncbi.nlm.nih.gov/pubmed/17550854",
                "http://www.ncbi.nlm.nih.gov/pubmed/18503142",
                "http://www.ncbi.nlm.nih.gov/pubmed/17376551",
                "http://www.ncbi.nlm.nih.gov/pubmed/8800739",
                "http://www.ncbi.nlm.nih.gov/pubmed/11380448",
                "http://www.ncbi.nlm.nih.gov/pubmed/8273075",
                "http://www.ncbi.nlm.nih.gov/pubmed/24584019",
                "http://www.ncbi.nlm.nih.gov/pubmed/23325252",
                "http://www.ncbi.nlm.nih.gov/pubmed/26558786"
            ],
            "id": "5ab144fefcf4565872000012",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16352308",
                    "endSection": "abstract",
                    "offsetInBeginSection": 234,
                    "offsetInEndSection": 370,
                    "text": "We investigated, whether homozygosity for CRP +1444C>T is associated with an increased risk of spontaneous venous thromboembolism (VTE)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17550854",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1788,
                    "offsetInEndSection": 1921,
                    "text": "This finding suggests that spontaneous venous thromboembolism may be a condition associated with an enhanced risk of atherosclerosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17550854",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 166,
                    "text": "BACKGROUND AND OBJECTIVES\nA high incidence of atherosclerotic lesions and cardiovascular events has been reported in patients with spontaneous venous thromboembolism."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18503142",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 156,
                    "text": "Comparison of the plasminogen activator inhibitor-1 4G/5G gene polymorphism in females with venous thromboembolism during pregnancy or spontaneous abortion."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16352308",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 100,
                    "text": "C-reactive protein 3' UTR +1444C>T polymorphism in patients with spontaneous venous thromboembolism."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17550854",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 76,
                    "text": "Endothelial dysfunction in patients with spontaneous venous thromboembolism."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17550854",
                    "endSection": "abstract",
                    "offsetInBeginSection": 275,
                    "offsetInEndSection": 379,
                    "text": "We have evaluated endothelial function in patients with a history of spontaneous venous thromboembolism."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18503142",
                    "endSection": "abstract",
                    "offsetInBeginSection": 266,
                    "offsetInEndSection": 506,
                    "text": "The objective of this study was, to explore the significance of genetic polymorphisms of PAI-1 4G/5G with particular emphasis on 4G alleles in pregnant women suffering from venous thromboembolism or early spontaneous abortion, respectively."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17550854",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1639,
                    "offsetInEndSection": 1787,
                    "text": "INTERPRETATION AND CONCLUSIONS\nPatients with spontaneous venous thromboembolism have endothelial dysfunction, unlike age- and sex- matched controls."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17376551",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 84,
                    "text": "Spontaneous coronary artery dissection and pulmonary thromboembolism: a case report."
                }
            ]
        },
        {
            "body": "Is a mutation of the  ZIKV's membrane protein prM responsible for the microcephaly in new-born infants?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28971967",
                "http://www.ncbi.nlm.nih.gov/pubmed/28932235",
                "http://www.ncbi.nlm.nih.gov/pubmed/28049830",
                "http://www.ncbi.nlm.nih.gov/pubmed/28931684",
                "http://www.ncbi.nlm.nih.gov/pubmed/27366760",
                "http://www.ncbi.nlm.nih.gov/pubmed/28100662",
                "http://www.ncbi.nlm.nih.gov/pubmed/28198446",
                "http://www.ncbi.nlm.nih.gov/pubmed/29297281",
                "http://www.ncbi.nlm.nih.gov/pubmed/27019049",
                "http://www.ncbi.nlm.nih.gov/pubmed/27795432"
            ],
            "id": "5ac0aee419833b0d7b000004",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28971967",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "A single mutation in the prM protein of Zika virus contributes to fetal microcephaly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28971967",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 112,
                    "text": "Zika virus (ZIKV) has evolved into a global health threat because of its unexpected causal link to microcephaly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28971967",
                    "endSection": "abstract",
                    "offsetInBeginSection": 743,
                    "offsetInEndSection": 894,
                    "text": "This functional adaption makes ZIKV more virulent to human NPCs, thus contributing to the increased incidence of microcephaly in recent ZIKV epidemics."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28971967",
                    "endSection": "abstract",
                    "offsetInBeginSection": 245,
                    "offsetInEndSection": 558,
                    "text": "Here we show that a single serine-to-asparagine substitution [Ser139\u2192Asn139 (S139N)] in the viral polyprotein substantially increased ZIKV infectivity in both human and mouse neural progenitor cells (NPCs) and led to more severe microcephaly in the mouse fetus, as well as higher mortality rates in neonatal mice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28932235",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1081,
                    "offsetInEndSection": 1268,
                    "text": "It is now well established that the virus is responsible for the so called congenital Zika syndrome (CZS), whose most dramatic features are microcephaly, arthrogryposis and ocular damage."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28049830",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 74,
                    "text": "The Zika virus (ZIKV) causes microcephaly and the Guillain-Barr\u00e9 syndrome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28931684",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 276,
                    "text": "Zika virus (ZIKV), a mosquito-transmitted flavivirus, responsible for sporadic outbreaks of mild and febrile illness in Africa and Asia, re-emerged in the last decade causing serious human diseases including microcephaly, congenital malformations, and Guillain-Barr\u00e9 syndrome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27366760",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 157,
                    "text": "Zika virus (ZIKV) infection is a new emerging threat around the globe which might be responsible for microcephaly and Guillain-Barre syndrome in the infants."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28100662",
                    "endSection": "abstract",
                    "offsetInBeginSection": 264,
                    "offsetInEndSection": 471,
                    "text": "Here, we investigated whether ZIKV infection alters centrosome number and spindle positioning, because such defects are thought to be at the root of inherited primary autosomal recessive microcephaly (MCPH)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28198446",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 93,
                    "text": "A Mutation Identified in Neonatal Microcephaly Destabilizes Zika Virus NS1 Assembly in Vitro."
                }
            ]
        },
        {
            "body": "What is the aim of the PhenCode database?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22069583",
                "http://www.ncbi.nlm.nih.gov/pubmed/15608195",
                "http://www.ncbi.nlm.nih.gov/pubmed/21247929",
                "http://www.ncbi.nlm.nih.gov/pubmed/24870141",
                "http://www.ncbi.nlm.nih.gov/pubmed/15608196",
                "http://www.ncbi.nlm.nih.gov/pubmed/11752251",
                "http://www.ncbi.nlm.nih.gov/pubmed/9399852",
                "http://www.ncbi.nlm.nih.gov/pubmed/24794510",
                "http://www.ncbi.nlm.nih.gov/pubmed/25486646",
                "http://www.ncbi.nlm.nih.gov/pubmed/27822083"
            ],
            "id": "5ad4f4f5133db5eb7800000a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22069583",
                    "endSection": "abstract",
                    "offsetInBeginSection": 230,
                    "offsetInEndSection": 329,
                    "text": "The aim of this article is to present what type of information users can access from each database."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15608195",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 70,
                    "text": "PDB_TM is a database for transmembrane proteins with known structures."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15608195",
                    "endSection": "abstract",
                    "offsetInBeginSection": 678,
                    "offsetInEndSection": 741,
                    "text": "The PDB_TM database is available at http://www.enzim.hu/PDB_TM."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21247929",
                    "endSection": "abstract",
                    "offsetInBeginSection": 676,
                    "offsetInEndSection": 739,
                    "text": "Database URL: http://www.cerealab.unimore.it/jws/cerealab.jnlp."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24870141",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 227,
                    "text": "In this chapter we aim to provide an overview of DNA variant databases, commonly known as Locus-Specific Databases (LSDBs), or Gene-Disease Specific Databases (GDSDBs), but the term variant database will be used for simplicity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15608196",
                    "endSection": "abstract",
                    "offsetInBeginSection": 448,
                    "offsetInEndSection": 614,
                    "text": "The database structure allows visualization of folding data in a useful and novel way, with a long-term aim of facilitating data mining and bioinformatics approaches."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11752251",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 205,
                    "text": "EXProt is a non-redundant protein database containing a selection of entries from genome annotation projects and public databases, aimed at including only proteins with an experimentally verified function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9399852",
                    "endSection": "abstract",
                    "offsetInBeginSection": 423,
                    "offsetInEndSection": 573,
                    "text": "The GPCRDB is an EU sponsored project aimed at building a generic molecular class specific database capable of dealing with highly heterogeneous data."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21247929",
                    "endSection": "abstract",
                    "offsetInBeginSection": 451,
                    "offsetInEndSection": 675,
                    "text": "The database is divided into three sub-schemas corresponding to the species of interest: wheat, barley and rice; each sub-schema is then divided into two sub-ontologies, regarding genotypic and phenotypic data, respectively."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15608195",
                    "endSection": "abstract",
                    "offsetInBeginSection": 538,
                    "offsetInEndSection": 677,
                    "text": "By using TMDET algorithm, the PDB_TM database can be automatically updated every week, keeping it synchronized with the latest PDB updates."
                }
            ]
        },
        {
            "body": "What is the basis of the Sp3 procedure used in proteomics?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24816567",
                "http://www.ncbi.nlm.nih.gov/pubmed/23150225",
                "http://www.ncbi.nlm.nih.gov/pubmed/25412371",
                "http://www.ncbi.nlm.nih.gov/pubmed/15291549",
                "http://www.ncbi.nlm.nih.gov/pubmed/18479089",
                "http://www.ncbi.nlm.nih.gov/pubmed/16390119",
                "http://www.ncbi.nlm.nih.gov/pubmed/25753366",
                "http://www.ncbi.nlm.nih.gov/pubmed/27672695",
                "http://www.ncbi.nlm.nih.gov/pubmed/26248184",
                "http://www.ncbi.nlm.nih.gov/pubmed/21405051"
            ],
            "id": "5ac28c0c95d006272400000a",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24816567",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "Metal-free oxidative synthesis of quinazolinones via dual amination of sp3 C-H bonds."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24816567",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 99,
                    "text": "A novel metal-free synthesis of quinazolinones via dual amination of sp(3) C-H bonds was developed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23150225",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "Visible-light-mediated direct sp(3) C-H amination of benzocyclic amines via \u03b1-aminoalkyl radicals by using photoredox catalysts is described here."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25412371",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 187,
                    "text": "A copper-catalyzed method for the oxidation of allylic and benzylic sp(3) C-H by aqueous tert-butyl hydroperoxide (T-Hydro) in water using a recyclable fluorous ligand has been developed."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23150225",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 113,
                    "text": "Direct sp3 C-H amination of nitrogen-containing benzoheterocycles mediated by visible-light-photoredox catalysts."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25412371",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 48,
                    "text": "Allylic and benzylic sp3 C-H oxidation in water."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24816567",
                    "endSection": "abstract",
                    "offsetInBeginSection": 100,
                    "offsetInEndSection": 216,
                    "text": "The sp(3) carbon in methylarenes or adjacent to a heteroatom in DMSO, DMF or DMA was used as the one carbon synthon."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15291549",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 111,
                    "text": "This communication describes a new palladium-catalyzed method for the oxygenation of unactivated sp3 C-H bonds."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18479089",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 105,
                    "text": "Pd(II)-catalyzed cross-coupling of sp3 C-H Bonds with sp2 and sp3 boronic acids using air as the oxidant."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16390119",
                    "endSection": "abstract",
                    "offsetInBeginSection": 233,
                    "offsetInEndSection": 323,
                    "text": "This methodology provides a direct way to use allylic sp3 C-H bonds for forming C-C bonds."
                }
            ]
        },
        {
            "body": "What is \"enhancer hijacking\"?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27490482",
                "http://www.ncbi.nlm.nih.gov/pubmed/26065614",
                "http://www.ncbi.nlm.nih.gov/pubmed/25043047",
                "http://www.ncbi.nlm.nih.gov/pubmed/14998483",
                "http://www.ncbi.nlm.nih.gov/pubmed/26334669",
                "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                "http://www.ncbi.nlm.nih.gov/pubmed/15331574",
                "http://www.ncbi.nlm.nih.gov/pubmed/26351658",
                "http://www.ncbi.nlm.nih.gov/pubmed/25414315",
                "http://www.ncbi.nlm.nih.gov/pubmed/26229090"
            ],
            "id": "5abc9157fcf456587200001e",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27490482",
                    "endSection": "abstract",
                    "offsetInBeginSection": 895,
                    "offsetInEndSection": 1003,
                    "text": "EBV therefore drives lymphomagenesis by hijacking long-range enhancer hubs and specific cellular co-factors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26065614",
                    "endSection": "abstract",
                    "offsetInBeginSection": 209,
                    "offsetInEndSection": 526,
                    "text": "The so-called omics revolution, enabled by high-throughput sequencing, has empowered large consortia and independent groups alike to make major genetic discoveries, from dominant-negative histone mutations and hijacking of distal enhancer elements, to new oncogenic gene fusions and aberrantly active gene expression."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25043047",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 70,
                    "text": "Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25043047",
                    "endSection": "abstract",
                    "offsetInBeginSection": 903,
                    "offsetInEndSection": 1131,
                    "text": "Our results, supported by evidence from mouse models, identify GFI1 and GFI1B as prominent medulloblastoma oncogenes and implicate 'enhancer hijacking' as an efficient mechanism driving oncogene activation in a childhood cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14998483",
                    "endSection": "abstract",
                    "offsetInBeginSection": 103,
                    "offsetInEndSection": 285,
                    "text": "It now seems that a short, but important, list of key regulatory proteins are victims of protein hijacking: Bid, Bim, NF-kappaB, SREBP, and perhaps the intracellular portion of MUC1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26334669",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1236,
                    "offsetInEndSection": 1473,
                    "text": "Synergy of FoxO3a activation with SHP-1 hijacking thus enables the toxin to rapidly trigger a persistent accumulation of BimEL, thereby activating the pro-apoptotic programme of macrophages and subverting the innate immunity of the host."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                    "endSection": "abstract",
                    "offsetInBeginSection": 751,
                    "offsetInEndSection": 880,
                    "text": "We additionally pursued cancer-type-specific analyses and uncovered IGF2 as a target for enhancer hijacking in colorectal cancer."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15331574",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 174,
                    "text": "\"Hijacking\" the thyrotropin receptor: A chimeric receptor-lysosome associated membrane protein enhances deoxyribonucleic acid vaccination and induces Graves' hyperthyroidism."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26351658",
                    "endSection": "abstract",
                    "offsetInBeginSection": 178,
                    "offsetInEndSection": 295,
                    "text": "In E-Learning systems the users must be forced to perform reauthentication to overcome the session hijacking problem."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                    "endSection": "abstract",
                    "offsetInBeginSection": 235,
                    "offsetInEndSection": 476,
                    "text": "Here we present a framework for inferring cancer-related gene overexpression resulting from CRE reorganization (e.g., enhancer hijacking) by integrating SCNAs, gene expression data and information on topologically associating domains (TADs)."
                }
            ]
        },
        {
            "body": "What disease is tinea ?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/10948816",
                "http://www.ncbi.nlm.nih.gov/pubmed/14996619",
                "http://www.ncbi.nlm.nih.gov/pubmed/12748593",
                "http://www.ncbi.nlm.nih.gov/pubmed/8821157",
                "http://www.ncbi.nlm.nih.gov/pubmed/21834814",
                "http://www.ncbi.nlm.nih.gov/pubmed/12894115",
                "http://www.ncbi.nlm.nih.gov/pubmed/25396139",
                "http://www.ncbi.nlm.nih.gov/pubmed/3754806",
                "http://www.ncbi.nlm.nih.gov/pubmed/10354029",
                "http://www.ncbi.nlm.nih.gov/pubmed/24134312"
            ],
            "id": "5aa67b4fd6d6b54f7900000f",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10948816",
                    "endSection": "abstract",
                    "offsetInBeginSection": 535,
                    "offsetInEndSection": 687,
                    "text": "Tinea pedis may be a risk factor for streptococcal infections such as erysipelas, mainly in tropical countries, where tinea pedis is a frequent disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14996619",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 64,
                    "text": "Tinea capitis is primarily a disease of pre-adolescent children."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12748593",
                    "endSection": "abstract",
                    "offsetInBeginSection": 544,
                    "offsetInEndSection": 665,
                    "text": "Among superficial mycoses, tinea pedis is viewed as the pivotal disease because it is intractable and is the most common."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8821157",
                    "endSection": "abstract",
                    "offsetInBeginSection": 195,
                    "offsetInEndSection": 262,
                    "text": "Iatrogenic disease (tinea incognito) is a new and more subtle form."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21834814",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1148,
                    "offsetInEndSection": 1308,
                    "text": "CONCLUSIONS\nThe diagnosis of tinea nigra is significantly improved by dermoscopy, the disease should be considered as a cause of palmar or plantar pigmentation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12894115",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "Tinea capitis is generally thought to be a common disease in children but not in adults."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25396139",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "Tinea capitis is generally thought to be a common disease in children but not in adults."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3754806",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 165,
                    "text": "A case of tinea corporis involving the skin overlying the thyroid gland is described in a 36-year-old man who had received radioiodine treatment for Graves' disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10354029",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1187,
                    "offsetInEndSection": 1335,
                    "text": "These data confirm that tinea pedis, a potentially transmissible disease, is common in Australian schoolchildren, including those in primary school."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24134312",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 103,
                    "text": "Tinea capitis is a common disease of childhood that typically follows one of several clinical patterns."
                }
            ]
        },
        {
            "body": "How are deletion breakpoints defined?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/15732063",
                "http://www.ncbi.nlm.nih.gov/pubmed/16293123",
                "http://www.ncbi.nlm.nih.gov/pubmed/12297986",
                "http://www.ncbi.nlm.nih.gov/pubmed/7887422",
                "http://www.ncbi.nlm.nih.gov/pubmed/11001932",
                "http://www.ncbi.nlm.nih.gov/pubmed/9428363",
                "http://www.ncbi.nlm.nih.gov/pubmed/8875237",
                "http://www.ncbi.nlm.nih.gov/pubmed/10090893",
                "http://www.ncbi.nlm.nih.gov/pubmed/7528885",
                "http://www.ncbi.nlm.nih.gov/pubmed/8314578"
            ],
            "id": "5abc9c1efcf4565872000020",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15732063",
                    "endSection": "abstract",
                    "offsetInBeginSection": 293,
                    "offsetInEndSection": 621,
                    "text": "Fluorescence in situ hybridization (FISH) and molecular studies defined the breakpoints at 7q21.11 and 7q21.3 on the paternal chromosome 7, with the proximal deletion breakpoint between the elastin gene (localized at 7q11.23) and D7S2517, and the distal breakpoint between D7S652 and the COL1A2 gene (localized at 7q21.3-q22.1)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16293123",
                    "endSection": "abstract",
                    "offsetInBeginSection": 837,
                    "offsetInEndSection": 965,
                    "text": "The two breakpoints share sequence homology suggesting that homologous recombination may have been responsible for the deletion."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12297986",
                    "endSection": "abstract",
                    "offsetInBeginSection": 300,
                    "offsetInEndSection": 495,
                    "text": "Deletion breakpoints, mechanisms, and lengths, as well as inventories of affected genes, have been elucidated for deletions of AZFa and of AZFc but not for deletions of AZFb or of AZFb plus AZFc."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7887422",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1109,
                    "offsetInEndSection": 1415,
                    "text": "Twelve of 15 patients with deletion breakpoints as far distal as D11S1345 had trigonocephaly, while patients with deletions distal to D11S912 did not, suggesting that, if hemizygosity for a single gene is responsible for this dysmorphic feature, the gene may lie distal to D11S1345 and proximal to D11S912."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16293123",
                    "endSection": "abstract",
                    "offsetInBeginSection": 685,
                    "offsetInEndSection": 836,
                    "text": "The breakpoints were positioned at 65.3091 and 65.3489 Mb of dog chromosome 10, in intron 1 and intron 2 of COMMD1 respectively, a deletion of 39.7 kb."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11001932",
                    "endSection": "abstract",
                    "offsetInBeginSection": 231,
                    "offsetInEndSection": 372,
                    "text": "By sequence-tagged site (STS) content mapping, we roughly defined deletion breakpoints in two unrelated, azoospermic men with AZFa deletions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16293123",
                    "endSection": "abstract",
                    "offsetInBeginSection": 282,
                    "offsetInEndSection": 499,
                    "text": "Subsequently, the deletion of exon 2 of the copper metabolism domain containing 1 (COMMD1) gene (formerly MURR1) was shown to be the major cause of copper toxicosis, although the deletion breakpoints were not defined."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9428363",
                    "endSection": "abstract",
                    "offsetInBeginSection": 435,
                    "offsetInEndSection": 663,
                    "text": "In the present study, 15 closely spaced microsatellite markers were used to finely map deletion breakpoints and to test for allelic loss of 7q markers in 12 uterine leiomyoma tumor samples with cytogenetically defined deletions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8875237",
                    "endSection": "abstract",
                    "offsetInBeginSection": 872,
                    "offsetInEndSection": 1135,
                    "text": "A degree of breakpoint clustering was found, but the identification of a number of deletion types, based on the position of proximal and distal breakpoints as defined by microsatellite analysis, strongly supports a leukaemogenic mechanism involving gene deletion."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10090893",
                    "endSection": "abstract",
                    "offsetInBeginSection": 246,
                    "offsetInEndSection": 429,
                    "text": "More than 90% of patients with VCFS and a 22q11 deletion have a similar 3-Mb hemizygous deletion, suggesting that sequences at the breakpoints confer susceptibility to rearrangements."
                }
            ]
        },
        {
            "body": "How is the nuclear localization of lncRNA mediated?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27198227",
                "http://www.ncbi.nlm.nih.gov/pubmed/25555588",
                "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                "http://www.ncbi.nlm.nih.gov/pubmed/26578588",
                "http://www.ncbi.nlm.nih.gov/pubmed/28275212",
                "http://www.ncbi.nlm.nih.gov/pubmed/26943771",
                "http://www.ncbi.nlm.nih.gov/pubmed/23828888",
                "http://www.ncbi.nlm.nih.gov/pubmed/29213066",
                "http://www.ncbi.nlm.nih.gov/pubmed/26826711",
                "http://www.ncbi.nlm.nih.gov/pubmed/27250657"
            ],
            "id": "5ab8fb5bfcf4565872000017",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27198227",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "HuR and GRSF1 modulate the nuclear export and mitochondrial localization of the lncRNA RMRP."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27198227",
                    "endSection": "abstract",
                    "offsetInBeginSection": 850,
                    "offsetInEndSection": 1040,
                    "text": "Our findings indicate that RBPs HuR and GRSF1 govern the cytoplasmic and mitochondrial localization of the lncRNA RMRP, which is encoded by nuclear DNA but has key functions in mitochondria."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25555588",
                    "endSection": "abstract",
                    "offsetInBeginSection": 252,
                    "offsetInEndSection": 393,
                    "text": "We believe that Microcell Mediated Chromosome Transfer (MMCT) is a suitable approach for functional analysis of lncRNAs and nuclear dynamics."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                    "endSection": "abstract",
                    "offsetInBeginSection": 601,
                    "offsetInEndSection": 863,
                    "text": "Mutational analyses indicated that nuclear localization of BORG was mediated through a novel RNA motif consisting of the pentamer sequence AGCCC with sequence restrictions at positions -8 (T or A) and -3 (G or C) relative to the first nucleotide of the pentamer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                    "endSection": "abstract",
                    "offsetInBeginSection": 150,
                    "offsetInEndSection": 427,
                    "text": "As many lncRNAs regulate nuclear events and thus must localize to nuclei, we analyzed the sequence requirements for nuclear localization in an intergenic lncRNA named BORG (BMP2-OP1-responsive gene), which is both spliced and polyadenylated but is strictly localized in nuclei."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25555588",
                    "endSection": "abstract",
                    "offsetInBeginSection": 153,
                    "offsetInEndSection": 251,
                    "text": "However, the mechanisms underlying the lncRNA mediated silencing of multiple genes remain unknown."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26578588",
                    "endSection": "abstract",
                    "offsetInBeginSection": 788,
                    "offsetInEndSection": 1067,
                    "text": "To address whether localization of the lncRNA influences susceptibility to degradation by either ASOs or RNAi, nuclear lncRNAs (MALAT1 and NEAT1), cytoplasmic lncRNAs (DANCR and OIP5-AS1) and dual-localized lncRNAs (TUG1, CasC7 and HOTAIR) were compared for knockdown efficiency."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27198227",
                    "endSection": "abstract",
                    "offsetInBeginSection": 441,
                    "offsetInEndSection": 584,
                    "text": "In cultured human cells, HuR bound RMRP in the nucleus and mediated its CRM1 (chromosome region maintenance 1)-dependent export to the cytosol."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 83,
                    "text": "A novel RNA motif mediates the strict nuclear localization of a long noncoding RNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28275212",
                    "endSection": "abstract",
                    "offsetInBeginSection": 2045,
                    "offsetInEndSection": 2149,
                    "text": "Moreover, we identified a new lncRNA FLRL2, that might participate NAFLD pathogenesis mediated by Arntl."
                }
            ]
        },
        {
            "body": "What is ATAC-seq?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28166220",
                "http://www.ncbi.nlm.nih.gov/pubmed/28550296",
                "http://www.ncbi.nlm.nih.gov/pubmed/27832532",
                "http://www.ncbi.nlm.nih.gov/pubmed/27443938",
                "http://www.ncbi.nlm.nih.gov/pubmed/29155775",
                "http://www.ncbi.nlm.nih.gov/pubmed/27903897",
                "http://www.ncbi.nlm.nih.gov/pubmed/29181276",
                "http://www.ncbi.nlm.nih.gov/pubmed/25559105",
                "http://www.ncbi.nlm.nih.gov/pubmed/28891464",
                "http://www.ncbi.nlm.nih.gov/pubmed/25679813"
            ],
            "id": "5abd31e0fcf456587200002c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28166220",
                    "endSection": "abstract",
                    "offsetInBeginSection": 103,
                    "offsetInEndSection": 267,
                    "text": "It is unknown whether and to what extent neuronal activity may trigger changes in chromatin accessibility, a major mode of epigenetic regulation of gene expression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28550296",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 82,
                    "text": "ATAC-seq is a high-throughput sequencing technique that identifies open chromatin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28166220",
                    "endSection": "abstract",
                    "offsetInBeginSection": 871,
                    "offsetInEndSection": 1116,
                    "text": "Our results reveal dynamic changes of chromatin accessibility in adult mammalian brains and suggest an epigenetic mechanism by which transient neuronal activation leads to dynamic changes in gene expression via modifying chromatin accessibility."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27832532",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 175,
                    "text": "Assay for transposase-accessible chromatin with high-throughput sequencing (ATAC-seq) is a useful method to map genome-wide chromatin accessibility and nucleosome positioning."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28550296",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1159,
                    "offsetInEndSection": 1397,
                    "text": "This strategy reduced the amount of sequencing required to call a high number of peaks, which could lead to cost reduction when performing ATAC-seq on large numbers of samples and in cell types that contain a large amount of mitochondria."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27443938",
                    "endSection": "abstract",
                    "offsetInBeginSection": 893,
                    "offsetInEndSection": 1168,
                    "text": "ATAC-seq is a very efficient technique that, using a very low number of cells as starting material, allows the identification of active chromatin regions genome wide, whereas 4C-seq detects the subset of sequences that interact specifically with the promoter of a given gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29155775",
                    "endSection": "abstract",
                    "offsetInBeginSection": 631,
                    "offsetInEndSection": 1000,
                    "text": "ATAC-seq is a robust and sensitive alternative to DNase I hypersensitivity analysis coupled with next-generation sequencing (DNase-seq) and formaldehyde-assisted isolation of regulatory elements (FAIRE-seq) for genome-wide analysis of chromatin accessibility and to the sequencing of micrococcal nuclease-sensitive sites (MNase-seq) to determine nucleosome positioning."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29155775",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 168,
                    "text": "Assay for Transposase-Accessible Chromatin with high-throughput sequencing (ATAC-seq) is a method used for the identification of open (accessible) regions of chromatin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28166220",
                    "endSection": "abstract",
                    "offsetInBeginSection": 268,
                    "offsetInEndSection": 496,
                    "text": "Here we compared chromatin accessibility landscapes of adult mouse dentate granule neurons in vivo before and after synchronous neuronal activation using an assay for transposase-accessible chromatin using sequencing (ATAC-seq)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28550296",
                    "endSection": "abstract",
                    "offsetInBeginSection": 334,
                    "offsetInEndSection": 578,
                    "text": "We tested two approaches to decrease wasted sequencing in ATAC-seq libraries generated from lymphoblastoid cell lines: targeted cleavage of mitochondrial DNA fragments using CRISPR technology and removal of detergent from the cell lysis buffer."
                }
            ]
        },
        {
            "body": "What is the TALE-iD method used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25475013",
                "http://www.ncbi.nlm.nih.gov/pubmed/23019222",
                "http://www.ncbi.nlm.nih.gov/pubmed/26443226",
                "http://www.ncbi.nlm.nih.gov/pubmed/28674932",
                "http://www.ncbi.nlm.nih.gov/pubmed/26854857",
                "http://www.ncbi.nlm.nih.gov/pubmed/25539004",
                "http://www.ncbi.nlm.nih.gov/pubmed/24228087",
                "http://www.ncbi.nlm.nih.gov/pubmed/25643171",
                "http://www.ncbi.nlm.nih.gov/pubmed/26308041",
                "http://www.ncbi.nlm.nih.gov/pubmed/21625552"
            ],
            "id": "5a8d8f39fcd1d6a10c000024",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25475013",
                    "endSection": "abstract",
                    "offsetInBeginSection": 450,
                    "offsetInEndSection": 590,
                    "text": "This platform is fully compatible with the Golden Gate TALEN and TAL Effector Kit 2.0, a widely used and efficient method for TALE assembly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23019222",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 69,
                    "text": "Site-specific recombinases are powerful tools for genome engineering."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25475013",
                    "endSection": "abstract",
                    "offsetInBeginSection": 956,
                    "offsetInEndSection": 1168,
                    "text": "Together, our results suggest that this multicolor TALE-KRAB vector platform is a promising and versatile tool for knockdown of multiple gene targets and could greatly facilitate dissection of molecular pathways."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26443226",
                    "endSection": "abstract",
                    "offsetInBeginSection": 630,
                    "offsetInEndSection": 723,
                    "text": "This technology is an efficient, cost- and time-effective method for creating new rat models."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25475013",
                    "endSection": "abstract",
                    "offsetInBeginSection": 114,
                    "offsetInEndSection": 293,
                    "text": "Because it allows sequence-specific DNA binding, transcription activator-like effector (TALE) offers a new genetic perturbation technique that allows for gene-specific repression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25475013",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 113,
                    "text": "Stable and efficient knockdown of multiple gene targets is highly desirable for dissection of molecular pathways."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28674932",
                    "endSection": "abstract",
                    "offsetInBeginSection": 72,
                    "offsetInEndSection": 306,
                    "text": "The use of transcription activator-like effectors (TALEs) is a powerful genome-engineering tool, which can facilitate genome editing and transcriptional modulation, and has been used for genetic modification in a variety of organisms."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23019222",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1117,
                    "offsetInEndSection": 1361,
                    "text": "The TALER architecture described herein provides a platform for insertion of customized TALE domains, thus significantly expanding the targeting capacity of engineered recombinases and their potential applications in biotechnology and medicine."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26854857",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 96,
                    "text": "FusX: A Rapid One-Step Transcription Activator-Like Effector Assembly System for Genome Science."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25539004",
                    "endSection": "abstract",
                    "offsetInBeginSection": 198,
                    "offsetInEndSection": 411,
                    "text": "This domain is both predictable and programmable, which simplifies elucidation of TALE function in planta and facilitates generation of DNA-binding modules with desired specificity for biotechnological approaches."
                }
            ]
        },
        {
            "body": "What is Paget's Disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/7695525",
                "http://www.ncbi.nlm.nih.gov/pubmed/19537656",
                "http://www.ncbi.nlm.nih.gov/pubmed/15389972",
                "http://www.ncbi.nlm.nih.gov/pubmed/16429324",
                "http://www.ncbi.nlm.nih.gov/pubmed/18638386",
                "http://www.ncbi.nlm.nih.gov/pubmed/10560346",
                "http://www.ncbi.nlm.nih.gov/pubmed/15458537",
                "http://www.ncbi.nlm.nih.gov/pubmed/15377360",
                "http://www.ncbi.nlm.nih.gov/pubmed/27815949",
                "http://www.ncbi.nlm.nih.gov/pubmed/17447970"
            ],
            "id": "5aa67b6ad6d6b54f79000010",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7695525",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 71,
                    "text": "Paget's disease of the breast: what the radiologist may expect to find."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7695525",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 121,
                    "text": "Paget's disease of the nipple is characterized by the presence of Paget's cells in the epidermis of the nipple or areola."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19537656",
                    "endSection": "abstract",
                    "offsetInBeginSection": 79,
                    "offsetInEndSection": 158,
                    "text": "Paget's disease is characterized by abnormal resorption and deposition of bone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15389972",
                    "endSection": "abstract",
                    "offsetInBeginSection": 524,
                    "offsetInEndSection": 598,
                    "text": "Paget's disease is an autosomal dominant trait with genetic heterogeneity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16429324",
                    "endSection": "abstract",
                    "offsetInBeginSection": 195,
                    "offsetInEndSection": 269,
                    "text": "Paget's disease is an autosomal dominant trait with genetic heterogeneity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18638386",
                    "endSection": "abstract",
                    "offsetInBeginSection": 811,
                    "offsetInEndSection": 929,
                    "text": "CONCLUSION\nIt is possible that hyperprolactinemia is unrecognised in other patients with Paget's disease of the skull."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10560346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 34,
                    "offsetInEndSection": 229,
                    "text": "Unlike Paget's disease of the nipple, which is always associated with a subjacent breast adenocarcinoma, perianal Paget's disease is not always associated with a subjacent or visceral malignancy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16429324",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 123,
                    "text": "Paget's disease of bone is a chronic focal skeletal disorder characterized by increased bone resorption by the osteoclasts."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15458537",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 107,
                    "text": "BACKGROUND\nExtramammary Paget's disease is a rare neoplasm primarily affecting apocrine gland bearing skin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15377360",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 118,
                    "text": "Triple extramammary Paget's disease, which consists ordinarily of bilateral axillary and genital lesions, is uncommon."
                }
            ]
        },
        {
            "body": "What is the function of penicillinase, also known as beta lactamase?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/806305",
                "http://www.ncbi.nlm.nih.gov/pubmed/8494361",
                "http://www.ncbi.nlm.nih.gov/pubmed/219920",
                "http://www.ncbi.nlm.nih.gov/pubmed/6231593",
                "http://www.ncbi.nlm.nih.gov/pubmed/9624479",
                "http://www.ncbi.nlm.nih.gov/pubmed/6460968",
                "http://www.ncbi.nlm.nih.gov/pubmed/1629597",
                "http://www.ncbi.nlm.nih.gov/pubmed/6795623",
                "http://www.ncbi.nlm.nih.gov/pubmed/16742589",
                "http://www.ncbi.nlm.nih.gov/pubmed/406836"
            ],
            "id": "5aae651ffcf456587200000d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/806305",
                    "endSection": "abstract",
                    "offsetInBeginSection": 212,
                    "offsetInEndSection": 501,
                    "text": "In both cases, we have shown the simultaneous biosynthesis of two enzymes: an inducible and chromosome cephalosporinase frequently found in this germ, and a constitutive beta lactamase, with a penicillinase activity which has been identified with the extrachromosomic beta lactamase R-TEM."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/806305",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 71,
                    "text": "[Identification of the beta lactamase R-TEM of Pseudomonas aeruginosa]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/806305",
                    "endSection": "abstract",
                    "offsetInBeginSection": 502,
                    "offsetInEndSection": 766,
                    "text": "These two enzymes have been separated by affinity chromatography, characterized by their kinetic constants given by computerized microacidimetry, and their isoelectric points which are respectively 9.2 for the cephalosporinase and 5.40 for the penicillinase R-TEM."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/806305",
                    "endSection": "abstract",
                    "offsetInBeginSection": 78,
                    "offsetInEndSection": 160,
                    "text": "aeruginosa resistant to classical beta lactam antibiotics including carbenicillin."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8494361",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 116,
                    "text": "The Pseudomonas cepacia 249 chromosomal penicillinase is a member of the AmpC family of chromosomal beta-lactamases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8494361",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 89,
                    "text": "Pseudomonas cepacia 249 produces an inducible beta-lactamase with penicillinase activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/219920",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 155,
                    "text": "Penicillinase (beta-lactamase I, EC 3.5.2.6) secreted by Bacillus cereus, strain 569/H, was covalently attached to aminoethyl cellulose via glutaraldehyde."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/806305",
                    "endSection": "abstract",
                    "offsetInBeginSection": 161,
                    "offsetInEndSection": 211,
                    "text": "These two strains hydrolyse all these antibiotics."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6231593",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1107,
                    "offsetInEndSection": 1160,
                    "text": "penicillinase plus cephalosporinase) are exceptional."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9624479",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1595,
                    "offsetInEndSection": 1724,
                    "text": "We conclude that the major beta-lactamase of M. tuberculosis is a class A beta-lactamase with predominant penicillinase activity."
                }
            ]
        },
        {
            "body": "The common house cat, Felis silvestris catus and the domestic dog, Canis familiaris both belong to what taxonomic order?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11426732",
                "http://www.ncbi.nlm.nih.gov/pubmed/21658128",
                "http://www.ncbi.nlm.nih.gov/pubmed/27938443",
                "http://www.ncbi.nlm.nih.gov/pubmed/551363",
                "http://www.ncbi.nlm.nih.gov/pubmed/28196774",
                "http://www.ncbi.nlm.nih.gov/pubmed/28576619",
                "http://www.ncbi.nlm.nih.gov/pubmed/17727851",
                "http://www.ncbi.nlm.nih.gov/pubmed/22154254",
                "http://www.ncbi.nlm.nih.gov/pubmed/22770702",
                "http://www.ncbi.nlm.nih.gov/pubmed/27195685"
            ],
            "id": "5ab1483bfcf4565872000014",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11426732",
                    "endSection": "abstract",
                    "offsetInBeginSection": 268,
                    "offsetInEndSection": 274,
                    "text": "canis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11426732",
                    "endSection": "abstract",
                    "offsetInBeginSection": 133,
                    "offsetInEndSection": 263,
                    "text": "This ascaridoid nematode was previously assumed to be Toxocara canis, which it superficially resembles, or designated Toxocara sp."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11426732",
                    "endSection": "title",
                    "offsetInBeginSection": 29,
                    "offsetInEndSection": 105,
                    "text": "(Nematoda: Ascaridoidea) from the domestic cat (Felis catus Linnaeus, 1758)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11426732",
                    "endSection": "abstract",
                    "offsetInBeginSection": 29,
                    "offsetInEndSection": 132,
                    "text": "from the small intestine of the domestic cat (Felis catus L.) in Malaysia is described and illustrated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21658128",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 109,
                    "text": "Domestic dogs (Canis familiaris) and cats (Felis catus) are the most abundant mammalian carnivores worldwide."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11426732",
                    "endSection": "abstract",
                    "offsetInBeginSection": 275,
                    "offsetInEndSection": 403,
                    "text": "The new species differs from T. canis in the shape of the cervical alae in cross section, spicule length, and the lip structure."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27938443",
                    "endSection": "title",
                    "offsetInBeginSection": 26,
                    "offsetInEndSection": 30,
                    "text": "nov."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/551363",
                    "endSection": "abstract",
                    "offsetInBeginSection": 352,
                    "offsetInEndSection": 630,
                    "text": "The chief disseminators in 2 of these areas were found to be the dog (Canis familiaris) and the black-backed jackal (C. mesomelas); in the third area, the yellow mongoose (Cynictis penicillata), and in the fourth Genetta and Felis spp., including the domestic cat (Felis catis)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28196774",
                    "endSection": "abstract",
                    "offsetInBeginSection": 76,
                    "offsetInEndSection": 243,
                    "text": "in free-ranging jaguars (Panthera onca), domestic dogs (Canis lupus familiaris) and domestic cats (Felis catus) from the Cerrado, Amazon and Pantanal biomes of Brazil."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28576619",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 137,
                    "text": "Three species of Hepatozoon, namely, Hepatozoon felis, Hepatozoon canis and Hepatozoon silvestris may affect domestic and/or wild felids."
                }
            ]
        },
        {
            "body": "What is caused by the ectopic expression of CTCF?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19308701",
                "http://www.ncbi.nlm.nih.gov/pubmed/28857086",
                "http://www.ncbi.nlm.nih.gov/pubmed/27880914",
                "http://www.ncbi.nlm.nih.gov/pubmed/27080371",
                "http://www.ncbi.nlm.nih.gov/pubmed/19369356",
                "http://www.ncbi.nlm.nih.gov/pubmed/26549033",
                "http://www.ncbi.nlm.nih.gov/pubmed/26268681",
                "http://www.ncbi.nlm.nih.gov/pubmed/28862757",
                "http://www.ncbi.nlm.nih.gov/pubmed/21465478",
                "http://www.ncbi.nlm.nih.gov/pubmed/23933634"
            ],
            "id": "5abcf6b9fcf4565872000027",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19308701",
                    "endSection": "abstract",
                    "offsetInBeginSection": 579,
                    "offsetInEndSection": 766,
                    "text": "Here we review what is known about the roles of cohesin and CTCF in regulating gene expression in mammalian cells, and we discuss how cohesin might mediate the insulator function of CTCF."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28857086",
                    "endSection": "abstract",
                    "offsetInBeginSection": 240,
                    "offsetInEndSection": 403,
                    "text": "CCCTC-binding factor (CTCF) is a DNA-binding, zinc-finger protein that regulates the expression of its target gene by organizing higher order chromatin structures."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19308701",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 61,
                    "text": "How cohesin and CTCF cooperate in regulating gene expression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27880914",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 110,
                    "text": "CCCTC-binding factor (CTCF) is an organizer of higher-order chromatin structure and regulates gene expression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27080371",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1160,
                    "offsetInEndSection": 1377,
                    "text": "Although it is not clear whether CTCF affects Hoxc gene expression solely through its looping activity, CTCF-mediated chromatin structural modulation could be an another tier of Hox gene regulation during development."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19369356",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1173,
                    "offsetInEndSection": 1405,
                    "text": "Ectopic expression of Rad21 repressed CTCF-regulated transcription of KSHV lytic genes, and a Rad21-CTCF chimeric protein converted CTCF into an efficient transcriptional repressor of KSHV genes normally activated in the G(2) phase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26549033",
                    "endSection": "abstract",
                    "offsetInBeginSection": 812,
                    "offsetInEndSection": 1021,
                    "text": "The CTCF dimer then interacted with suppressor of zeste 12 homologue (SUZ12), which is a domain of Polycomb repressive complex 2 (PRC2), promoting the methylation of H3K27 and the silencing of GAD1 expression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26268681",
                    "endSection": "abstract",
                    "offsetInBeginSection": 834,
                    "offsetInEndSection": 1066,
                    "text": "Depletion of the BORIS gene leads to altered transcription of a large number of genes and the differentiation of K562 cells, while the ectopic expression of this CTCF paralog leads to specific changes in transcription in MCF7 cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27080371",
                    "endSection": "abstract",
                    "offsetInBeginSection": 572,
                    "offsetInEndSection": 728,
                    "text": "We found that CTCF binding between Hoxc11 and -c12 is important for CTCF-mediated chromosomal loop formation and concomitant posterior Hoxc gene expression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28862757",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1014,
                    "offsetInEndSection": 1228,
                    "text": "Depletion of CTCF resulted in reduced motility and invasiveness in HCC cells that could be reversed by ectopic expression of FOXM1, suggesting that FOXM1 is one of the important downstream effectors of CTCF in HCC."
                }
            ]
        },
        {
            "body": "What is the dardarin protein?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17622782",
                "http://www.ncbi.nlm.nih.gov/pubmed/17394548",
                "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                "http://www.ncbi.nlm.nih.gov/pubmed/16026116",
                "http://www.ncbi.nlm.nih.gov/pubmed/16115731",
                "http://www.ncbi.nlm.nih.gov/pubmed/18213618",
                "http://www.ncbi.nlm.nih.gov/pubmed/22988875",
                "http://www.ncbi.nlm.nih.gov/pubmed/17116211",
                "http://www.ncbi.nlm.nih.gov/pubmed/18855661",
                "http://www.ncbi.nlm.nih.gov/pubmed/16149095"
            ],
            "id": "5ac0fccf19833b0d7b000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17622782",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "BACKGROUND\nRecently, mutations in LRRK2 encoding the protein dardarin have been linked to an autosomal dominant form of parkinsonism."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17394548",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 178,
                    "text": "Several mutations have been found in the leucine-rich repeat kinase 2 gene (LRRK2), encoding the protein dardarin, which are associated with autosomal dominant Parkinson disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                    "endSection": "abstract",
                    "offsetInBeginSection": 103,
                    "offsetInEndSection": 204,
                    "text": "Dardarin is a large protein, and mutations are found throughout the gene including the kinase domain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16026116",
                    "endSection": "abstract",
                    "offsetInBeginSection": 117,
                    "offsetInEndSection": 296,
                    "text": "It is now known that there are two autosomal dominant disease genes, alpha-synuclein and dardarin, and three genes responsible for autosomal recessive PD, parkin, DJ-1 and PINK-1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 102,
                    "text": "Mutations in the LRRK2 gene, coding for dardarin, cause dominantly inherited Parkinson's disease (PD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16115731",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 166,
                    "text": "Mutations in the leucine-rich repeat kinase 2 (LRRK 2), encoding dardarin protein, have been demonstrated to be linked to autosomal dominant Parkinson's disease (PD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                    "endSection": "abstract",
                    "offsetInBeginSection": 858,
                    "offsetInEndSection": 1000,
                    "text": "We also show that dardarin protein is expressed within human midbrain neurons and that C-terminal epitopes are also found in some Lewy bodies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18213618",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 105,
                    "text": "Mutation of LRRK2, encoding dardarin, is the most common known genetic cause of Parkinson's disease (PD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22988875",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 160,
                    "text": "Mutations in LRRK2 (leucine-rich repeat kinase 2) (also known as PARK8 or dardarin) are responsible for the autosomal-dominant form of PD (Parkinson's disease)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17394548",
                    "endSection": "abstract",
                    "offsetInBeginSection": 634,
                    "offsetInEndSection": 784,
                    "text": "We show that mutations in dardarin are more prone to form inclusion bodies in transfected cells and are more toxic than equivalent mutations in LRRK1."
                }
            ]
        },
        {
            "body": "In which syndrome is the RPS19 gene most frequently mutated?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17376718",
                "http://www.ncbi.nlm.nih.gov/pubmed/18768533",
                "http://www.ncbi.nlm.nih.gov/pubmed/19898770",
                "http://www.ncbi.nlm.nih.gov/pubmed/29222326",
                "http://www.ncbi.nlm.nih.gov/pubmed/17053056",
                "http://www.ncbi.nlm.nih.gov/pubmed/27550323",
                "http://www.ncbi.nlm.nih.gov/pubmed/16289379",
                "http://www.ncbi.nlm.nih.gov/pubmed/15082795",
                "http://www.ncbi.nlm.nih.gov/pubmed/16458028",
                "http://www.ncbi.nlm.nih.gov/pubmed/12393682"
            ],
            "id": "5a896c26fcd1d6a10c000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17376718",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 233,
                    "text": "The gene encoding the small subunit ribosomal protein 19 (RPS19) is mutated in about 25% of cases of the bone marrow failure syndrome Diamond Blackfan Anemia (DBA), a childhood disease characterized by failure of red cell production."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18768533",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 240,
                    "text": "BACKGROUND\nMutations in the ribosomal protein S19 gene (RPS19) have been found in 25% of patients with Diamond-Blackfan anemia, a rare syndrome of congenital bone marrow failure characterized by erythroblastopenia and various malformations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19898770",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 165,
                    "text": "Diamond-Blackfan anemia is a bone marrow failure syndrome associated with heterozygous mutations in the ribosomal protein S19 (RPS19) gene in a subgroup of patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29222326",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 262,
                    "text": "A mutation in the gene encoding the small subunit-associated ribosomal protein RPS19, leading to RPS19 haploinsufficiency, is one of the ribosomal protein gene defects responsible for the rare inherited bone marrow failure syndrome Diamond Blackfan anemia (DBA)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17053056",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 140,
                    "text": "The gene encoding the ribosomal protein S19 (RPS19) is frequently mutated in Diamond-Blackfan anemia (DBA), a congenital erythroblastopenia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27550323",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 267,
                    "text": "Diamond blackfan anemia (DBA) is a well-known inherited bone marrow failure syndrome mostly caused by mutations in ribosomal protein (RP) genes but also rarely in the hematopoietic transcription factor gene, GATA1, or TSR2, a ribosomal protein (Rps26) chaperone gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16289379",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 174,
                    "text": "The gene encoding ribosomal protein S19 (RPS19) is mutated in approximately 25% of patients with Diamond-Blackfan anemia (DBA), which is a rare congenital erythroblastopenia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17376718",
                    "endSection": "abstract",
                    "offsetInBeginSection": 234,
                    "offsetInEndSection": 358,
                    "text": "In these cases DBA is inherited as an autosomal dominant trait and RPS19 haploinsufficiency is thought to cause the disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15082795",
                    "endSection": "abstract",
                    "offsetInBeginSection": 109,
                    "offsetInEndSection": 253,
                    "text": "The gene encoding RPS19 is mutated in approximately 25% of patients with Diamond-Blackfan anemia, which is a rare congenital erythroblastopenia."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17376718",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 160,
                    "text": "Cells depleted for RPS19, a protein associated with Diamond Blackfan Anemia, show defects in 18S ribosomal RNA synthesis and small ribosomal subunit production."
                }
            ]
        },
        {
            "body": "What type of sequences do enhancers evolve from?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/15014138",
                "http://www.ncbi.nlm.nih.gov/pubmed/21593416",
                "http://www.ncbi.nlm.nih.gov/pubmed/21424652",
                "http://www.ncbi.nlm.nih.gov/pubmed/25635462",
                "http://www.ncbi.nlm.nih.gov/pubmed/21798176",
                "http://www.ncbi.nlm.nih.gov/pubmed/50895",
                "http://www.ncbi.nlm.nih.gov/pubmed/22102826",
                "http://www.ncbi.nlm.nih.gov/pubmed/21151964",
                "http://www.ncbi.nlm.nih.gov/pubmed/23805311",
                "http://www.ncbi.nlm.nih.gov/pubmed/8290549"
            ],
            "id": "5ac37afc0340b9f058000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15014138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 877,
                    "offsetInEndSection": 1010,
                    "text": "The starting sequences considered are either real enhancers from the Drosophila melanogaster genome, or randomized versions of these."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21593416",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1283,
                    "offsetInEndSection": 1474,
                    "text": "We suggest that the novel optic lobe enhancer evolved by exploiting the cryptic activity of extant regulatory sequences, and this may reflect a general mechanism whereby new enhancers evolve."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21424652",
                    "endSection": "abstract",
                    "offsetInBeginSection": 250,
                    "offsetInEndSection": 254,
                    "text": "Fig."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15014138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 260,
                    "offsetInEndSection": 400,
                    "text": "One way in which changes in gene expression can evolve is through the acquisition of new transcription factor targets in enhancer sequences."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25635462",
                    "endSection": "abstract",
                    "offsetInBeginSection": 696,
                    "offsetInEndSection": 907,
                    "text": "Our data further reveal that recently evolved enhancers can be associated with genes under positive selection, demonstrating the power of this approach for annotating regulatory adaptations in genomic sequences."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15014138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 109,
                    "offsetInEndSection": 259,
                    "text": "Transcriptional control is brought about by the interactions of transcription factors with short target motifs in the DNAs of promoters and enhancers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21798176",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1249,
                    "offsetInEndSection": 1408,
                    "text": "The results show that the repetitive sequences are rapidly evolving in the S. purpuratus genome and may serve as a renewable pool of transcriptional enhancers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21424652",
                    "endSection": "abstract",
                    "offsetInBeginSection": 255,
                    "offsetInEndSection": 257,
                    "text": "1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21424652",
                    "endSection": "abstract",
                    "offsetInBeginSection": 255,
                    "offsetInEndSection": 257,
                    "text": "1."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15014138",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 60,
                    "text": "Expected rates and modes of evolution of enhancer sequences."
                }
            ]
        },
        {
            "body": "What nerve is involved in carpal tunnel syndrome?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21845587",
                "http://www.ncbi.nlm.nih.gov/pubmed/15521353",
                "http://www.ncbi.nlm.nih.gov/pubmed/3225421",
                "http://www.ncbi.nlm.nih.gov/pubmed/7694630",
                "http://www.ncbi.nlm.nih.gov/pubmed/12475522",
                "http://www.ncbi.nlm.nih.gov/pubmed/21812236",
                "http://www.ncbi.nlm.nih.gov/pubmed/12881666",
                "http://www.ncbi.nlm.nih.gov/pubmed/19280893",
                "http://www.ncbi.nlm.nih.gov/pubmed/9283839",
                "http://www.ncbi.nlm.nih.gov/pubmed/28718333"
            ],
            "id": "5abcf010fcf4565872000023",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21845587",
                    "endSection": "abstract",
                    "offsetInBeginSection": 259,
                    "offsetInEndSection": 378,
                    "text": "Unlike Guyon's canal syndrome, carpal tunnel syndrome (CTS) is the most common nerve entrapment of the upper extremity."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21845587",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 93,
                    "text": "Ulnar nerve entrapment in Guyon's canal due to recurrent carpal tunnel syndrome: case report."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21845587",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 94,
                    "text": "Guyon's canal syndrome is a compression neuropathy of the ulnar nerve entrapment at the wrist."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15521353",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 80,
                    "text": "Carpal tunnel syndrome is the most common peripheral nerve compression syndrome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3225421",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 155,
                    "text": "We report a case of carpal tunnel syndrome associated with median nerve motor branch compression by a large superficial palmar branch of the radial artery."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7694630",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 142,
                    "text": "The two most frequently diagnosed nerve compression syndromes of the upper extremities are carpal tunnel syndrome and cubital tunnel syndrome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12475522",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "A case of the entrapment neuropathy of the palmar cutaneous branch of the median nerve, concomitant with carpal tunnel syndrome is presented."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21812236",
                    "endSection": "abstract",
                    "offsetInBeginSection": 299,
                    "offsetInEndSection": 380,
                    "text": "Carpal tunnel syndrome is caused by compression of the median nerve at the wrist."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12881666",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1938,
                    "offsetInEndSection": 2079,
                    "text": "Forearm mixed nerve conduction velocity cannot replace Fmot or Fsen in the assessment of retrograde axonal atrophy in carpal tunnel syndrome."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12475522",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 128,
                    "text": "Entrapment neuropathy of the palmar cutaneous branch of the median nerve concomitant with carpal tunnel syndrome: a case report."
                }
            ]
        },
        {
            "body": "What is the function of LOX proteins in the ECM?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16085123",
                "http://www.ncbi.nlm.nih.gov/pubmed/11499844",
                "http://www.ncbi.nlm.nih.gov/pubmed/28428687",
                "http://www.ncbi.nlm.nih.gov/pubmed/25111273",
                "http://www.ncbi.nlm.nih.gov/pubmed/25875748",
                "http://www.ncbi.nlm.nih.gov/pubmed/28273952",
                "http://www.ncbi.nlm.nih.gov/pubmed/17931358",
                "http://www.ncbi.nlm.nih.gov/pubmed/25063458",
                "http://www.ncbi.nlm.nih.gov/pubmed/25146937",
                "http://www.ncbi.nlm.nih.gov/pubmed/19369240"
            ],
            "id": "5ad243e30340b9f058000016",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16085123",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 228,
                    "text": "Lysyl oxidase (LOX) is a copper- and lysyl-tyrosyl cofactor containing amine oxidase that has been known to play a critical role in the catalysis of lysine-derived crosslinks in extracellular matrix (ECM) proteins in the dermis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11499844",
                    "endSection": "abstract",
                    "offsetInBeginSection": 170,
                    "offsetInEndSection": 377,
                    "text": "Because lysyl oxidase (LOX) is the main collagen cross-linking enzyme that might account for irreversible fibrosis, its expression was studied together with expression of extracellular matrix (ECM) proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28428687",
                    "endSection": "abstract",
                    "offsetInBeginSection": 139,
                    "offsetInEndSection": 373,
                    "text": "Lysyl oxidase (LOX) plays a critical role in the formation and repair of the ECM by oxidizing lysine residues in elastin and collagen, thereby initiating the formation of covalent cross linkages which stabilize these fibrous proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25111273",
                    "endSection": "abstract",
                    "offsetInBeginSection": 495,
                    "offsetInEndSection": 711,
                    "text": "Lysyl oxidase (lox), an extracellular enzyme that catalyzes the cross-linking of ECM proteins, plays an essential role during diaphragmatic and pulmonary development by controlling the formation of connective tissue."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25875748",
                    "endSection": "abstract",
                    "offsetInBeginSection": 153,
                    "offsetInEndSection": 275,
                    "text": "Concurrent with remodeling is the induction of the enzyme lysyl oxidase (LOX) through which ECM proteins are cross-linked."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28273952",
                    "endSection": "abstract",
                    "offsetInBeginSection": 136,
                    "offsetInEndSection": 285,
                    "text": "Lysyl oxidase (LOX) and LOX-like (LOXL) proteins play crucial roles in ECM remodeling due to their collagen crosslinking and intracellular functions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25111273",
                    "endSection": "abstract",
                    "offsetInBeginSection": 2049,
                    "offsetInEndSection": 2365,
                    "text": "CONCLUSIONS\nDecreased lox expression during diaphragmatic development and lung branching morphogenesis may interfere with normal cross-linking of ECM proteins, disrupting the integrity of connective tissue, and contributing to the diaphragmatic defect and impaired airway formation in the nitrofen-induced CDH model."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358",
                    "endSection": "abstract",
                    "offsetInBeginSection": 404,
                    "offsetInEndSection": 645,
                    "text": "While the catalytic function of LOX is essential for cross-linking of ECM proteins, we also reported that LOX induced invasive and metastatic properties in breast tumour epithelial cells through hydrogen peroxide-mediated FAK/Src activation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16085123",
                    "endSection": "abstract",
                    "offsetInBeginSection": 229,
                    "offsetInEndSection": 426,
                    "text": "Changes in the composition and crosslinked state of the ECM and alterations in LOX synthesis and activity are known to be associated with aging and a range of acquired and heritable skin disorders."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25063458",
                    "endSection": "abstract",
                    "offsetInBeginSection": 284,
                    "offsetInEndSection": 396,
                    "text": "Drosophila lox is a non-essential gene encoding a secreted protein that stiffens the extracellular matrix (ECM)."
                }
            ]
        },
        {
            "body": "Please list 3 diseases treated with Valtrex(valacyclovir)",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/2398994",
                "http://www.ncbi.nlm.nih.gov/pubmed/7851626",
                "http://www.ncbi.nlm.nih.gov/pubmed/2587453",
                "http://www.ncbi.nlm.nih.gov/pubmed/28089147",
                "http://www.ncbi.nlm.nih.gov/pubmed/20879013",
                "http://www.ncbi.nlm.nih.gov/pubmed/26479422",
                "http://www.ncbi.nlm.nih.gov/pubmed/26916568",
                "http://www.ncbi.nlm.nih.gov/pubmed/10091802",
                "http://www.ncbi.nlm.nih.gov/pubmed/24885821",
                "http://www.ncbi.nlm.nih.gov/pubmed/17630083"
            ],
            "id": "5abcf755fcf4565872000028",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2398994",
                    "endSection": "abstract",
                    "offsetInBeginSection": 255,
                    "offsetInEndSection": 257,
                    "text": "3."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2398994",
                    "endSection": "abstract",
                    "offsetInBeginSection": 377,
                    "offsetInEndSection": 379,
                    "text": "4."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2398994",
                    "endSection": "abstract",
                    "offsetInBeginSection": 495,
                    "offsetInEndSection": 497,
                    "text": "5."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2398994",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1104,
                    "offsetInEndSection": 1106,
                    "text": "6."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2398994",
                    "endSection": "abstract",
                    "offsetInBeginSection": 104,
                    "offsetInEndSection": 106,
                    "text": "2."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2398994",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 2,
                    "text": "1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7851626",
                    "endSection": "abstract",
                    "offsetInBeginSection": 196,
                    "offsetInEndSection": 198,
                    "text": "2."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7851626",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 2,
                    "text": "1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2398994",
                    "endSection": "abstract",
                    "offsetInBeginSection": 897,
                    "offsetInEndSection": 899,
                    "text": "B."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2587453",
                    "endSection": "abstract",
                    "offsetInBeginSection": 896,
                    "offsetInEndSection": 1045,
                    "text": "Stage III or IV disease in children over age 3 years with more than 5 degrees of varus angulation should be treated with corrective valgus osteotomy."
                }
            ]
        },
        {
            "body": "Which olfactory gene senses androsterone?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16675527",
                "http://www.ncbi.nlm.nih.gov/pubmed/1737068",
                "http://www.ncbi.nlm.nih.gov/pubmed/9566734",
                "http://www.ncbi.nlm.nih.gov/pubmed/20440461",
                "http://www.ncbi.nlm.nih.gov/pubmed/8921833",
                "http://www.ncbi.nlm.nih.gov/pubmed/3138978",
                "http://www.ncbi.nlm.nih.gov/pubmed/27873871",
                "http://www.ncbi.nlm.nih.gov/pubmed/2881811",
                "http://www.ncbi.nlm.nih.gov/pubmed/8422755",
                "http://www.ncbi.nlm.nih.gov/pubmed/23321429"
            ],
            "id": "5ace17c30340b9f058000009",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16675527",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1337,
                    "offsetInEndSection": 1593,
                    "text": "In support of this model, we show here that mutations M265I or R331H, residues predicted by crystal structure to interact with the carboxylic acid tail of CDCA but not with androsterone, altered CDCA activation but had no effect on androsterone activation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16675527",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1594,
                    "offsetInEndSection": 1715,
                    "text": "Activation of FXR by androsterone may provide an additional means for physiological or pharmacological modulation of FXR."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16675527",
                    "endSection": "abstract",
                    "offsetInBeginSection": 989,
                    "offsetInEndSection": 1157,
                    "text": "Site-directed mutagenesis of the hFXR-LBD defined amino acids Asn354 and Ser345 as critical for differential species sensitivity to CDCA and androsterone, respectively."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16675527",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "The nuclear hormone receptor farnesoid X receptor (FXR) is activated by androsterone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16675527",
                    "endSection": "abstract",
                    "offsetInBeginSection": 66,
                    "offsetInEndSection": 165,
                    "text": "Here, we demonstrate that androsterone, a metabolic product of testosterone, is also an FXR ligand."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16675527",
                    "endSection": "abstract",
                    "offsetInBeginSection": 516,
                    "offsetInEndSection": 769,
                    "text": "Nuclear magnetic resonance spectroscopy demonstrated the direct binding of androsterone to purified human FXR (hFXR) ligand-binding domain (LBD) protein, resulting in the recruitment of steroid receptor coactivator protein-1 (SRC-1) coactivator peptide."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16675527",
                    "endSection": "abstract",
                    "offsetInBeginSection": 770,
                    "offsetInEndSection": 988,
                    "text": "In HEK293 cells, androsterone activated gal4-mouse FXR-LBD and gal4-hFXR-LBD fusion proteins, although in contrast to CDCA, androsterone activation was significantly greater for the mouse FXR-LBD than for the hFXR-LBD."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1737068",
                    "endSection": "abstract",
                    "offsetInBeginSection": 892,
                    "offsetInEndSection": 1128,
                    "text": "Based on these lines of evidence, it is concluded that the large portion of androsterone UDPGT gene is deleted in LA Wistar rats, which results in the absence of androsterone UDPGT mRNA and consequently the corresponding enzyme protein."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1737068",
                    "endSection": "abstract",
                    "offsetInBeginSection": 623,
                    "offsetInEndSection": 891,
                    "text": "Genomic DNA amplifications with synthetic primers which have nucleotide sequences corresponding to the 5'-region of androsterone UDPGT cDNA, suggested that androsterone UDPGT gene has exon 1 with a length of some 700 bp and that this exon is deleted in LA Wistar rats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16675527",
                    "endSection": "abstract",
                    "offsetInBeginSection": 166,
                    "offsetInEndSection": 291,
                    "text": "Treatment of castrated male mice with androsterone induced expression of the FXR target gene small heterodimer partner (SHP)."
                }
            ]
        },
        {
            "body": "Where in the body would the navicular bone be found?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20525052",
                "http://www.ncbi.nlm.nih.gov/pubmed/28099198",
                "http://www.ncbi.nlm.nih.gov/pubmed/2681808",
                "http://www.ncbi.nlm.nih.gov/pubmed/24788547",
                "http://www.ncbi.nlm.nih.gov/pubmed/9622323",
                "http://www.ncbi.nlm.nih.gov/pubmed/10029187",
                "http://www.ncbi.nlm.nih.gov/pubmed/10665729",
                "http://www.ncbi.nlm.nih.gov/pubmed/1505361",
                "http://www.ncbi.nlm.nih.gov/pubmed/24705744",
                "http://www.ncbi.nlm.nih.gov/pubmed/2735530"
            ],
            "id": "5abd13e1fcf4565872000029",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20525052",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1279,
                    "offsetInEndSection": 1854,
                    "text": "There were significant associations between a cystic structure in the distal third of the navicular bone and the presence of either a distal border fragment or entheseous new bone at the insertion of the DSIL, swelling of the DSIL and increased signal intensity in the DSIL in fat suppressed images; between distal elongation of the flexor border of the navicular bone and the presence of one or more distal border fragments and between swelling of the body of the DSIL and irregularity of its palmar border or increased signal intensity in fat suppressed images in the DSIL."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20525052",
                    "endSection": "abstract",
                    "offsetInBeginSection": 962,
                    "offsetInEndSection": 1278,
                    "text": "RESULTS\nThere were significant correlations between the presence of a cystic structure in the distal third of the navicular bone, or a distal border fragment, or increased signal intensity in fat suppressed images at the insertion of the DSIL on the distal phalanx and the histological grade of the body of the DSIL."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28099198",
                    "endSection": "abstract",
                    "offsetInBeginSection": 523,
                    "offsetInEndSection": 721,
                    "text": "Both an accessory navicular and the body of the navicular bone may develop osteomyelitis in immunocompromised patients; early diagnosis is important for prescribing effective conservative treatment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2681808",
                    "endSection": "abstract",
                    "offsetInBeginSection": 72,
                    "offsetInEndSection": 356,
                    "text": "Analysis based on these cases and on 36 patients suffering from identical fractures reported in the literature led to a new mechanical assumption: the axial compression on the foot, as a result of falling from height, causes impaction of the talus into the body of the navicular bone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24788547",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 377,
                    "text": "OBJECTIVE\nTo test the anecdotal observation that isolated navicular collapse is associated with diabetes mellitus, we quantified the size of the tarsal navicular bone in subjects with and without diabetes and tested for association of size with age, height, weight, body mass index (BMI), gender, smoking, bone mineral density (BMD), duration, and level of control of diabetes."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28099198",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 77,
                    "text": "Osteomyelitis of the accessory and body of the navicular bone: a case report."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28099198",
                    "endSection": "abstract",
                    "offsetInBeginSection": 155,
                    "offsetInEndSection": 254,
                    "text": "He was admitted to our hospital with osteomyelitis of the accessory and body of the navicular bone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9622323",
                    "endSection": "abstract",
                    "offsetInBeginSection": 2558,
                    "offsetInEndSection": 2762,
                    "text": "The histological and histomorphometric changes in the navicular bone and palmar fibrocartilage were considered similar of those found in articular hyaline cartilage and subchondral bone in osteoarthritis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2681808",
                    "endSection": "abstract",
                    "offsetInBeginSection": 423,
                    "offsetInEndSection": 568,
                    "text": "Favorable results are obtained in a vertical two-part fracture, by an open reduction and internal fixation of the tarsal navicular body fracture."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10029187",
                    "endSection": "abstract",
                    "offsetInBeginSection": 303,
                    "offsetInEndSection": 595,
                    "text": "In ponies, navicular bone measurements were smallest for light ponies and regularly increased with body size, but in horses, navicular bone dimensions were smallest for the athletic halfbred, intermediate for draft horse, thoroughbreds and sedentary halfbreds and largest for heavy halfbreds."
                }
            ]
        },
        {
            "body": "Name an lncRNA associated with dilated cardiomyopathy.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26141701",
                "http://www.ncbi.nlm.nih.gov/pubmed/14660611",
                "http://www.ncbi.nlm.nih.gov/pubmed/25119045",
                "http://www.ncbi.nlm.nih.gov/pubmed/16001775",
                "http://www.ncbi.nlm.nih.gov/pubmed/17010801",
                "http://www.ncbi.nlm.nih.gov/pubmed/20666274",
                "http://www.ncbi.nlm.nih.gov/pubmed/28430627",
                "http://www.ncbi.nlm.nih.gov/pubmed/20392463",
                "http://www.ncbi.nlm.nih.gov/pubmed/8644625",
                "http://www.ncbi.nlm.nih.gov/pubmed/25834770"
            ],
            "id": "5ac716810340b9f058000003",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26141701",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 97,
                    "text": "Microarray profiling of long non-coding RNA (lncRNA) associated with hypertrophic cardiomyopathy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26141701",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 195,
                    "text": "BACKGROUND\nHypertrophic cardiomyopathy (HCM) is an inherited disorder with around 1400 known mutations; however the molecular pathways leading from genotype to phenotype are not fully understood."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14660611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 470,
                    "offsetInEndSection": 703,
                    "text": "Cypher/ZASP appears to be an ideal candidate for the cardiomyopathy causative gene, because Cypher/ZASP encodes a Z-disc associated protein, and recent studies have demonstrated that Cypher/ZASP knock-out mice develop cardiomyopathy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25119045",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1662,
                    "offsetInEndSection": 1823,
                    "text": "Human MHRT also originates from MYH7 loci and is repressed in various types of myopathic hearts, suggesting a conserved lncRNA mechanism in human cardiomyopathy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16001775",
                    "endSection": "abstract",
                    "offsetInBeginSection": 298,
                    "offsetInEndSection": 399,
                    "text": "Hypertrophic cardiomyopathy is characterized by ventricular hypertrophy, which is usually asymmetric."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17010801",
                    "endSection": "abstract",
                    "offsetInBeginSection": 216,
                    "offsetInEndSection": 380,
                    "text": "Mutations in the gene encoding PLN have been associated with dilated cardiomyopathy characterized by early onset and the presence of lethal ventricular arrhythmias."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20666274",
                    "endSection": "abstract",
                    "offsetInBeginSection": 321,
                    "offsetInEndSection": 408,
                    "text": "Dilated cardiomyopathy is associated with an increased risk of intracardiac thrombosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28430627",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 197,
                    "text": "In the previous study, we generated a rat model of dilated cardiomyopathy (DCM) induced by adriamycin and found that the expression of lncRNA H19 was significantly upregulated in myocardial tissue."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14660611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 108,
                    "text": "Dilated cardiomyopathy is characterized by ventricular dilation with systolic dysfunction of cardiac muscle."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16001775",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 28,
                    "text": "[Idiopathic cardiomyopathy]."
                }
            ]
        },
        {
            "body": "Which gene is responsible for red hair?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20046591",
                "http://www.ncbi.nlm.nih.gov/pubmed/8354355",
                "http://www.ncbi.nlm.nih.gov/pubmed/28024137",
                "http://www.ncbi.nlm.nih.gov/pubmed/21552526",
                "http://www.ncbi.nlm.nih.gov/pubmed/10958658",
                "http://www.ncbi.nlm.nih.gov/pubmed/12500677",
                "http://www.ncbi.nlm.nih.gov/pubmed/19571053",
                "http://www.ncbi.nlm.nih.gov/pubmed/10364557",
                "http://www.ncbi.nlm.nih.gov/pubmed/12597376",
                "http://www.ncbi.nlm.nih.gov/pubmed/11030758"
            ],
            "id": "5ace19420340b9f05800000a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20046591",
                    "endSection": "abstract",
                    "offsetInBeginSection": 367,
                    "offsetInEndSection": 511,
                    "text": "Recently, mutations in P2RY5 gene, encoding a G-protein coupled receptor, have been shown to be responsible for autosomal recessive woolly hair."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8354355",
                    "endSection": "abstract",
                    "offsetInBeginSection": 340,
                    "offsetInEndSection": 450,
                    "text": "Mating experiments indicated that an autosomal recessive gene is responsible for the inheritance of long hair."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28024137",
                    "endSection": "abstract",
                    "offsetInBeginSection": 115,
                    "offsetInEndSection": 190,
                    "text": "A specific variant of MC1R gene (R allele) is responsible for the red hair."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21552526",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 120,
                    "text": "A deletion in exon 9 of the LIPH gene is responsible for the rex hair coat phenotype in rabbits (Oryctolagus cuniculus)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20046591",
                    "endSection": "abstract",
                    "offsetInBeginSection": 512,
                    "offsetInEndSection": 611,
                    "text": "Here, we report the second Japanese case of congenital woolly hair, showing no P2RY5 gene mutation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10958658",
                    "endSection": "abstract",
                    "offsetInBeginSection": 563,
                    "offsetInEndSection": 869,
                    "text": "In this report, we show that the phenotype of the circler mutant, mariner, is due to mutations in the gene encoding Myosin VIIA, an unconventional myosin which is expressed in sensory hair cells and is responsible for various types of hearing disorder in humans, namely Usher 1B syndrome, DFNB2 and DFNA11."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21552526",
                    "endSection": "abstract",
                    "offsetInBeginSection": 917,
                    "offsetInEndSection": 1002,
                    "text": "In humans, several mutations in this major gene cause alopecia, hair loss phenotypes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12500677",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1360,
                    "offsetInEndSection": 1504,
                    "text": "The mutant gene we is probably responsible for a disrupted induction signal from the dermal papilla towards ectodermal cells of a hair follicle."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19571053",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 91,
                    "text": "BACKGROUND\nRed hair color is caused by variants of the melanocortin-1 receptor (MC1R) gene."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10364557",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 68,
                    "text": "Math1: an essential gene for the generation of inner ear hair cells."
                }
            ]
        },
        {
            "body": "Which bacteria was EcoRI, restriction endonuclease isolated from?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/8246264",
                "http://www.ncbi.nlm.nih.gov/pubmed/2992974",
                "http://www.ncbi.nlm.nih.gov/pubmed/344144",
                "http://www.ncbi.nlm.nih.gov/pubmed/25272021",
                "http://www.ncbi.nlm.nih.gov/pubmed/11596089",
                "http://www.ncbi.nlm.nih.gov/pubmed/9653552",
                "http://www.ncbi.nlm.nih.gov/pubmed/3029579",
                "http://www.ncbi.nlm.nih.gov/pubmed/349563",
                "http://www.ncbi.nlm.nih.gov/pubmed/1750690",
                "http://www.ncbi.nlm.nih.gov/pubmed/8370544"
            ],
            "id": "5abd5a62fcf4565872000031",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8246264",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 407,
                    "text": "High-level mupirocin resistance in coagulase-negative staphylococci isolated from patients undergoing peritoneal dialysis was investigated by transfer of the resistance determinants, usually in the form of a plasmid, to Staphylococcus aureus strains, cleavage of the plasmid by restriction endonuclease and hybridisation with a probe comprising a 4.05 kb EcoRI fragment of a plasmid from a S. aureus strain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2992974",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 149,
                    "text": "Purified restriction endonuclease EcoRI isolated from Escherichia coli BS 5 was used for the production of enzyme-specific IgG antibodies in rabbits."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/344144",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 283,
                    "text": "DNA isolated from each of the seven arginine transducing phages lambdaargA2cI857susS7, phi80ppc argECBH, phi80argF, phi80argF ilambdacI857, lambdaargF2, lambdaargF23 and lambdaargI valScI857susS7 has been specifically cleaved by the restriction endonucleases EcoRI, SmaI and HindIII."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25272021",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 281,
                    "text": "A simple and facile approach was developed for monitoring EcoRI endonuclease activity and inhibition, in which a hairpin-like DNA containing restriction cutting site for EcoRI endonuclease acts as the sensing element and Hoechst dyes as the signal indicator in a label-free format."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11596089",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 285,
                    "text": "Twelve strains of adenovirus serotype 19, isolated from cases of epidemic keratoconjunctivitis in Japan in 1992, 1993, 1997, and 1998, were analyzed by DNA restriction analysis, using restriction endonucleases BamHI, BglI, BglII, EcoRI, HindIII, KpnI, PstI, SacI, SalI, SmaI, and XhoI."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9653552",
                    "endSection": "abstract",
                    "offsetInBeginSection": 218,
                    "offsetInEndSection": 330,
                    "text": "EcoRI is a homodimeric restriction endonuclease, the dimeric interface of which consists of a four-helix bundle."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3029579",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 237,
                    "text": "The localization of KpnI, SacI, XhoI, AvaI, PstI, BglI, BamHI, EcoRI, PmiI, SalI, BglII, restriction endonuclease cleavage sites in HindIII-F-fragments of DNA from vaccinia strains WR, Copenhagen, LIVP and neurovaccine has been detected."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2992974",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 103,
                    "text": "Immunoelectron microscopic localization of the restriction endonuclease EcoRI in Escherichia coli BS 5."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3029579",
                    "endSection": "abstract",
                    "offsetInBeginSection": 324,
                    "offsetInEndSection": 477,
                    "text": "The fragments also differ from the analogue of Tian Tan vaccinia strain in the pattern of restriction by AvaI, XhoI, PstI, EcoRI and BamHI endonucleases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11596089",
                    "endSection": "abstract",
                    "offsetInBeginSection": 286,
                    "offsetInEndSection": 493,
                    "text": "Among these 11 restriction endonucleases, EcoRI, PstI, SacI, and SmaI were discriminative enzymes, showing restriction patterns different from those reported previously for the prototype and the variant 19a."
                }
            ]
        },
        {
            "body": "Which is the main reason for the increase in the incidence of cryptococcal disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27187754",
                "http://www.ncbi.nlm.nih.gov/pubmed/12491162",
                "http://www.ncbi.nlm.nih.gov/pubmed/14606338",
                "http://www.ncbi.nlm.nih.gov/pubmed/15525297",
                "http://www.ncbi.nlm.nih.gov/pubmed/14617302",
                "http://www.ncbi.nlm.nih.gov/pubmed/11428412",
                "http://www.ncbi.nlm.nih.gov/pubmed/2345321",
                "http://www.ncbi.nlm.nih.gov/pubmed/28904437",
                "http://www.ncbi.nlm.nih.gov/pubmed/16034947",
                "http://www.ncbi.nlm.nih.gov/pubmed/9827275"
            ],
            "id": "5ace37d50340b9f058000011",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27187754",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 201,
                    "text": "Cryptococcal meningitis is a leading infectious disease worldwide as a result of the high burden of HIV and AIDS, although its cumulative incidence is very low in children compared with that in adults."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12491162",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1014,
                    "offsetInEndSection": 1223,
                    "text": "The incidence rates of CNS opportunistic infections (cryptococcal meningitis, toxoplasmosis, progressive multifocal leukoencephalopathy) and primary CNS lymphoma have decreased since the introduction of HAART."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14606338",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "The incidence of infections due to non-neoformans cryptococcal species is increasing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15525297",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1652,
                    "offsetInEndSection": 1791,
                    "text": "The incidence of cryptococcal meningitis appeared to be decreasing whereas the incidence of cerebral toxoplasmosis seemed to be increasing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14617302",
                    "endSection": "abstract",
                    "offsetInBeginSection": 255,
                    "offsetInEndSection": 463,
                    "text": "An increase in the incidence of primary pulmonary cryptococcal infections has been reported recently in solid organ recipients; these infections were generally symptomatic with an accelerated clinical course."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11428412",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 219,
                    "text": "Pulmonary cryptococcal infections occur in both immunocompetent and immunocompromised individuals, with a reported increased incidence of diffuse pulmonary disease in acquired immune deficiency syndrome (AIDS) patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15525297",
                    "endSection": "abstract",
                    "offsetInBeginSection": 861,
                    "offsetInEndSection": 1013,
                    "text": "The incidence of cryptococcal meningitis appeared to be decreasing since 1994 whereas the incidence of cerebral toxoplasmosis appeared to be increasing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2345321",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 147,
                    "text": "There is a growing demand for laboratory diagnosis of cryptococcal meningitis, which is partly due to the increasing incidence of AIDS in Thailand."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12491162",
                    "endSection": "abstract",
                    "offsetInBeginSection": 698,
                    "offsetInEndSection": 860,
                    "text": "The incidence of HIV-associated distal sensory polyneuropathy has decreased, although the incidence of antiretroviral drug-induced toxic neuropathy has increased."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12491162",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 276,
                    "text": "Highly active antiretroviral therapy (HAART) is effective in suppressing systemic human immunodeficiency virus (HIV) viral load and has decreased mortality rates and the incidence of systemic opportunistic infections in patients with acquired immunodeficiency syndrome (AIDS)."
                }
            ]
        },
        {
            "body": "Which genes are responsible for the high-altitude adaptation of Tibetans?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20838600",
                "http://www.ncbi.nlm.nih.gov/pubmed/22503288",
                "http://www.ncbi.nlm.nih.gov/pubmed/26053282",
                "http://www.ncbi.nlm.nih.gov/pubmed/23666208",
                "http://www.ncbi.nlm.nih.gov/pubmed/22233893",
                "http://www.ncbi.nlm.nih.gov/pubmed/26294746",
                "http://www.ncbi.nlm.nih.gov/pubmed/28585440",
                "http://www.ncbi.nlm.nih.gov/pubmed/23874230",
                "http://www.ncbi.nlm.nih.gov/pubmed/25501874",
                "http://www.ncbi.nlm.nih.gov/pubmed/28116332"
            ],
            "id": "5ace20fa0340b9f05800000c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20838600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1617,
                    "offsetInEndSection": 1857,
                    "text": "Our results indicate that several key HIF-regulatory and targeted genes are responsible for adaptation to high altitude in Andeans and Tibetans, and several different chromosomal regions are implicated in the putative response to selection."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20838600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1858,
                    "offsetInEndSection": 2100,
                    "text": "These data suggest a genetic role in high-altitude adaption and provide a basis for future genotype/phenotype association studies necessary to confirm the role of selection-nominated candidate genes and gene regions in adaptation to altitude."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22503288",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 86,
                    "text": "Recent studies have identified genes involved in high-altitude adaptation in Tibetans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26053282",
                    "endSection": "abstract",
                    "offsetInBeginSection": 383,
                    "offsetInEndSection": 469,
                    "text": "Recent studies have identified genes involved in high-altitude adaptation in Tibetans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22503288",
                    "endSection": "abstract",
                    "offsetInBeginSection": 87,
                    "offsetInEndSection": 370,
                    "text": "Genetic variants/haplotypes within regions containing three of these genes (EPAS1, EGLN1, and PPARA) are associated with relatively decreased hemoglobin levels observed in Tibetans at high altitude, providing corroborative evidence for genetic adaptation to this extreme environment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20838600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 732,
                    "offsetInEndSection": 921,
                    "text": "In addition, groups of genes functioning in oxygen metabolism and sensing were examined to test the hypothesis that particular pathways have been involved in genetic adaptation to altitude."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20838600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1154,
                    "offsetInEndSection": 1351,
                    "text": "The Tibetan and Andean patterns of genetic adaptation are largely distinct from one another, with both populations showing evidence of positive natural selection in different genes or gene regions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20838600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 922,
                    "offsetInEndSection": 1153,
                    "text": "Applying four population genetic statistics commonly used for detecting signatures of natural selection, we identified selection-nominated candidate genes and gene regions in these two populations (Andeans and Tibetans) separately."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23666208",
                    "endSection": "abstract",
                    "offsetInBeginSection": 784,
                    "offsetInEndSection": 1027,
                    "text": "It is highly prevalent in Tibetans (70.9% on average) but extremely rare in Han Chinese, Japanese, Europeans, and Africans (0.56-2.27%), suggesting that it might be the causal mutation of EGLN1 contributing to high-altitude hypoxic adaptation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22233893",
                    "endSection": "abstract",
                    "offsetInBeginSection": 746,
                    "offsetInEndSection": 998,
                    "text": "Our findings provide clues for the existence of adaptive selection for the ATP6, ATP8, Cyt b, ND2, COX2, tRNA alanine and 12S rRNA genes in Tibetans which likely contributed to adaptation to their specific geographic environment, such as high altitude."
                }
            ]
        },
        {
            "body": "Which is the main protein in brown adipose tissue (BAT) active in thermogenesis?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24876128",
                "http://www.ncbi.nlm.nih.gov/pubmed/27561621",
                "http://www.ncbi.nlm.nih.gov/pubmed/28082439",
                "http://www.ncbi.nlm.nih.gov/pubmed/23603815",
                "http://www.ncbi.nlm.nih.gov/pubmed/23550082",
                "http://www.ncbi.nlm.nih.gov/pubmed/16219868",
                "http://www.ncbi.nlm.nih.gov/pubmed/3887525",
                "http://www.ncbi.nlm.nih.gov/pubmed/16464973",
                "http://www.ncbi.nlm.nih.gov/pubmed/24901355",
                "http://www.ncbi.nlm.nih.gov/pubmed/19906816"
            ],
            "id": "5a8980d2fcd1d6a10c00000d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24876128",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 152,
                    "text": "Brown adipose tissue (BAT) plays an essential role in metabolic homeostasis by dissipating energy via thermogenesis through uncoupling protein 1 (UCP1)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27561621",
                    "endSection": "abstract",
                    "offsetInBeginSection": 141,
                    "offsetInEndSection": 465,
                    "text": "Brown adipocytes are responsible for performing non-shivering thermogenesis, which is exclusively mediated by uncoupling protein (UCP) -1 (a protein found in the inner mitochondrial membrane), the hallmark of BAT, responsible for the uncoupling of the proton leakage from the ATP production, therefore, generating heat (i.e."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28082439",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 152,
                    "text": "18F-FDG PET imaging is routinely used to investigate brown adipose tissue (BAT) thermogenesis, which requires mitochondrial uncoupling protein 1 (UCP1)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23603815",
                    "endSection": "abstract",
                    "offsetInBeginSection": 123,
                    "offsetInEndSection": 334,
                    "text": "Central to these pathologies is the fat depot: white adipose tissue (WAT) stores excess calories, and brown adipose tissue (BAT) consumes fuel for thermogenesis using tissue-specific uncoupling protein 1 (UCP1)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23550082",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 213,
                    "text": "Brown adipose tissue (BAT) plays a key role in energy homeostasis and thermogenesis in animals, conferring protection against diet-induced obesity and hypothermia through the action of uncoupling protein 1 (UCP1)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16219868",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 158,
                    "text": "Acute cold exposure leads to norepinephrine release in brown adipose tissue (BAT) and activates uncoupling protein (UCP)1-mediated nonshivering thermogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27561621",
                    "endSection": "abstract",
                    "offsetInBeginSection": 482,
                    "offsetInEndSection": 792,
                    "text": "Besides UCP1, other compounds are essential not only to thermogenesis, but also to the proliferation and differentiation of BAT, including peroxisome proliferator-activated receptor (PPAR) family, PPARgamma coactivator 1 (PGC1)-alpha, and PRD1-BF-1-RIZ1 homologous domain protein containing protein (PRDM) -16."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24876128",
                    "endSection": "abstract",
                    "offsetInBeginSection": 153,
                    "offsetInEndSection": 308,
                    "text": "Previously, we reported that the TATA-binding protein associated factor 7L (TAF7L) is an important regulator of white adipose tissue (WAT) differentiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3887525",
                    "endSection": "abstract",
                    "offsetInBeginSection": 80,
                    "offsetInEndSection": 207,
                    "text": "Thermogenesis in brown adipocytes is related to the presence of a specific mitochondrial component called \"uncoupling protein\"."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28082439",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "Dissociation Between Brown Adipose Tissue 18F-FDG Uptake and Thermogenesis in Uncoupling Protein 1-Deficient Mice."
                }
            ]
        },
        {
            "body": "Which method is Proseek based on?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28930774",
                "http://www.ncbi.nlm.nih.gov/pubmed/26475405",
                "http://www.ncbi.nlm.nih.gov/pubmed/29392211",
                "http://www.ncbi.nlm.nih.gov/pubmed/29050213",
                "http://www.ncbi.nlm.nih.gov/pubmed/27383427",
                "http://www.ncbi.nlm.nih.gov/pubmed/19040730",
                "http://www.ncbi.nlm.nih.gov/pubmed/28083617",
                "http://www.ncbi.nlm.nih.gov/pubmed/28437237",
                "http://www.ncbi.nlm.nih.gov/pubmed/28734077",
                "http://www.ncbi.nlm.nih.gov/pubmed/27710869"
            ],
            "id": "5a9e202bde7cb99d40000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28930774",
                    "endSection": "abstract",
                    "offsetInBeginSection": 738,
                    "offsetInEndSection": 948,
                    "text": "The samples were analyzed with a multiplex proximity extension assay in which 92 inflammation-related proteins were measured simultaneously (Proseek Multiplex Inflammation I; Olink Bioscience, Uppsala, Sweden)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26475405",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1057,
                    "offsetInEndSection": 1175,
                    "text": "Laboratory analyses were performed by Proximity Extension Assay (Proseek Multiplex CVD I(96 \u00d7 96)), ELISAs and RT-PCR."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29392211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 366,
                    "offsetInEndSection": 542,
                    "text": "To simultaneously measure 92 inflammatory biomarkers, we used the proximity extension assay with the Proseek Multiplex Inflammation I panel (Olink Bioscience, Uppsala, Sweden)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29050213",
                    "endSection": "abstract",
                    "offsetInBeginSection": 160,
                    "offsetInEndSection": 575,
                    "text": "Using highly-sensitive Proximity Extension ImmunoAssay on 92 cancer biomarkers (Proseek Multiplex, Olink), enhanced serum levels of Adrenomedullin (ADM, Pcorr= .0004), Growth differentiation factor 15 (GDF15, Pcorr= .003), and soluble Major histocompatibility complex class I-related chain A (sMICA, Pcorr= .023), all prosurvival and chemoprotective factors for myeloma cells, were detected in MM comparing to MGUS."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27383427",
                    "endSection": "abstract",
                    "offsetInBeginSection": 767,
                    "offsetInEndSection": 929,
                    "text": "In addition to conventional laboratory tests, 92 inflammatory proteins were analysed with a multiplex system (Proseek Multiplex Inflammation I, Olink Bioscience)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19040730",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 44,
                    "text": "ProSeeK: a web server for MLPA probe design."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19040730",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1548,
                    "offsetInEndSection": 1676,
                    "text": "ProSeeK will become a useful tool for all laboratories that are currently using MLPA in their research projects for CNV studies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28083617",
                    "endSection": "abstract",
                    "offsetInBeginSection": 543,
                    "offsetInEndSection": 828,
                    "text": "Serum concentrations of 92 inflammation-associated proteins were measured in samples obtained from 80 aHSCT patients 14\u00a0days after transplantation and from 23 healthy control subjects by a novel sensitive proximity extension assay technology using Proseek Multiplex Inflammation I kit."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28437237",
                    "endSection": "abstract",
                    "offsetInBeginSection": 750,
                    "offsetInEndSection": 962,
                    "text": "Blood samples were obtained at baseline (0 hour), 6, 24, and 96 hours post PCI, and stored at -80\u00b0C until they were analyzed by PROSEEK Multiplex CVD and PROSEEK Multiplex INF (Olink Bioscience, Uppsala, Sweden)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28734077",
                    "endSection": "abstract",
                    "offsetInBeginSection": 524,
                    "offsetInEndSection": 702,
                    "text": "METHODS AND RESULTS\nPlasma concentrations of MMP12 were measured at baseline in 3394 subjects with high-risk for cardiovascular disease (CVD) using the Olink ProSeek CVD I array."
                }
            ]
        },
        {
            "body": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19657584",
                "http://www.ncbi.nlm.nih.gov/pubmed/26851573",
                "http://www.ncbi.nlm.nih.gov/pubmed/12566936",
                "http://www.ncbi.nlm.nih.gov/pubmed/19194374",
                "http://www.ncbi.nlm.nih.gov/pubmed/16110245",
                "http://www.ncbi.nlm.nih.gov/pubmed/16584839",
                "http://www.ncbi.nlm.nih.gov/pubmed/21601990",
                "http://www.ncbi.nlm.nih.gov/pubmed/16436187",
                "http://www.ncbi.nlm.nih.gov/pubmed/17007976",
                "http://www.ncbi.nlm.nih.gov/pubmed/12554604"
            ],
            "id": "5a99566e1d1251d03b00000f",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19657584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 222,
                    "text": "Monoamine oxidase A and B (MAOA and MAOB) appear to be involved in the pathogenesis of Major Depression, and vulnerability of Major Depression is associated with personality traits relating to positive and negative affect."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26851573",
                    "endSection": "abstract",
                    "offsetInBeginSection": 369,
                    "offsetInEndSection": 641,
                    "text": "Platelet MAO-B activity has been associated with psychopathy- and aggression-related personality traits, while variants of the MAOA and MAOB genes have been associated with diverse clinical phenotypes, including aggressiveness, antisocial problems and violent delinquency."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12566936",
                    "endSection": "abstract",
                    "offsetInBeginSection": 133,
                    "offsetInEndSection": 274,
                    "text": "We hypothesised that a functional polymorphism in the 5' untranslated region of the MAOA gene is associated with specific personality traits."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19194374",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 121,
                    "text": "A polymorphism of the MAOA gene is associated with emotional brain markers and personality traits on an antisocial index."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19657584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 223,
                    "offsetInEndSection": 463,
                    "text": "This study aimed to investigate associations between MAOA and MAOB polymorphisms and personality traits of positive and negative emotionality in healthy volunteers, to elucidate mechanisms underlying personality and the risk for depression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16110245",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 209,
                    "text": "Monoamine oxidase A (MAOA), a mitochondrial outer membrane enzyme, degrades biogenic amines including norepinephrine, dopamine and serotonin, which have been implicated in the expression of personality traits."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16584839",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 207,
                    "text": "Catechol-O-methyltransferase (COMT) and monoamine oxidase A (MAOA) are both involved in the degradation of various biogenic amines which have been hypothesized to have a relationship with personality traits."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21601990",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 226,
                    "text": "Personality trait research has shown associations with many genes, prominently those of the catecholamine metabolism such as dopamine beta hydroxylase (DBH), catechol-O-methyltransferase (COMT), and monoamine oxidase A (MAOA)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19657584",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 103,
                    "text": "Negative emotionality: monoamine oxidase B gene variants modulate personality traits in healthy humans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16436187",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 377,
                    "text": "By conferring allele-specific transcriptional activity on the monoamine oxidase A (MAOA) gene in humans, length variation of a repetitive sequence [(variable number of tandem repeat (VNTR)] in the MAOA promoter influences a constellation of personality traits related to aggressive and antisocial behavior and increases the risk of neurodevelopmental and psychiatric disorders."
                }
            ]
        },
        {
            "body": "What is the function of HDAC  proteins?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22728920",
                "http://www.ncbi.nlm.nih.gov/pubmed/11306585",
                "http://www.ncbi.nlm.nih.gov/pubmed/22621256",
                "http://www.ncbi.nlm.nih.gov/pubmed/24483782",
                "http://www.ncbi.nlm.nih.gov/pubmed/28337317",
                "http://www.ncbi.nlm.nih.gov/pubmed/16264908",
                "http://www.ncbi.nlm.nih.gov/pubmed/17786239",
                "http://www.ncbi.nlm.nih.gov/pubmed/26927903",
                "http://www.ncbi.nlm.nih.gov/pubmed/19826124",
                "http://www.ncbi.nlm.nih.gov/pubmed/18929655"
            ],
            "id": "5aafc37afcf4565872000010",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22728920",
                    "endSection": "abstract",
                    "offsetInBeginSection": 101,
                    "offsetInEndSection": 288,
                    "text": "Some HDAC isoforms can also modulate the function of nonhistone proteins implicated in regulatory processes, and therefore HDACs are recognized as useful targets for therapeutic purposes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11306585",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 115,
                    "text": "The Rpd3 histone deacetylase (HDAC) functions in a large complex containing many proteins including Sin3 and Sap30."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22621256",
                    "endSection": "abstract",
                    "offsetInBeginSection": 177,
                    "offsetInEndSection": 286,
                    "text": "HDAC is a family of enzymes involved in deacetylation of lysine residues on histone and non-histone proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24483782",
                    "endSection": "abstract",
                    "offsetInBeginSection": 207,
                    "offsetInEndSection": 549,
                    "text": "RECENT ADVANCES\nBesides the classical function of HDACs as HDAC enzymes controlling the transcription, it is becoming increasingly evident that these proteins are involved in the regulation of several other cellular processes by their ability to deacetylate hundreds of proteins with different functions in both the cytoplasm and the nucleus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28337317",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "Histone deacetylase (HDAC) proteins are epigenetic regulators that deacetylate protein substrates, leading to subsequent changes in cell function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16264908",
                    "endSection": "abstract",
                    "offsetInBeginSection": 500,
                    "offsetInEndSection": 702,
                    "text": "In addition to chromatin protein, transcription factors, cell-signaling regulatory proteins, and proteins regulating cell death are substrates of HDACs and may be altered in function by HDAC inhibitors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17786239",
                    "endSection": "abstract",
                    "offsetInBeginSection": 147,
                    "offsetInEndSection": 420,
                    "text": "We show that class II histone deacetylase (HDAC) proteins, which function as transcriptional repressors of the myocyte enhancer factor 2 (MEF2) transcription factor, fail to accumulate in the soleus, a slow muscle, compared with fast muscles (e.g., white vastus lateralis)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26927903",
                    "endSection": "abstract",
                    "offsetInBeginSection": 780,
                    "offsetInEndSection": 896,
                    "text": "Rpd3, the Drosophila HDAC1 homolog, is a class I lysine deacetylase and a member of a large family of HDAC proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11306585",
                    "endSection": "abstract",
                    "offsetInBeginSection": 760,
                    "offsetInEndSection": 941,
                    "text": "In contrast, HDAC activity was not detected in immunoprecipitates of HA-Pho23 or HA-Sap30 from strains lacking Rpd3, suggesting that Rpd3 is the HDAC associated with these proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17786239",
                    "endSection": "abstract",
                    "offsetInBeginSection": 421,
                    "offsetInEndSection": 564,
                    "text": "Accordingly, pharmacological blockade of proteasome function specifically increases expression of class II HDAC proteins in the soleus in vivo."
                }
            ]
        },
        {
            "body": "What is the H4S47C cleavage mapping method used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/2413446",
                "http://www.ncbi.nlm.nih.gov/pubmed/19378164",
                "http://www.ncbi.nlm.nih.gov/pubmed/8502555",
                "http://www.ncbi.nlm.nih.gov/pubmed/2192360",
                "http://www.ncbi.nlm.nih.gov/pubmed/24698368",
                "http://www.ncbi.nlm.nih.gov/pubmed/8449495",
                "http://www.ncbi.nlm.nih.gov/pubmed/7596819",
                "http://www.ncbi.nlm.nih.gov/pubmed/19377938",
                "http://www.ncbi.nlm.nih.gov/pubmed/10079758",
                "http://www.ncbi.nlm.nih.gov/pubmed/17033956"
            ],
            "id": "5a885add61bb38fb24000017",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2413446",
                    "endSection": "abstract",
                    "offsetInBeginSection": 616,
                    "offsetInEndSection": 766,
                    "text": "The peptide antibody method used, called cleavage mapping, should be a convenient technique for mapping residues and ligand binding sites in proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19378164",
                    "endSection": "abstract",
                    "offsetInBeginSection": 159,
                    "offsetInEndSection": 344,
                    "text": "Site-directed cleavage of DNA is a method for mapping the location of interaction of a specific site in a protein such as a linker histone within a large complex such as the nucleosome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8502555",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1260,
                    "offsetInEndSection": 1452,
                    "text": "The approach of using the lambda-terminase cleavage reaction is a simple one-step procedure with a high specificity which is particularly suitable for mapping very large genomes of eucaryotes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2192360",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 142,
                    "text": "UNLABELLED\nPartial cleavage of DNA with the restriction endonuclease NotI (5'...GC/GGCCGC...3') is an important technique for genomic mapping."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24698368",
                    "endSection": "abstract",
                    "offsetInBeginSection": 122,
                    "offsetInEndSection": 256,
                    "text": "In this study, we developed a fast and reliable method for mapping the recognition and cleavage site of the restriction endonucleases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8449495",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 281,
                    "text": "To design a strategy for more efficient long-range physical mapping of large mammalian genomes, we have developed a method for directional mapping from anchor points of randomly integrated retroviral proviruses containing sequences that provide unique cleavage sites in the genome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24698368",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1299,
                    "offsetInEndSection": 1432,
                    "text": "In this study, we demonstrate an efficient and general applicable method for identifying endonuclease recognition and cleavage sites."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8502555",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "A new method for specific cleavage of megabase-size chromosomal DNA by lambda-terminase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7596819",
                    "endSection": "abstract",
                    "offsetInBeginSection": 623,
                    "offsetInEndSection": 905,
                    "text": "This recombination-based cleavage method provides a novel approach for structural and functional analyses of eukaryotic chromosomes as it allows direct isolation of chromosome regions that correspond to phenotypes revealed through Cre-lox mediated chromosome rearrangements in vivo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8502555",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "The development of methods for cleavage of DNA at specific site(s) that are widely spaced would facilitate physical mapping of large genomes."
                }
            ]
        },
        {
            "body": "Which human gene encode for DNA polymerase \u03b8?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11356150",
                "http://www.ncbi.nlm.nih.gov/pubmed/2676986",
                "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                "http://www.ncbi.nlm.nih.gov/pubmed/29079701",
                "http://www.ncbi.nlm.nih.gov/pubmed/11205331",
                "http://www.ncbi.nlm.nih.gov/pubmed/2999787",
                "http://www.ncbi.nlm.nih.gov/pubmed/27657134",
                "http://www.ncbi.nlm.nih.gov/pubmed/1775172",
                "http://www.ncbi.nlm.nih.gov/pubmed/2217198",
                "http://www.ncbi.nlm.nih.gov/pubmed/11058111"
            ],
            "id": "5aacd487fcf4565872000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11356150",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 110,
                    "text": "The human RAD30B gene has recently been shown to encode a novel DNA polymerase, DNA polymerase iota (poliota)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2676986",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 143,
                    "text": "REV3, a Saccharomyces cerevisiae gene whose function is required for induced mutagenesis, is predicted to encode a nonessential DNA polymerase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "DNA polymerase theta (pol \u03b8) is an evolutionarily conserved protein encoded by the POLQ gene in mammalian genomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2676986",
                    "endSection": "abstract",
                    "offsetInBeginSection": 122,
                    "offsetInEndSection": 547,
                    "text": "The nucleotide sequence of this gene encodes a predicted protein of Mr 172,956 showing significant sequence similarity to Epstein-Barr virus DNA polymerase and to other members of a class of DNA polymerases including human DNA polymerase alpha and yeast DNA polymerase I. REV3 protein shows less sequence identity, and presumably a more distant evolutionary relationship, to the latter two enzymes than they do to each other."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29079701",
                    "endSection": "abstract",
                    "offsetInBeginSection": 819,
                    "offsetInEndSection": 1091,
                    "text": "Surprisingly, mutagenic repair by polymerase theta (Pol \u03b8, encoded by the Polq gene) is most prevalent for blunt double-strand breaks (DSBs), while cNHEJ dictates mutagenic repair of DSBs with protruding ends, in which the cNHEJ polymerases lambda and mu play minor roles."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                    "endSection": "abstract",
                    "offsetInBeginSection": 885,
                    "offsetInEndSection": 1152,
                    "text": "However, challenges for expression and purification are presented by the large size of pol \u03b8 (2590 residues in humans) and unusual juxtaposition of domains (a helicase-like domain and distinct DNA polymerase, separated by a region predicted to be largely disordered)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11205331",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1007,
                    "offsetInEndSection": 1105,
                    "text": "Very recently RAD30B has also been shown to encode a novel DNA polymerase, designated as Pol iota."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 68,
                    "text": "Expression and Structural Analyses of Human DNA Polymerase \u03b8 (POLQ)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2999787",
                    "endSection": "abstract",
                    "offsetInBeginSection": 442,
                    "offsetInEndSection": 652,
                    "text": "The predicted polymerase polypeptide shares extensive sequence homology with the Epstein-Barr virus open frame predicted to encode DNA polymerase and with a 13-amino acid segment of adenovirus 2 DNA polymerase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27657134",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "The gene encoding DNA polymerase \u03b8 (Pol\u03b8) was discovered over ten years ago as having a role in suppressing genome instability in mammalian cells."
                }
            ]
        },
        {
            "body": "In what percentage of skeletal muscle fibers is dystrophin expression restored after PPMO- mediated exon skipping?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28373570",
                "http://www.ncbi.nlm.nih.gov/pubmed/24942628",
                "http://www.ncbi.nlm.nih.gov/pubmed/18384691",
                "http://www.ncbi.nlm.nih.gov/pubmed/7516752",
                "http://www.ncbi.nlm.nih.gov/pubmed/8213828",
                "http://www.ncbi.nlm.nih.gov/pubmed/18647087",
                "http://www.ncbi.nlm.nih.gov/pubmed/28566768",
                "http://www.ncbi.nlm.nih.gov/pubmed/21507246",
                "http://www.ncbi.nlm.nih.gov/pubmed/26449883",
                "http://www.ncbi.nlm.nih.gov/pubmed/27285612"
            ],
            "id": "5ac0a82d19833b0d7b000003",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28373570",
                    "endSection": "abstract",
                    "offsetInBeginSection": 767,
                    "offsetInEndSection": 907,
                    "text": "Intravenous injections with PPMOs restored dystrophin expression in the myocardium and cardiac Purkinje fibers, as well as skeletal muscles."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24942628",
                    "endSection": "abstract",
                    "offsetInBeginSection": 730,
                    "offsetInEndSection": 848,
                    "text": "administration of the PPMO restored the dystrophin expression in nearly 100% skeletal muscle fibers in all age groups."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18384691",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 278,
                    "text": "BACKGROUND\nExon skipping oligonucleotides (ESOs) of 2'O-Methyl (2'OMe) and morpholino chemistry have been shown to restore dystrophin expression in muscle fibers from the mdx mouse, and are currently being tested in phase I clinical trials for Duchenne Muscular Dystrophy (DMD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18384691",
                    "endSection": "abstract",
                    "offsetInBeginSection": 955,
                    "offsetInEndSection": 1313,
                    "text": "Three weekly intramuscular injections of 5 microg of ESO complexed with PEI2K-PEG550 copolymers resulted in about 500 dystrophin-positive fibers and about 12% of normal levels of dystrophin expression at 3 weeks after the initial injection, which is significantly greater than for injections of ESO alone, which are known to be almost completely ineffective."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28373570",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1592,
                    "offsetInEndSection": 1761,
                    "text": "We demonstrate that rescued dystrophin expression in the Purkinje fibers leads to the improvement/prevention of cardiac conduction abnormalities in the dystrophic heart."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18384691",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "Nanopolymers improve delivery of exon skipping oligonucleotides and concomitant dystrophin expression in skeletal muscle of mdx mice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28373570",
                    "endSection": "abstract",
                    "offsetInBeginSection": 908,
                    "offsetInEndSection": 1019,
                    "text": "Vacuole degeneration of cardiac Purkinje fibers, as seen in DMD patients, was ameliorated in PPMO-treated dogs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7516752",
                    "endSection": "abstract",
                    "offsetInBeginSection": 558,
                    "offsetInEndSection": 722,
                    "text": "In DMD, a very small percentage of muscle fibers show dystrophin staining along the sarcolemma, presumably due to a second in-frame deletion in the dystrophin gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8213828",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 231,
                    "text": "Although many Duchenne muscular dystrophy patients have a deletion in the dystrophin gene which disrupts the translational reading frame, they express dystrophin in a small proportion of skeletal muscle fibers (\"revertant fibers\")."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7516752",
                    "endSection": "abstract",
                    "offsetInBeginSection": 971,
                    "offsetInEndSection": 1192,
                    "text": "Our results suggest that the entire dystrophin-glycoprotein complex is restored in revertants and, thus, the linkage between the subsarcolemmal cytoskeleton and the extracellular matrix is restored in these muscle fibers."
                }
            ]
        },
        {
            "body": "Which miRNA is associated with the circular RNA ciRS-7?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                "http://www.ncbi.nlm.nih.gov/pubmed/24014594",
                "http://www.ncbi.nlm.nih.gov/pubmed/27796758",
                "http://www.ncbi.nlm.nih.gov/pubmed/27040487",
                "http://www.ncbi.nlm.nih.gov/pubmed/29236709",
                "http://www.ncbi.nlm.nih.gov/pubmed/26211738",
                "http://www.ncbi.nlm.nih.gov/pubmed/28970820",
                "http://www.ncbi.nlm.nih.gov/pubmed/28049499",
                "http://www.ncbi.nlm.nih.gov/pubmed/25070500",
                "http://www.ncbi.nlm.nih.gov/pubmed/28820337"
            ],
            "id": "5ac725250340b9f058000006",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 579,
                    "offsetInEndSection": 747,
                    "text": "ciRS-7 contains more than 70 selectively conserved miRNA target sites, and it is highly and widely associated with Argonaute (AGO) proteins in a miR-7-dependent manner."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24014594",
                    "endSection": "abstract",
                    "offsetInBeginSection": 300,
                    "offsetInEndSection": 484,
                    "text": "Particularly, the recently identified circular RNA, ciRS-7, which acts as a designated miR-7 inhibitor/sponge, has conceptually changed the mechanistic understanding of miRNA networks."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 451,
                    "offsetInEndSection": 578,
                    "text": "Here we show that this circRNA acts as a miR-7 sponge; we term this circular transcript ciRS-7 (circular RNA sponge for miR-7)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1105,
                    "offsetInEndSection": 1307,
                    "text": "We further show that the testis-specific circRNA, sex-determining region Y (Sry), serves as a miR-138 sponge, suggesting that miRNA sponge effects achieved by circRNA formation are a general phenomenon."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24014594",
                    "endSection": "abstract",
                    "offsetInBeginSection": 107,
                    "offsetInEndSection": 299,
                    "text": "The identification of competing endogenous RNA and circular RNA (circRNA) as important regulators of miRNA activity underscores the increasing complexity of ncRNA-mediated regulatory networks."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 179,
                    "offsetInEndSection": 357,
                    "text": "Recently, miRNA activity has been shown to be affected by the presence of miRNA sponge transcripts, the so-called competing endogenous RNA in humans and target mimicry in plants."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24014594",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "MicroRNAs (miRNA) play important roles in fine-tuning gene expression and are often deregulated in cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 922,
                    "offsetInEndSection": 1104,
                    "text": "In the mouse brain, we observe overlapping co-expression of ciRS-7 and miR-7, particularly in neocortical and hippocampal neurons, suggesting a high degree of endogenous interaction."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 59,
                    "text": "Natural RNA circles function as efficient microRNA sponges."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 358,
                    "offsetInEndSection": 450,
                    "text": "We previously identified a highly expressed circular RNA (circRNA) in human and mouse brain."
                }
            ]
        },
        {
            "body": "Which are the two main bacterial phyla in human gut?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27900395",
                "http://www.ncbi.nlm.nih.gov/pubmed/26271635",
                "http://www.ncbi.nlm.nih.gov/pubmed/21829462",
                "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                "http://www.ncbi.nlm.nih.gov/pubmed/27638955",
                "http://www.ncbi.nlm.nih.gov/pubmed/25873372",
                "http://www.ncbi.nlm.nih.gov/pubmed/23982459",
                "http://www.ncbi.nlm.nih.gov/pubmed/24324923",
                "http://www.ncbi.nlm.nih.gov/pubmed/22025614",
                "http://www.ncbi.nlm.nih.gov/pubmed/20941585"
            ],
            "id": "5abd2ce0fcf456587200002a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27900395",
                    "endSection": "abstract",
                    "offsetInBeginSection": 147,
                    "offsetInEndSection": 304,
                    "text": "Out of thousands of bacterial species-level phylotypes inhabiting the human gut, the majority belong to two dominant phyla, the Bacteroidetes and Firmicutes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26271635",
                    "endSection": "abstract",
                    "offsetInBeginSection": 594,
                    "offsetInEndSection": 732,
                    "text": "We show that, unlike other mammalian herbivores, sloth gut communities are dominated by the bacterial phyla Proteobacteria and Firmicutes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21829462",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 267,
                    "text": "The human gut microbiota is considered one of the most fascinating reservoirs of microbial diversity hosting between 400 to 1000 bacterial species distributed among nine phyla with Firmicutes, Bacteroidetes and Actinobacteria representing around 75% of the diversity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "The adult human distal gut microbial community is typically dominated by 2 bacterial phyla (divisions), the Firmicutes and the Bacteroidetes."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 100,
                    "text": "Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1517,
                    "offsetInEndSection": 1764,
                    "text": "This simplified model of the human gut microbiota illustrates niche specialization and functional redundancy within members of its major bacterial phyla, and the importance of host glycans as a nutrient foundation that ensures ecosystem stability."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27638955",
                    "endSection": "abstract",
                    "offsetInBeginSection": 459,
                    "offsetInEndSection": 845,
                    "text": "As results, 132 bacterial genera and some unidentified operational taxonomic units within 29 phyla in the gut bacteria were detected, with Spirochaetes (11-55%), Firmicutes (7-18%), Bacteroidetes (7-31%), and Proteobacteria (8-14%) as the main phyla, and Treponema, TG5, Dysgonomonas, Tannerella, za29, Lactococcus, Pseudomonas, and SJA-88 as the common genera in all the four termites."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25873372",
                    "endSection": "abstract",
                    "offsetInBeginSection": 961,
                    "offsetInEndSection": 1208,
                    "text": "Analyses of sequenced bacterial genomes revealed that the cut cluster is present in many human gut bacteria, is predictive of choline utilization in sequenced isolates, and is widely but discontinuously distributed across multiple bacterial phyla."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23982459",
                    "endSection": "abstract",
                    "offsetInBeginSection": 334,
                    "offsetInEndSection": 577,
                    "text": "Here we reconstructed GEMs for three key species, (Bacteroides thetaiotamicron, Eubacterium rectale and Methanobrevibacter smithii) as relevant representatives of three main phyla in the human gut (Bacteroidetes, Firmicutes and Euryarchaeota)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24324923",
                    "endSection": "abstract",
                    "offsetInBeginSection": 3223,
                    "offsetInEndSection": 3415,
                    "text": "CONCLUSION/SIGNIFICANCE\nOur data show a high bacterial diversity in P. americana gut, with communities composed mostly by the phyla Bacteroidetes, Firmicutes, Proteobacteria and Synergistetes."
                }
            ]
        },
        {
            "body": "What are 7 symptoms of yellow fever?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11000957",
                "http://www.ncbi.nlm.nih.gov/pubmed/20970723",
                "http://www.ncbi.nlm.nih.gov/pubmed/6376649",
                "http://www.ncbi.nlm.nih.gov/pubmed/19869707",
                "http://www.ncbi.nlm.nih.gov/pubmed/23873723",
                "http://www.ncbi.nlm.nih.gov/pubmed/27087559",
                "http://www.ncbi.nlm.nih.gov/pubmed/18261201",
                "http://www.ncbi.nlm.nih.gov/pubmed/19869938",
                "http://www.ncbi.nlm.nih.gov/pubmed/17253051",
                "http://www.ncbi.nlm.nih.gov/pubmed/11579875"
            ],
            "id": "5aac5469fcf4565872000005",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11000957",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "Yellow fever is an arthropod-borne disease with symptoms ranging from mild fever to acute hepatonephritis, hemorrhages and shock often fatal."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11000957",
                    "endSection": "abstract",
                    "offsetInBeginSection": 142,
                    "offsetInEndSection": 254,
                    "text": "The pathophysiology of severe yellow fever in humans and in monkeys susceptible to the virus is largely unknown."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20970723",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 74,
                    "text": "Yellow fever is a mosquito-borne disease, which can cause serious illness."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11000957",
                    "endSection": "abstract",
                    "offsetInBeginSection": 335,
                    "offsetInEndSection": 467,
                    "text": "The degree of severity in yellow fever disease is linked to different factors related to virus virulence and to host susceptibility."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20970723",
                    "endSection": "abstract",
                    "offsetInBeginSection": 427,
                    "offsetInEndSection": 601,
                    "text": "Yellow fever vaccination centres are often subject to inspection in many countries, although the requirements for Yellow fever vaccinators (YFV) vary from country to country."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11000957",
                    "endSection": "abstract",
                    "offsetInBeginSection": 468,
                    "offsetInEndSection": 636,
                    "text": "A better knowledge of the complex interactions between the virus and the host is requested before initiating new actions in prophylaxy and therapy against yellow fever."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11000957",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 84,
                    "text": "[Recent knowledge on the pathogenesis of yellow fever and questions for the future]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6376649",
                    "endSection": "abstract",
                    "offsetInBeginSection": 690,
                    "offsetInEndSection": 909,
                    "text": "Future users of this dengue-2 vaccine may wish to employ immunization schedules that include preliminary immunization against yellow fever and must be prepared to accept mild vaccine-related symptoms in some recipients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19869707",
                    "endSection": "abstract",
                    "offsetInBeginSection": 3,
                    "offsetInEndSection": 167,
                    "text": "The yellow fever now in South America, the present yellow fever of Africa and the historic yellow fever of Panama and other American countries are the same disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20970723",
                    "endSection": "abstract",
                    "offsetInBeginSection": 75,
                    "offsetInEndSection": 314,
                    "text": "The World Health Organization (WHO) requires travellers to have vaccination against Yellow fever for all international travel going into and from Yellow fever endemic areas in order to prevent the spread of this potentially deadly disease."
                }
            ]
        },
        {
            "body": "Which test is used for the definition of colour-blindness?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25452008",
                "http://www.ncbi.nlm.nih.gov/pubmed/29291080",
                "http://www.ncbi.nlm.nih.gov/pubmed/314267",
                "http://www.ncbi.nlm.nih.gov/pubmed/306798",
                "http://www.ncbi.nlm.nih.gov/pubmed/310055",
                "http://www.ncbi.nlm.nih.gov/pubmed/26591383",
                "http://www.ncbi.nlm.nih.gov/pubmed/1495767",
                "http://www.ncbi.nlm.nih.gov/pubmed/16431664",
                "http://www.ncbi.nlm.nih.gov/pubmed/4049749",
                "http://www.ncbi.nlm.nih.gov/pubmed/18942220"
            ],
            "id": "5ad6e431133db5eb7800000e",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25452008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 965,
                    "offsetInEndSection": 1096,
                    "text": "To test for colour-blindness, we used a cognitive approach involving a harbour seal trained to use a concept of same and different."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25452008",
                    "endSection": "title",
                    "offsetInBeginSection": 25,
                    "offsetInEndSection": 84,
                    "text": "Behavioural evidence for colour-blindness in harbour seals."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25452008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1294,
                    "offsetInEndSection": 1382,
                    "text": "However, the seal responded with \"same\", providing strong evidence for colour-blindness."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25452008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 469,
                    "offsetInEndSection": 632,
                    "text": "Using a psychophysical discrimination experiment, we showed that a harbour seal can solve a colour discrimination task by means of brightness discrimination alone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25452008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 890,
                    "offsetInEndSection": 964,
                    "text": "This finding speaks against rod-cone-based colour vision in harbour seals."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25452008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 633,
                    "offsetInEndSection": 889,
                    "text": "Performing a series of experiments in which two harbour seals had to discriminate the brightness of colours, we also found strong evidence for purely scotopic (rod-based) vision at light levels that lead to mesopic (rod-cone-based) vision in other mammals."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25452008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 115,
                    "offsetInEndSection": 295,
                    "text": "Nevertheless, earlier studies showed that these marine mammals can discriminate colours and a colour vision mechanism has been proposed which contrasts signals from cones and rods."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25452008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 296,
                    "offsetInEndSection": 468,
                    "text": "However, these earlier studies underestimated the brightness discrimination abilities of these animals, so that they could have discriminated colours using brightness only."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25452008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "All seals and cetaceans have lost at least one of two ancestral cone classes and should therefore be colour-blind."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25452008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1097,
                    "offsetInEndSection": 1196,
                    "text": "We tested this seal with pairs of isoluminant stimuli that were either same or different in colour."
                }
            ]
        },
        {
            "body": "Of what origin is the MCF-7 cell line?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/849449",
                "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                "http://www.ncbi.nlm.nih.gov/pubmed/10961387",
                "http://www.ncbi.nlm.nih.gov/pubmed/11964080",
                "http://www.ncbi.nlm.nih.gov/pubmed/176383",
                "http://www.ncbi.nlm.nih.gov/pubmed/7507345",
                "http://www.ncbi.nlm.nih.gov/pubmed/16883051",
                "http://www.ncbi.nlm.nih.gov/pubmed/16606541",
                "http://www.ncbi.nlm.nih.gov/pubmed/10601320",
                "http://www.ncbi.nlm.nih.gov/pubmed/23112854"
            ],
            "id": "5ac08fe7d0c506ce46000003",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/849449",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 120,
                    "text": "In a mammary gland cell line (MCF-7) of human origin, insulin stimulated the rates of RNA, DNA and protein biosynthesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1277,
                    "offsetInEndSection": 1352,
                    "text": "MCF-7/ADR and the breast cancer cell line MCF-7 are not of the same origin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 556,
                    "offsetInEndSection": 838,
                    "text": "Since the MCF-7/ADR' cell line was definitely derived from parental MCF-7 cells, we were able to directly compare these cell lines together with MCF-7/ADR using immunocytochemical, morphological, and consecutive DNA fingerprinting analyses to determine the true origin of MCF-7/ADR."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 222,
                    "offsetInEndSection": 327,
                    "text": "Many recent studies still describe MCF-7/ADR cells as originating from the breast cancer cell line MCF-7."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10961387",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 452,
                    "text": "Genistein, a prominent isoflavone in soy products, produced dose- and time-dependent in vitro growth inhibition at high concentrations (at least 185 microM) with an IC50 of 7.0-274.2 microM after 72 h incubation in four breast cancer cell lines (DD-762, Sm-MT, MCF-7 and MDA-MB-231) and one breast epithelial cell line (HBL- 100) of human and animal origin; it stimulated estrogen-receptor-positive MCF-7 cells at low concentrations (3.7 nM-37 microM)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11964080",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 178,
                    "text": "Distinctive alterations of invasiveness, drug resistance and cell-cell organization in 3D-cultures of MCF-7, a human breast cancer cell line, and its multidrug resistant variant."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 391,
                    "offsetInEndSection": 555,
                    "text": "In this study, a new adriamycin (ADR)-resistant cell line MCF-7/ADR' was reproduced using the same procedure employed during the initial establishment of MCF-7/ADR."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "MCF-7/ADR cells (re-designated NCI/ADR-RES) are not derived from MCF-7 breast cancer cells: a loss for breast cancer multidrug-resistant research."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/176383",
                    "endSection": "abstract",
                    "offsetInBeginSection": 201,
                    "offsetInEndSection": 314,
                    "text": "To further characterize the tumor origin of the MCF-7 line, cells were grown on collagen-coated cellulos sponges."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/176383",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 107,
                    "text": "Reexpression of the original tumor pattern by a human breast carcinoma cell line (MCF-7) in sponge culture."
                }
            ]
        },
        {
            "body": "Is lumican a secreted protein?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/15966909",
                "http://www.ncbi.nlm.nih.gov/pubmed/27126993",
                "http://www.ncbi.nlm.nih.gov/pubmed/18083934",
                "http://www.ncbi.nlm.nih.gov/pubmed/17632767",
                "http://www.ncbi.nlm.nih.gov/pubmed/12714648",
                "http://www.ncbi.nlm.nih.gov/pubmed/15849191",
                "http://www.ncbi.nlm.nih.gov/pubmed/22266188",
                "http://www.ncbi.nlm.nih.gov/pubmed/17050378",
                "http://www.ncbi.nlm.nih.gov/pubmed/11259366",
                "http://www.ncbi.nlm.nih.gov/pubmed/8099356"
            ],
            "id": "5ad255210340b9f058000018",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15966909",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 218,
                    "text": "BACKGROUND\nSmall leucine-rich proteoglycans (SLRPs) decorin, biglycan, fibromodulin and lumican are secreted extracellular matrix molecules that associate with fibrillar collagens and regulate collagen fibrillogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27126993",
                    "endSection": "abstract",
                    "offsetInBeginSection": 374,
                    "offsetInEndSection": 449,
                    "text": "Lumican is a secreted proteoglycan that regulates collagen fibril assembly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18083934",
                    "endSection": "abstract",
                    "offsetInBeginSection": 526,
                    "offsetInEndSection": 703,
                    "text": "were included, collagen alpha2 (I), matrix extracellular phosphoglycoprotein, secreted phosphoprotein 24, chondroadherin, lumican, perlecan, thrombospondin 1, nucleobindin, etc."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15966909",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 140,
                    "text": "Distinctive localization and function for lumican, fibromodulin and decorin to regulate collagen fibril organization in periodontal tissues."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15966909",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1775,
                    "offsetInEndSection": 1958,
                    "text": "CONCLUSIONS\nThese findings indicate that decorin, fibromodulin and lumican coordinately regulate the fibrillar and suprafibrillar organization of collagen in the periodontal ligament."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27126993",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1531,
                    "offsetInEndSection": 1790,
                    "text": "CONCLUSIONS\nOur results demonstrate that activated pancreatic stellate cells within PDAC secrete lumican under the negative control of TGF-\u03b2; once secreted, the extracellular lumican enhances stellate cell adhesion and mobility in a collagen-rich environment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27126993",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1156,
                    "offsetInEndSection": 1371,
                    "text": "We demonstrate that the cytokine, TGF-\u03b2, negatively regulates lumican gene transcription within HPSCs through its canonical signaling pathway and binding of SMAD4 to novel SBEs identified within the promoter region."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17632767",
                    "endSection": "abstract",
                    "offsetInBeginSection": 532,
                    "offsetInEndSection": 885,
                    "text": "In vitro assays that modeled key steps in the angiogenic process showed that several identified genes possessed pro- or anti-angiogenic activities (e.g., SMOC-2, secreted modular calcium-binding protein-2; CRELD-2, cysteine-rich with EGF-like domains-1; MAGP-2, microfibril-associated glycoprotein-2; lumican; and ECM-1, extracellular matrix protein-1)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15966909",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1487,
                    "offsetInEndSection": 1688,
                    "text": "Targeted deletion of decorin, fibromodulin, lumican or both lumican and fibromodulin resulted in abnormal collagen fibril and fibril bundle morphology that was most evident in the periodontal ligament."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12714648",
                    "endSection": "abstract",
                    "offsetInBeginSection": 223,
                    "offsetInEndSection": 278,
                    "text": "Lumican is a keratan sulfate proteoglycan core protein."
                }
            ]
        },
        {
            "body": "Cytochrome p450 CYP3A is induced by rifampicin  and compounds used to treat what virus?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23975654",
                "http://www.ncbi.nlm.nih.gov/pubmed/23071008",
                "http://www.ncbi.nlm.nih.gov/pubmed/27490210",
                "http://www.ncbi.nlm.nih.gov/pubmed/21241325",
                "http://www.ncbi.nlm.nih.gov/pubmed/26910068",
                "http://www.ncbi.nlm.nih.gov/pubmed/24056704",
                "http://www.ncbi.nlm.nih.gov/pubmed/7628309",
                "http://www.ncbi.nlm.nih.gov/pubmed/9413920",
                "http://www.ncbi.nlm.nih.gov/pubmed/11336977",
                "http://www.ncbi.nlm.nih.gov/pubmed/19371336"
            ],
            "id": "5ab2cc66fcf4565872000015",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23975654",
                    "endSection": "abstract",
                    "offsetInBeginSection": 222,
                    "offsetInEndSection": 696,
                    "text": "Clinical studies in healthy subjects were performed to evaluate potential pharmacokinetic interactions between vortioxetine (Lu AA21004) and co-administered agents, including fluconazole (cytochrome P450 [CYP] 2C9, CYP2C19 and CYP3A inhibitor), ketoconazole (CYP3A and P-glycoprotein inhibitor), rifampicin (CYP inducer), bupropion (CYP2D6 inhibitor and CYP2B6 substrate), ethinyl estradiol/levonorgestrel (CYP3A substrates) and omeprazole (CYP2C19 substrate and inhibitor)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23071008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 224,
                    "text": "Induction of the cytochrome P450 (CYP) family of enzymes by coadministered compounds can result in drug-drug interactions, as in the case of the coadministration of rifampicin with many CYP3A substrates, including midazolam."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27490210",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 341,
                    "text": "In this study with crucian carp (Carassius auratus gibelio), the effect on enrofloxacin (EF) and its metabolite ciprofloxacin (CF) and on the activity of cytochrome P450 1A (CYP1A) and cytochrome P450 3A (CYP3A) was estimated following the oral administration of rifampicin (RIF) (12mg/kg) and \u03b2-naphthoflavone (BNF) (12mg/kg), respectively."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21241325",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 280,
                    "text": "The influence of pretreatment with ketoconazole [cytochrome P450 3A (CYP3A) + P-glycoprotein (P-gp) inhibitor], elacridar (selective P-gp inhibitor) and rifampicin (CYP3A + P-gp inducer) on oral morphine pharmacokinetics and pharmacodynamics was investigated in experimental dogs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23071008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 804,
                    "offsetInEndSection": 993,
                    "text": "The E(max) and EC(50) values in two separate lots of hepatocytes for CYP3A induction by rifampicin in a 96-well format were similar when discrete probe was compared with the probe cocktail."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26910068",
                    "endSection": "abstract",
                    "offsetInBeginSection": 352,
                    "offsetInEndSection": 660,
                    "text": "In this investigation, we tested the hypothesis that induction of cytochrome P450 (Cyp)3a11 gene by paclitaxel is downregulated by the inflammatory mediator, lipopolysaccharide (LPS), and that the pro-inflammatory cytokine, tumor necrosis factor (TNF)-\u03b1, attenuates human CYP3A4 gene induction by rifampicin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23975654",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1623,
                    "offsetInEndSection": 1734,
                    "text": "CONCLUSION\nDosage adjustment may be required when vortioxetine is co-administered with bupropion or rifampicin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23975654",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1210,
                    "offsetInEndSection": 1514,
                    "text": "Steady-state AUC and C max of vortioxetine increased when co-administered with bupropion (128 and 114\u00a0%, respectively), fluconazole (46 and 15\u00a0%, respectively) and ketoconazole (30 and 26\u00a0%, respectively), and decreased by 72 and 51\u00a0%, respectively, when vortioxetine was co-administered with rifampicin."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26910068",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 116,
                    "text": "In Vitro Approaches to Study Regulation of Hepatic Cytochrome P450 (CYP) 3A Expression by Paclitaxel and Rifampicin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24056704",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 303,
                    "text": "AIM\nTo investigate the metabolism of GLS4, a heteroaryldihydropyrimidine compound with anti-hepatitis B virus activity, in dog and human liver microsomes in vitro and evaluate the effects of ketoconazole (a potent CYP3A inhibitor) or rifampicin (a potent CYP3A inducer) on GLS4 pharmacokinetics in dogs."
                }
            ]
        },
        {
            "body": "Which human chromosome is the product of fusion?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/3325883",
                "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                "http://www.ncbi.nlm.nih.gov/pubmed/28259884",
                "http://www.ncbi.nlm.nih.gov/pubmed/15815621",
                "http://www.ncbi.nlm.nih.gov/pubmed/10637483",
                "http://www.ncbi.nlm.nih.gov/pubmed/20132013",
                "http://www.ncbi.nlm.nih.gov/pubmed/12769020",
                "http://www.ncbi.nlm.nih.gov/pubmed/12836614",
                "http://www.ncbi.nlm.nih.gov/pubmed/19332641",
                "http://www.ncbi.nlm.nih.gov/pubmed/28333343"
            ],
            "id": "5ace238e0340b9f05800000d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3325883",
                    "endSection": "abstract",
                    "offsetInBeginSection": 372,
                    "offsetInEndSection": 592,
                    "text": "The results also demonstrate that the product of the activated met gene is a fusion protein and that the amino terminal end of this fusion protein, which is encoded by human chromosome 1, exhibits homology to laminin B1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 143,
                    "text": "Human chromosome 2 is a product of a telomere fusion of two ancestral chromosomes and loss/degeneration of one of the two original centromeres."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28259884",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 128,
                    "text": "The Dicentric Chromosome dic(20;22) Is a Recurrent Abnormality in Myelodysplastic Syndromes and Is a Product of Telomere Fusion."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15815621",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 144,
                    "text": "Human chromosome 2 is unique to the human lineage in being the product of a head-to-head fusion of two intermediate-sized ancestral chromosomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10637483",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1138,
                    "offsetInEndSection": 1246,
                    "text": "Our data indicate that the CALM/AF10 fusion product on the der(10) chromosome is critical to leukemogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20132013",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1031,
                    "offsetInEndSection": 1159,
                    "text": "Hybrid clone 2 had a diploid set of murine chromosomes complements and also contained an interspecies chromosome fusion product."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12769020",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 349,
                    "text": "The molecular pathogenesis of alveolar soft part sarcoma, a rare tumor with uncertain histogenesis, was elucidated recently and was shown to be due to a translocation between chromosome 17q25 and Xp11 resulting in a fusion product between TFE3 (a transcription factor gene) at chromosome Xp11 and a novel gene designated as ASPL at chromosome 17q25."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12836614",
                    "endSection": "abstract",
                    "offsetInBeginSection": 850,
                    "offsetInEndSection": 1052,
                    "text": "Chromosome translocations can lead to the deregulated expression of a normal gene product, but in most cases of leukemia, chromosome rearrangements result in the expression of a chimeric fusion protein."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19332641",
                    "endSection": "abstract",
                    "offsetInBeginSection": 415,
                    "offsetInEndSection": 644,
                    "text": "The recombinant chromosome that harbors the beta/delta fusion gene in elephants is structurally similar to the \"anti-Lepore\" duplication mutant of humans (the reciprocal exchange product of the hemoglobin Lepore deletion mutant)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28333343",
                    "endSection": "abstract",
                    "offsetInBeginSection": 632,
                    "offsetInEndSection": 961,
                    "text": "We investigate the most recent product of a chromosome fusion event fixed in the human lineage, human chromosome 2, whose stability was acquired by the suppression of one centromere, resulting in a unique difference in chromosome number between humans (46 chromosomes) and our most closely related ape relatives (48 chromosomes)."
                }
            ]
        },
        {
            "body": "Where is the EpCam protein mainly located?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26356670",
                "http://www.ncbi.nlm.nih.gov/pubmed/23484855",
                "http://www.ncbi.nlm.nih.gov/pubmed/23026194",
                "http://www.ncbi.nlm.nih.gov/pubmed/20728540",
                "http://www.ncbi.nlm.nih.gov/pubmed/24183651",
                "http://www.ncbi.nlm.nih.gov/pubmed/20974811",
                "http://www.ncbi.nlm.nih.gov/pubmed/26054340",
                "http://www.ncbi.nlm.nih.gov/pubmed/17940847",
                "http://www.ncbi.nlm.nih.gov/pubmed/22391566",
                "http://www.ncbi.nlm.nih.gov/pubmed/16054130"
            ],
            "id": "5ac09a7b19833b0d7b000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26356670",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 267,
                    "text": "Epithelial cell adhesion molecule (EpCAM) is a type I transmembrane protein that is expressed in the majority of normal epithelial tissues and is overexpressed in most epithelial cancers including breast cancer, where it plays an important role in cancer progression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23484855",
                    "endSection": "abstract",
                    "offsetInBeginSection": 460,
                    "offsetInEndSection": 663,
                    "text": "EpCAM directly binds to Kremen1 and disrupts the Kremen1-Dickkopf2 (Dkk2) interaction, which prevents Kremen1-Dkk2-mediated removal of Lipoprotein-receptor-related protein 6 (Lrp6) from the cell surface."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23484855",
                    "endSection": "abstract",
                    "offsetInBeginSection": 139,
                    "offsetInEndSection": 371,
                    "text": "To learn how response to the liver-inductive Wnt2bb signal is achieved, we identify an endoderm-enriched, single transmembrane protein, epithelial-cell-adhesion-molecule (EpCAM), as an endoderm-specific Wnt derepressor in zebrafish."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23026194",
                    "endSection": "abstract",
                    "offsetInBeginSection": 478,
                    "offsetInEndSection": 563,
                    "text": "EPCAM protein, expressed in epithelial tissues, is encoded by the EPCAM/TACSTD1 gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20728540",
                    "endSection": "abstract",
                    "offsetInBeginSection": 710,
                    "offsetInEndSection": 913,
                    "text": "Protein sequence analysis revealed a transmembrane domain and two epidermal growth factor (EGF)-like repeats in the extracellular region of gcEpCAM which were both conserved in EpCAM from fish to mammal."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24183651",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 134,
                    "text": "Epithelial cell adhesion molecule (EpCAM) is a cell-surface protein highly expressed in embryonic tissues and in malignant carcinomas."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20974811",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "Epithelial cell adhesion molecule (EpCAM) is best known as a tumor-associated protein highly expressed in carcinomas."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26054340",
                    "endSection": "abstract",
                    "offsetInBeginSection": 112,
                    "offsetInEndSection": 235,
                    "text": "Basolaterally located cld7 is enriched in glycolipid-enriched membrane domains (GEM), where it associates with EpCAM (EpC)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17940847",
                    "endSection": "abstract",
                    "offsetInBeginSection": 105,
                    "offsetInEndSection": 244,
                    "text": "Among different species, the amino acid sequence of EpCAM is highly homologous, indicating that EpCAM is an evolutionary conserved protein."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23026194",
                    "endSection": "abstract",
                    "offsetInBeginSection": 324,
                    "offsetInEndSection": 477,
                    "text": "Of interest, 3' exons deletions of the EPCAM gene, which is located upstream of MSH2 in chromosome 2, are associated with MSH2 promoter hypermethylation."
                }
            ]
        },
        {
            "body": "What is the drug target for Eliquis (Apixaban)?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23649961",
                "http://www.ncbi.nlm.nih.gov/pubmed/28008269",
                "http://www.ncbi.nlm.nih.gov/pubmed/24672216",
                "http://www.ncbi.nlm.nih.gov/pubmed/26095540",
                "http://www.ncbi.nlm.nih.gov/pubmed/26369819",
                "http://www.ncbi.nlm.nih.gov/pubmed/24624626",
                "http://www.ncbi.nlm.nih.gov/pubmed/25195485",
                "http://www.ncbi.nlm.nih.gov/pubmed/24391389",
                "http://www.ncbi.nlm.nih.gov/pubmed/23821689",
                "http://www.ncbi.nlm.nih.gov/pubmed/25682082"
            ],
            "id": "5abbe429fcf456587200001c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23649961",
                    "endSection": "abstract",
                    "offsetInBeginSection": 245,
                    "offsetInEndSection": 458,
                    "text": "The new oral anticoagulants (NOAC) include dabigatran etexilate (Pradaxa\u00ae), a direct thrombin inhibitor, and rivaroxaban (Xarelto\u00ae), Apixaban (Eliquis) and Edoxaban (Lixiana\u00ae), which are direct anti-Xa inhibitors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28008269",
                    "endSection": "abstract",
                    "offsetInBeginSection": 692,
                    "offsetInEndSection": 814,
                    "text": "The drugs were dabigatran etexilate mesylate (Pradaxa), rivaroxaban (Xarelto), apixaban (Eliquis), and edoxaban (Savaysa)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24672216",
                    "endSection": "abstract",
                    "offsetInBeginSection": 577,
                    "offsetInEndSection": 680,
                    "text": "Dabigatran (Pradaxa) and apixaban (Eliquis) have demonstrated improved efficacy compared with warfarin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26095540",
                    "endSection": "abstract",
                    "offsetInBeginSection": 216,
                    "offsetInEndSection": 482,
                    "text": "They include the oral direct thrombin inhibitor dabigatran etexilate (Pradaxa, Boehringer Ingelheim) and the oral direct FXa inhibitors rivaroxaban (Xarelto, Bayer HealthCare), apixaban (Eliquis, Bristol-Myers Squibb), and edoxaban (Lixiana/Savaysa, Daiichi-Sankyo)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26369819",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1763,
                    "offsetInEndSection": 1941,
                    "text": "Apixaban (Eliquis), rivaroxaban (Xarelto), and edoxaban (Savaysa) are the new Xa inhibitors that have been recently approved by the U.S. FDA and are in current clinical practice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24624626",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 332,
                    "text": "The new direct oral anticoagulants directly targeting thrombin (factor IIa) or factor-Xa, are currently used for the treatment of deep venous thrombosis and pulmonary embolism (rivaroxaban, Xarelto) or for the prevention of systemic embolism in non-valvular atrial fibrillation (rivaroxaban; dabigatran, Pradaxa; Apixaban, Eliquis)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25195485",
                    "endSection": "abstract",
                    "offsetInBeginSection": 364,
                    "offsetInEndSection": 690,
                    "text": "These new oral anticoagulants fall into two different categories: a direct thrombin inhibitor dabigatran etexilate (Pradaxa Boehringer-Ingelheim, Bracknell, Berkshire) and activated Factor X inhibitors rivaroxaban (Xarelto Bayer HealthCare, Newbury, Berkshire) and apixaban (Eliquis Bristol-Myers Squibb, Uxbridge, Middlesex)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24391389",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1291,
                    "offsetInEndSection": 1527,
                    "text": "Conflicting evidence exists regarding the ability of aPCCs to reverse the prolonged bleeding times caused by the anticoagulant agents dabigatran etexilate (Pradaxa), rivaroxaban (Xarelto), apixaban (Eliquis), and fondaparinux (Arixtra)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23821689",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 201,
                    "text": "The new oral anticoagulants dabigatran etexilate (Pradaxa), rivaroxaban (Xarelto), and apixaban (Eliquis) have predictable pharmacokinetic and pharmacodynamic profiles and are alternatives to warfarin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25682082",
                    "endSection": "abstract",
                    "offsetInBeginSection": 152,
                    "offsetInEndSection": 407,
                    "text": "These are small molecules, designed to directly inhibit specific steps in the coagulation pathway, with dabigatran (Pradaxa), inhibiting thrombin and rivaroxaban (Xarelto), apixiban (Eliquis), edoxaban (Lixiana), and betrixaban being factor Xa inhibitors."
                }
            ]
        },
        {
            "body": "What in vivo tau tracers are being used?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28914736",
                "http://www.ncbi.nlm.nih.gov/pubmed/25239654",
                "http://www.ncbi.nlm.nih.gov/pubmed/29564387",
                "http://www.ncbi.nlm.nih.gov/pubmed/28219440",
                "http://www.ncbi.nlm.nih.gov/pubmed/21605040",
                "http://www.ncbi.nlm.nih.gov/pubmed/24924676",
                "http://www.ncbi.nlm.nih.gov/pubmed/25358680",
                "http://www.ncbi.nlm.nih.gov/pubmed/26827784",
                "http://www.ncbi.nlm.nih.gov/pubmed/28654263",
                "http://www.ncbi.nlm.nih.gov/pubmed/27683159"
            ],
            "id": "5a7d5580faa1ab7d2e00001a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28914736",
                    "endSection": "abstract",
                    "offsetInBeginSection": 714,
                    "offsetInEndSection": 887,
                    "text": "Although diagnostic accuracy remains deceiving in non-Alzheimer's disease tauopathies, positron emission tomography tau tracers could be used to monitor disease progression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25239654",
                    "endSection": "abstract",
                    "offsetInBeginSection": 348,
                    "offsetInEndSection": 496,
                    "text": "Recently, several tau PET tracers including T807, THK-5117, and PBB3 have been developed and succeeded in imaging neurofibrillary pathology in vivo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29564387",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1153,
                    "offsetInEndSection": 1381,
                    "text": "Tracers are now being developed for evaluation of tau protein, which is associated with decreased cognitive function and neurodegenerative changes in AD, and is implicated in the pathogenesis of other neurodegenerative diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25239654",
                    "endSection": "abstract",
                    "offsetInBeginSection": 497,
                    "offsetInEndSection": 692,
                    "text": "For use of tau PET as a biomarker of tau pathology in Alzheimer's disease, PET tracers should have high affinity to PHF-tau and high selectivity for tau over amyloid-\u03b2 and other protein deposits."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28219440",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1262,
                    "offsetInEndSection": 1492,
                    "text": "In this review, we summarize recent findings on the most promising tau PET tracers to date, discuss what has been learnt from these findings, and offer some suggestions for the next steps that need to be achieved in a near future."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21605040",
                    "endSection": "abstract",
                    "offsetInBeginSection": 490,
                    "offsetInEndSection": 723,
                    "text": "One of the difficulties has been to find the proper molecular tracers to specifically tag pathognomonic lesions in AD brain, including not only amyloid aggregates but also filaments of the modified microtubule-associated protein tau."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21605040",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 95,
                    "text": "Molecular targets in the rational design of AD specific PET tracers: tau or amyloid aggregates?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24924676",
                    "endSection": "abstract",
                    "offsetInBeginSection": 561,
                    "offsetInEndSection": 875,
                    "text": "These tracers will allow new insights into tau pathology in the human brain, facilitating research into causes, diagnosis, and treatment of traumatic encephalopathy and major neurodegenerative dementias, such as Alzheimer's disease and some variants of frontotemporal lobar degeneration, in which tau plays a role."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28219440",
                    "endSection": "abstract",
                    "offsetInBeginSection": 903,
                    "offsetInEndSection": 1078,
                    "text": "The variety and complexity of the different types of tau deposits in the different diseases, however, has resulted in quite a challenge for the development of tau PET tracers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25239654",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 195,
                    "text": "In several neurodegenerative diseases that are collectively called tauopathies, progressive accumulation of tau in the brain is closely associated with neurodegeneration and cognitive impairment."
                }
            ]
        },
        {
            "body": "What is the Formalin test used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/9431444",
                "http://www.ncbi.nlm.nih.gov/pubmed/19168051",
                "http://www.ncbi.nlm.nih.gov/pubmed/6493793",
                "http://www.ncbi.nlm.nih.gov/pubmed/15659112",
                "http://www.ncbi.nlm.nih.gov/pubmed/10700330",
                "http://www.ncbi.nlm.nih.gov/pubmed/9231869",
                "http://www.ncbi.nlm.nih.gov/pubmed/10530494",
                "http://www.ncbi.nlm.nih.gov/pubmed/1484716",
                "http://www.ncbi.nlm.nih.gov/pubmed/8731171",
                "http://www.ncbi.nlm.nih.gov/pubmed/20832171"
            ],
            "id": "5abbfd97fcf456587200001d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9431444",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 145,
                    "text": "The formalin test for nociception, predominantly used with rodents, is characterized by continuous pain due to tissue injury induced by formalin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19168051",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 135,
                    "text": "The formalin test is used as a primary behavioural screen for assaying the antinociceptive activity of compounds in laboratory rodents."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9431444",
                    "endSection": "abstract",
                    "offsetInBeginSection": 146,
                    "offsetInEndSection": 357,
                    "text": "In addition to the pain generated by formalin itself, the classical formalin test for nociception comprises a number of additional strong stressful events such as restraint and injury caused by needle insertion."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6493793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 62,
                    "text": "The formalin test has been used in monkeys for assessing pain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19168051",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1543,
                    "offsetInEndSection": 1811,
                    "text": "Thus, for mechanistically-distinct compounds the predictive antinociceptive capacity of the formalin test can vary with the concentration of formalin injected, likely as a result of peripheral and central nociceptive signalling mechanisms being differentially engaged."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15659112",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1427,
                    "offsetInEndSection": 1673,
                    "text": "CONCLUSION\nThese data suggest that this automated movement detection system for formalin test is a simple, validated measure with good pharmacological sensitivity suitable for discovering novel analgesics or investigating central pain mechanisms."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19168051",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 219,
                    "text": "Pharmacological assessment of the rat formalin test utilizing the clinically used analgesic drugs gabapentin, lamotrigine, morphine, duloxetine, tramadol and ibuprofen: influence of low and high formalin concentrations."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9431444",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 97,
                    "text": "A new formalin test allowing simultaneous evaluation of cardiovascular and nociceptive responses."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15659112",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 148,
                    "text": "AIM\nTo investigate the validity and sensitivity of an automatic movement detection system developed by our laboratory for the formalin test in rats."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15659112",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "Validation of a simple automated movement detection system for formalin test in rats."
                }
            ]
        },
        {
            "body": "What drug treatment can cause a spinal epidural hematoma?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21799620",
                "http://www.ncbi.nlm.nih.gov/pubmed/23351908",
                "http://www.ncbi.nlm.nih.gov/pubmed/22175167",
                "http://www.ncbi.nlm.nih.gov/pubmed/29095302",
                "http://www.ncbi.nlm.nih.gov/pubmed/18685937",
                "http://www.ncbi.nlm.nih.gov/pubmed/24967052",
                "http://www.ncbi.nlm.nih.gov/pubmed/23276337",
                "http://www.ncbi.nlm.nih.gov/pubmed/19462797",
                "http://www.ncbi.nlm.nih.gov/pubmed/23006874",
                "http://www.ncbi.nlm.nih.gov/pubmed/27495842"
            ],
            "id": "5ab90a79fcf456587200001b",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21799620",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 98,
                    "text": "Drug interaction as cause of spontaneously resolving epidural spinal hematoma on warfarin therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21799620",
                    "endSection": "abstract",
                    "offsetInBeginSection": 656,
                    "offsetInEndSection": 789,
                    "text": "This case highlights the problem of drug interaction on warfarin therapy and also an unusual spontaneous recovery of spinal hematoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23351908",
                    "endSection": "abstract",
                    "offsetInBeginSection": 133,
                    "offsetInEndSection": 436,
                    "text": "We assume that the pathogenic cause of this rare disease was an overlap between three main factors: the surgical aggression of the internal anterior epidural venous plexus; a possible increase of intra-thoracic pressure due to chronic obstructive pulmonary disease; and double antiplatelet drug therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21799620",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1211,
                    "offsetInEndSection": 1254,
                    "text": "Drug interactions with warfarin are common."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21799620",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 311,
                    "text": "We present a case of a 42-year-old male, an old case of deep vein thrombosis on warfarin and other drugs like quetiapine, aspirin, diclofenac sodium, fenofibrate, atorvastatin, propanolol and citalopram for concurrent illnesses, who presented with widespread mucocutaneous bleeding and epidural spinal hematoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22175167",
                    "endSection": "abstract",
                    "offsetInBeginSection": 170,
                    "offsetInEndSection": 331,
                    "text": "Spinal anesthesia requires both a simple technique and a small volume of drug, produces profound analgesia, and is devoid of systemic pharmacologic side effects."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21799620",
                    "endSection": "abstract",
                    "offsetInBeginSection": 974,
                    "offsetInEndSection": 1064,
                    "text": "Thus intraspinal hemorrhage is a rare but dangerous complication of anticoagulant therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21799620",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1065,
                    "offsetInEndSection": 1210,
                    "text": "It must be suspected in any patient on anticoagulant agents who complains of local or referred spinal pain associated with neurological deficits."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21799620",
                    "endSection": "abstract",
                    "offsetInBeginSection": 312,
                    "offsetInEndSection": 408,
                    "text": "The epidural bleed presented clinically as a nontraumatic, rapidly improving myeloradiculopathy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21799620",
                    "endSection": "abstract",
                    "offsetInBeginSection": 409,
                    "offsetInEndSection": 501,
                    "text": "Magnetic resonance imaging (MRI) of the spine revealed an epidural hematoma at D12-L1 level."
                }
            ]
        },
        {
            "body": "List diseases caused by protein glutamine expanded repeats",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21610160",
                "http://www.ncbi.nlm.nih.gov/pubmed/19429504",
                "http://www.ncbi.nlm.nih.gov/pubmed/26517966",
                "http://www.ncbi.nlm.nih.gov/pubmed/18216249",
                "http://www.ncbi.nlm.nih.gov/pubmed/24497578",
                "http://www.ncbi.nlm.nih.gov/pubmed/25320121",
                "http://www.ncbi.nlm.nih.gov/pubmed/15639784",
                "http://www.ncbi.nlm.nih.gov/pubmed/26204228",
                "http://www.ncbi.nlm.nih.gov/pubmed/10098399",
                "http://www.ncbi.nlm.nih.gov/pubmed/10502825"
            ],
            "id": "5ac2776195d0062724000006",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21610160",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 137,
                    "text": "Expanded glutamine repeats of the ataxin-2 (ATXN2) protein cause spinocerebellar ataxia type 2 (SCA2), a rare neurodegenerative disorder."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19429504",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 184,
                    "text": "Huntington's Disease (HD) is a rare neurodegenerative disease caused by mutation of the huntingtin gene that results in a protein with an expanded stretch of glutamine repeats (polyQ)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26517966",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "BACKGROUND\nPolyglutamine (polyQ) disorders are caused by expanded CAG (Glutamine) repeats in neurons in the brain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18216249",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 159,
                    "text": "Polyglutamine diseases are inherited neurodegenerative disorders caused by expansion of CAG repeats encoding a glutamine tract in the disease-causing proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24497578",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 200,
                    "text": "The expansion of homopolymeric glutamine (polyQ) or alanine (polyA) repeats in certain proteins owing to genetic mutations induces protein aggregation and toxicity, causing at least 18 human diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25320121",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 189,
                    "text": "Polyglutamine diseases, including spinocerebellar ataxia type 3 (SCA3), are caused by CAG repeat expansions that encode abnormally long glutamine repeats in the respective disease proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15639784",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1207,
                    "offsetInEndSection": 1464,
                    "text": "Ataxin-3 (both full length and truncated) with normal glutamine repeats are not ubiquitinated, however, ataxin-3 with expanded polyglutamine is ubiquitinated and the ubiquitination depends on the misfolding propensity of the polyglutamine expanded ataxin-3."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26204228",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "Amino acid repeat runs are common occurrences in eukaryotic proteins, with glutamine (Q) and asparagine (N) as particularly frequent repeats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10098399",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 120,
                    "text": "Eight severe inherited neurodegenerative diseases are caused by expansion of glutamine repeats in the affected proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10502825",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "Huntington disease (HD) is a genetically dominant condition caused by expanded CAG repeats coding for glutamine in the HD gene product huntingtin."
                }
            ]
        },
        {
            "body": "What is the nucleotide composition of the Lamin Associated Domains (LADs)?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                "http://www.ncbi.nlm.nih.gov/pubmed/26654219",
                "http://www.ncbi.nlm.nih.gov/pubmed/23934658",
                "http://www.ncbi.nlm.nih.gov/pubmed/26883443",
                "http://www.ncbi.nlm.nih.gov/pubmed/28424353",
                "http://www.ncbi.nlm.nih.gov/pubmed/26798136",
                "http://www.ncbi.nlm.nih.gov/pubmed/25602132",
                "http://www.ncbi.nlm.nih.gov/pubmed/23964094",
                "http://www.ncbi.nlm.nih.gov/pubmed/15636422",
                "http://www.ncbi.nlm.nih.gov/pubmed/25784758"
            ],
            "id": "5a86e6fafaa1ab7d2e000036",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 856,
                    "offsetInEndSection": 1006,
                    "text": "De novo formation of adipogenic lamin A/C LADs occurs nonrandomly on GADs, which consist of megabase-size intergenic and repressive chromatin domains."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1378,
                    "offsetInEndSection": 1586,
                    "text": "Our results unveil an epigenetic prepatterning of adipogenic LADs by GADs, suggesting a coupling of developmentally regulated lamin A/C-genome interactions to a metabolically sensitive chromatin modification."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 727,
                    "offsetInEndSection": 855,
                    "text": "Lamin A/C LADs are found both in active and repressive chromatin contexts that can be influenced by cell differentiation status."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1007,
                    "offsetInEndSection": 1159,
                    "text": "Accordingly, whereas predifferentiation lamin A/C LADs are gene-rich, post-differentiation LADs harbor repressive features reminiscent of lamin B1 LADs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 143,
                    "offsetInEndSection": 378,
                    "text": "Here, we provide evidence for prepatterning of differentiation-driven formation of lamin A/C LADs by domains of histone H2B modified on serine 112 by the nutrient sensor O-linked N-acetylglucosamine (H2BS112GlcNAc), which we term GADs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26654219",
                    "endSection": "abstract",
                    "offsetInBeginSection": 250,
                    "offsetInEndSection": 424,
                    "text": "We reveal that the autophagy protein LC3/Atg8 directly interacts with the nuclear lamina protein LMNB1 (lamin B1), and binds to LMN/lamin-associated chromatin domains (LADs)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 142,
                    "text": "Dynamic interactions of nuclear lamins with chromatin through lamin-associated domains (LADs) contribute to spatial arrangement of the genome."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 115,
                    "text": "Prepatterning of differentiation-driven nuclear lamin A/C-associated chromatin domains by GlcNAcylated histone H2B."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23934658",
                    "endSection": "abstract",
                    "offsetInBeginSection": 602,
                    "offsetInEndSection": 855,
                    "text": "Mesas form at lamin B1-associated domains (LADs) in replicative senescence and oncogene-induced senescence and overlap DNA hypomethylation regions in cancer, suggesting that pre-malignant senescent chromatin changes foreshadow epigenetic cancer changes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26883443",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1596,
                    "offsetInEndSection": 1767,
                    "text": "We suggest that in somatic cells lamin B1 meshwork growth is coordinated with replication of LADs, and lamin A meshwork assembly seems to be chromatin-independent process."
                }
            ]
        },
        {
            "body": "What is the clathrin triskelia structure?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/18502808",
                "http://www.ncbi.nlm.nih.gov/pubmed/19925798",
                "http://www.ncbi.nlm.nih.gov/pubmed/7805851",
                "http://www.ncbi.nlm.nih.gov/pubmed/2868889",
                "http://www.ncbi.nlm.nih.gov/pubmed/15858577",
                "http://www.ncbi.nlm.nih.gov/pubmed/7738035",
                "http://www.ncbi.nlm.nih.gov/pubmed/25652138",
                "http://www.ncbi.nlm.nih.gov/pubmed/2573598",
                "http://www.ncbi.nlm.nih.gov/pubmed/7674375",
                "http://www.ncbi.nlm.nih.gov/pubmed/27410749"
            ],
            "id": "5ad4dd93133db5eb78000008",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18502808",
                    "endSection": "abstract",
                    "offsetInBeginSection": 314,
                    "offsetInEndSection": 591,
                    "text": "Recent static light scattering and dynamic light scattering studies of triskelia in solution showed that an individual triskelion has an intrinsic pucker similar to, but differing from, that inferred from a high resolution cryoEM structure of a triskelion in a clathrin basket."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19925798",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 107,
                    "text": "Atomic force microscopy (AFM) is used to characterize the structure and interactions of clathrin triskelia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18502808",
                    "endSection": "abstract",
                    "offsetInBeginSection": 168,
                    "offsetInEndSection": 313,
                    "text": "At low pH, or at physiological pH in the presence of assembly proteins, triskelia will self-assemble to form a closed clathrin cage, or \"basket\"."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7805851",
                    "endSection": "abstract",
                    "offsetInBeginSection": 498,
                    "offsetInEndSection": 711,
                    "text": "Using this technique, we have obtained what we believe are the first scanning force microscopy images of clathrin cages and of their in situ disassembly, yielding typical triskelia under non-denaturing conditions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19925798",
                    "endSection": "abstract",
                    "offsetInBeginSection": 387,
                    "offsetInEndSection": 605,
                    "text": "Increased numbers of triskelion dimers and assembly intermediates, as well as structures having dimensions similar to those of clathrin cages, are observed when the triskelia were immersed in a low salt, low pH buffer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2868889",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 255,
                    "text": "It is shown that in immunological, structural and functional terms the uncoating protein, which catalyses ATP-dependent dissociation of clathrin triskelia from clathrin-coated vesicles is intimately related to two major stress proteins of mammalian cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15858577",
                    "endSection": "abstract",
                    "offsetInBeginSection": 726,
                    "offsetInEndSection": 932,
                    "text": "Normal mitosis was rescued by clathrin triskelia but not the N-terminal domain of clathrin heavy chain, indicating that stabilization of kinetochore fibres was dependent on the unique structure of clathrin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18502808",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 167,
                    "text": "The clathrin triskelion, which is a three-legged pinwheel-shaped heteropolymer, is a major component in the protein coats of certain post-Golgi and endocytic vesicles."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18502808",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 58,
                    "text": "Clathrin triskelia show evidence of molecular flexibility."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7805851",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 154,
                    "text": "Covalent anchoring of proteins onto gold-directed NHS-terminated self-assembled monolayers in aqueous buffers: SFM images of clathrin cages and triskelia."
                }
            ]
        },
        {
            "body": "What is myelin?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/2752082",
                "http://www.ncbi.nlm.nih.gov/pubmed/28377211",
                "http://www.ncbi.nlm.nih.gov/pubmed/12605409",
                "http://www.ncbi.nlm.nih.gov/pubmed/24259565",
                "http://www.ncbi.nlm.nih.gov/pubmed/9014171",
                "http://www.ncbi.nlm.nih.gov/pubmed/27068622",
                "http://www.ncbi.nlm.nih.gov/pubmed/7683887",
                "http://www.ncbi.nlm.nih.gov/pubmed/6204014",
                "http://www.ncbi.nlm.nih.gov/pubmed/25682762",
                "http://www.ncbi.nlm.nih.gov/pubmed/28795433"
            ],
            "id": "5abcf108fcf4565872000025",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2752082",
                    "endSection": "abstract",
                    "offsetInBeginSection": 270,
                    "offsetInEndSection": 397,
                    "text": "To what extent, however, are the structure and intermembrane interactions of isolated myelin similar to those of intact myelin?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2752082",
                    "endSection": "abstract",
                    "offsetInBeginSection": 655,
                    "offsetInEndSection": 933,
                    "text": "Because x-ray scattering from isolated myelin sometimes consists of overlapping Bragg reflections or is continuous, we developed nonlinear least squares procedures for analyzing the total intensity distribution after film scaling, background subtraction, and Lorentz correction."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 454,
                    "offsetInEndSection": 649,
                    "text": "To investigate what MWF measures in the presence of debris, we compared MWF to transmission electron microscopy (TEM) derived myelin fraction that measures the amount of compact appearing myelin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 156,
                    "text": "Myelin content is an important marker for neuropathology and MRI generated myelin water fraction (MWF) has been shown to correlate well with myelin content."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 345,
                    "offsetInEndSection": 453,
                    "text": "This is of special concern when there is a mix of intact myelin and myelin debris, as in the case of injury."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 157,
                    "offsetInEndSection": 344,
                    "text": "However, because MWF is based on the amount of signal from myelin water, that is, the water trapped between the myelin lipid bilayers, the reading may depend heavily on myelin morphology."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12605409",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 155,
                    "text": "Proteolipid protein (PLP) is the primary protein component of CNS myelin, yet myelin from the PLP(null) mouse has only minor ultrastructural abnormalities."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1228,
                    "offsetInEndSection": 1391,
                    "text": "From the TEM images, it appears that as myelin degenerates, it tends to form large watery spaces within the myelin sheaths that are not classified as myelin water."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2752082",
                    "endSection": "abstract",
                    "offsetInBeginSection": 563,
                    "offsetInEndSection": 654,
                    "text": "The present study addresses the possibility that this is due to altered membrane structure."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24259565",
                    "endSection": "abstract",
                    "offsetInBeginSection": 677,
                    "offsetInEndSection": 893,
                    "text": "How oligodendrocytes determine the appropriate thickness of myelin for an axon of defined size during repair is unknown and identifying the signals that regulate myelin thickness has obvious therapeutic implications."
                }
            ]
        },
        {
            "body": "Is Brucella abortus the organism that causes brucillosis known to cause spontaneous abortions in humans?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22812618",
                "http://www.ncbi.nlm.nih.gov/pubmed/25566611",
                "http://www.ncbi.nlm.nih.gov/pubmed/27800616",
                "http://www.ncbi.nlm.nih.gov/pubmed/24609497",
                "http://www.ncbi.nlm.nih.gov/pubmed/26578650",
                "http://www.ncbi.nlm.nih.gov/pubmed/16739129",
                "http://www.ncbi.nlm.nih.gov/pubmed/28167945",
                "http://www.ncbi.nlm.nih.gov/pubmed/18390151",
                "http://www.ncbi.nlm.nih.gov/pubmed/10564509",
                "http://www.ncbi.nlm.nih.gov/pubmed/21829705"
            ],
            "id": "5aa6800ad6d6b54f79000011",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22812618",
                    "endSection": "abstract",
                    "offsetInBeginSection": 311,
                    "offsetInEndSection": 468,
                    "text": "It is speculated that brucellosis causes fewer spontaneous abortions in humans than animals due to the absence of Erythritol in the human placenta and fetus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1590,
                    "offsetInEndSection": 1720,
                    "text": "In conclusion, Brucella abortus cannot cause spontaneous abortion by altering the mouse cytokine profile towards Th1 in pregnancy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 291,
                    "offsetInEndSection": 449,
                    "text": "This study sought to determine if Brucella infection causes spontaneous abortion by causing the circulating cytokine profile be Th1 dominant during pregnancy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 154,
                    "offsetInEndSection": 290,
                    "text": "Brucellosis is an intracellular bacterium that elicits the Th1 response and is known to cause spontaneous abortion in mammalian species."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27800616",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 127,
                    "text": "Brucella abortus is the causative agent of brucellosis, which causes abortion in domestic animals and undulant fever in humans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24609497",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 194,
                    "text": "Brucella abortus is a gram-negative, facultative intracellular pathogen that causes brucellosis, a chronic zoonotic disease resulting in abortion in pregnant cattle and undulant fever in humans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26578650",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 186,
                    "text": "Brucella abortus is a Gram-negative intracellular bacterial pathogen that causes a zoonosis of worldwide occurrence, leading to undulant fever in humans and abortion in domestic animals."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16739129",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 125,
                    "text": "Brucella abortus is the etiologic agent of bovine brucellosis and causes a chronic disease in humans known as undulant fever."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28167945",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 186,
                    "text": "Brucella abortus is a Gram-negative, facultative intracellular bacterium that causes brucellosis, a worldwide zoonotic disease leading to undulant fever in humans and abortion in cattle."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18390151",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 110,
                    "text": "Brucella abortus is a bacterium which causes abortions and infertility in cattle and undulant fever in humans."
                }
            ]
        },
        {
            "body": "What percentage of Homo sapiens DNA is of Neanderthal origin?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/7942855",
                "http://www.ncbi.nlm.nih.gov/pubmed/10788336",
                "http://www.ncbi.nlm.nih.gov/pubmed/21151557",
                "http://www.ncbi.nlm.nih.gov/pubmed/17146600",
                "http://www.ncbi.nlm.nih.gov/pubmed/17110569",
                "http://www.ncbi.nlm.nih.gov/pubmed/24689136",
                "http://www.ncbi.nlm.nih.gov/pubmed/22946817",
                "http://www.ncbi.nlm.nih.gov/pubmed/23914934",
                "http://www.ncbi.nlm.nih.gov/pubmed/21404232",
                "http://www.ncbi.nlm.nih.gov/pubmed/15636070"
            ],
            "id": "5ace1a590340b9f05800000b",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7942855",
                    "endSection": "abstract",
                    "offsetInBeginSection": 470,
                    "offsetInEndSection": 670,
                    "text": "Although ancient, none of these haplogroups is old enough to be compatible with a Neanderthal origin, suggesting that Homo sapiens sapiens displaced H. s. neanderthaliensis, rather than mixed with it."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10788336",
                    "endSection": "abstract",
                    "offsetInBeginSection": 146,
                    "offsetInEndSection": 565,
                    "text": "When hybridized with genomic DNA of either human or Neanderthal origin, DNA extracted from two Neanderthal finds-the Os parietale, from Warendorf-Neuwarendorf, Germany, and a clavicula, from Krapina, Croatia-was shown to yield hybridization signals that differ by at least a factor of two compared to the signals obtained with the use of fossil DNA of an early Homo sapiens from the Vogelherd cave (Stetten I), Germany."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21151557",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 182,
                    "text": "BACKGROUND\nA fraction of the Neanderthal mitochondrial genome sequence has a similarity with a 5,839-bp nuclear DNA sequence of mitochondrial origin (numt) on the human chromosome 1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21151557",
                    "endSection": "abstract",
                    "offsetInBeginSection": 556,
                    "offsetInEndSection": 859,
                    "text": "PRINCIPAL FINDINGS\nExploiting bioinformatics, we uncovered an additional numt (mtAncestor-2) with a high similarity to the Neanderthal mtDNA and indicated that both numts represent almost identical replicas of the mtDNA sequences ancestral to the mitochondrial genomes of Neanderthals and modern humans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17146600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 246,
                    "text": "The retrieval of Neanderthal (Homo neanderthalsensis) mitochondrial DNA is thought to be among the most significant ancient DNA contributions to date, allowing conflicting hypotheses on modern human (Homo sapiens) evolution to be tested directly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17110569",
                    "endSection": "abstract",
                    "offsetInBeginSection": 381,
                    "offsetInEndSection": 674,
                    "text": "Several lines of evidence indicate that the 65,250 base pairs of hominid sequence so far identified in the library are of Neanderthal origin, the strongest being the ascertainment of sequence identities between Neanderthal and chimpanzee at sites where the human genomic sequence is different."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24689136",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 22,
                    "text": "Neanderthal paintings?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21151557",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1020,
                    "offsetInEndSection": 1151,
                    "text": "The overall rate of nonsynonymous evolution in Neanderthal mitochondrial protein-coding genes is not higher than in other lineages."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21151557",
                    "endSection": "abstract",
                    "offsetInBeginSection": 221,
                    "offsetInEndSection": 553,
                    "text": "Although this phenomenon may be attributed to contamination and mosaic assembly of Neanderthal mtDNA from short sequencing reads, we explain the mysterious similarity by integration of this numt (mtAncestor-1) into the nuclear genome of the common ancestor of Neanderthals and modern humans not long before their reproductive split."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17146600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 408,
                    "offsetInEndSection": 669,
                    "text": "Using Bayesian inference and the largest dataset to date, we find strong support for a monophyletic Neanderthal clade outside the diversity of contemporary humans, in agreement with the expectations of the Out-of-Africa replacement model of modern human origin."
                }
            ]
        },
        {
            "body": "What is Dupuytren's contracture?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/18847012",
                "http://www.ncbi.nlm.nih.gov/pubmed/15902016",
                "http://www.ncbi.nlm.nih.gov/pubmed/28383356",
                "http://www.ncbi.nlm.nih.gov/pubmed/9382632",
                "http://www.ncbi.nlm.nih.gov/pubmed/22872850",
                "http://www.ncbi.nlm.nih.gov/pubmed/6380478",
                "http://www.ncbi.nlm.nih.gov/pubmed/24024053",
                "http://www.ncbi.nlm.nih.gov/pubmed/21992150",
                "http://www.ncbi.nlm.nih.gov/pubmed/21935843",
                "http://www.ncbi.nlm.nih.gov/pubmed/20676061"
            ],
            "id": "5abcf66afcf4565872000026",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18847012",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 168,
                    "text": "Dupuytren's contracture is a connective tissue disorder characterized by contractile palmar aponeurosis leading to shortening and progressive digital flexion deformity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15902016",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 186,
                    "text": "Dupuytren's disease is a nonmalignant fibroproliferative disease that causes progressive and permanent contracture of the palmar fascia with subsequent flexion contracture of the digits."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28383356",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 200,
                    "text": "Needle aponeurotomy is emerging as a preferred choice of treatment for patients with Dupuytren's contracture keen on a quick, minimally invasive procedure that enables a rapid return of hand function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9382632",
                    "endSection": "abstract",
                    "offsetInBeginSection": 350,
                    "offsetInEndSection": 489,
                    "text": "The contracture is usually not severe in diabetes, is nodular in form, and usually crushes the palmar surface of the long and ring fingers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22872850",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 122,
                    "text": "Dupuytren's contracture is a condition commonly encountered by hand surgeons, although it is rare in the Asian population."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6380478",
                    "endSection": "abstract",
                    "offsetInBeginSection": 159,
                    "offsetInEndSection": 472,
                    "text": "In those patients with a strong inherited diathesis to the production of Dupuytren's Contracture, recurrence may occur or even by anticipated, and the placement of a skin graft strategically at a flexion crease is shown to act as a 'firebreak' between areas of potential flare-up of recurrent Dupuytren's Disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24024053",
                    "endSection": "abstract",
                    "offsetInBeginSection": 422,
                    "offsetInEndSection": 609,
                    "text": "Comorbid conditions associated with Dupuytren's contracture are repetitive trauma to the hands, diabetes, and seizures, but it has never before been associated with neuromuscular disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24024053",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 154,
                    "text": "Limb-girdle muscular dystrophies (LGMDs) is a heterogeneous group of muscular dystrophies that mostly affect the pelvic and shoulder girdle muscle groups."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21992150",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 129,
                    "text": "BACKGROUND\nDupuytren's contracture is a condition of the palmar fascia involving contractures of the fascia and skin in the hand."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21935843",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 118,
                    "text": "Dupuytren's contracture is a fibroproliferate disease of the palmar aponeurosis with a formation of nodules and cords."
                }
            ]
        },
        {
            "body": "What phenotype is associated with the V60L mutation in the human MC1R gene?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                "http://www.ncbi.nlm.nih.gov/pubmed/26710775",
                "http://www.ncbi.nlm.nih.gov/pubmed/18282187",
                "http://www.ncbi.nlm.nih.gov/pubmed/19452503",
                "http://www.ncbi.nlm.nih.gov/pubmed/19725989",
                "http://www.ncbi.nlm.nih.gov/pubmed/19339902",
                "http://www.ncbi.nlm.nih.gov/pubmed/12006619",
                "http://www.ncbi.nlm.nih.gov/pubmed/18637132",
                "http://www.ncbi.nlm.nih.gov/pubmed/22497627",
                "http://www.ncbi.nlm.nih.gov/pubmed/9571181"
            ],
            "id": "5ace2d600340b9f05800000e",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 700,
                    "offsetInEndSection": 1019,
                    "text": "In this family-based study, we assessed the associations of the four most frequent MC1R variants (V60L, V92M, R151C, and R160W) and the number of variants (1, \u22652 variants), alone or jointly with the host phenotypes (hair color, propensity to sunburn, and number of nevi), with melanoma risk in CDKN2A mutation carriers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1145,
                    "offsetInEndSection": 1393,
                    "text": "RESULTS\nCarrying any one of the four most frequent MC1R variants (V60L, V92M, R151C, R160W) in CDKN2A mutation carriers was associated with a statistically significantly increased risk for melanoma across all continents (1.24 \u00d7 10(-6) \u2264 P \u2264 .0007)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26710775",
                    "endSection": "abstract",
                    "offsetInBeginSection": 112,
                    "offsetInEndSection": 351,
                    "text": "In particular, rs1805007, rs1805008, and rs1805009 mutations causing the corresponding R151C, R160W, and D294H changes and associated with the phenotype (\"red-hair mutations\") are connected with melanoma and non-melanoma skin cancer risks."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18282187",
                    "endSection": "abstract",
                    "offsetInBeginSection": 856,
                    "offsetInEndSection": 1012,
                    "text": "Certain allelic variants of this gene, namely R151C, R160W and D294H, are strongly associated with red hair phenotype and increased melanoma susceptibility."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19452503",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1200,
                    "offsetInEndSection": 1391,
                    "text": "Moreover, T157 was phosphorylated in wild-type MC1R and a T157D mutation mimicking constitutive phosphorylation allowed normal traffic, and rescued the retention phenotype of R160W and R162P."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 113,
                    "text": "Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 134,
                    "offsetInEndSection": 348,
                    "text": "Penetrance of CDKN2A mutations is modified by pigmentation characteristics, nevus phenotypes, and some variants of the melanocortin-1 receptor gene (MC1R), which is known to have a role in the pigmentation process."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19725989",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1080,
                    "offsetInEndSection": 1191,
                    "text": "Common recurrent variants of the MC1R gene (V60L, R151C, R163Q and R160W) may predispose to malignant melanoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19339902",
                    "endSection": "abstract",
                    "offsetInBeginSection": 626,
                    "offsetInEndSection": 875,
                    "text": "This rare mutation, which has been described only once previously, may be involved in predisposition to the amelanotic phenotype in combination with germline MC1R variants and coordinate somatic expression of pigmentation genes and their regulators."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19452503",
                    "endSection": "abstract",
                    "offsetInBeginSection": 479,
                    "offsetInEndSection": 611,
                    "text": "Three highly penetrant RHC variants, R151C, R160W, and D294H are loss-of-function MC1R mutants with altered cell surface expression."
                }
            ]
        },
        {
            "body": "List proteins with HEAT repeats",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20060908",
                "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                "http://www.ncbi.nlm.nih.gov/pubmed/9391096",
                "http://www.ncbi.nlm.nih.gov/pubmed/14970380",
                "http://www.ncbi.nlm.nih.gov/pubmed/27802131",
                "http://www.ncbi.nlm.nih.gov/pubmed/10361086",
                "http://www.ncbi.nlm.nih.gov/pubmed/19777061",
                "http://www.ncbi.nlm.nih.gov/pubmed/9673349",
                "http://www.ncbi.nlm.nih.gov/pubmed/10378263",
                "http://www.ncbi.nlm.nih.gov/pubmed/21708948"
            ],
            "id": "5abd44b1fcf4565872000030",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20060908",
                    "endSection": "abstract",
                    "offsetInBeginSection": 149,
                    "offsetInEndSection": 383,
                    "text": "This strategy uses multiple HHpred alignments against proteins of known 3D structure to enable protein repeats referenced from the 3D structure to be traced back to the query protein sequence by using user-directed repeat assignments."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                    "endSection": "abstract",
                    "offsetInBeginSection": 155,
                    "offsetInEndSection": 438,
                    "text": "Using sensitive sequence analysis techniques we detected HEAT repeats in various chromosome-associated proteins, including four families of proteins associated with condensins and cohesins, which are nuclear complexes that contain structural maintenance of chromosome (SMC) proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9391096",
                    "endSection": "abstract",
                    "offsetInBeginSection": 605,
                    "offsetInEndSection": 850,
                    "text": "We show that the Arm repeats of alpha-Kaps and the HEAT motifs of beta-Kaps are similar, suggesting that the alpha-Kaps and beta-Kaps (and for that matter, all Arm and HEAT repeat-containing proteins) are members of the same protein superfamily."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14970380",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 90,
                    "text": "The Noc proteins involved in ribosome synthesis and export contain divergent HEAT repeats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27802131",
                    "endSection": "abstract",
                    "offsetInBeginSection": 393,
                    "offsetInEndSection": 723,
                    "text": "In this Opinion article, we will focus on HEAT repeats, flexible arrays of amphiphilic helices found in many eukaryotic proteins, such as karyopherins and condensins, and discuss how these uniquely designed helical repeats might underlie dynamic protein-protein interactions and support cellular functions in crowded environments."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10361086",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 227,
                    "text": "The recent elucidation of protein structures based upon repeating amino acid motifs, including the armadillo motif, the HEAT motif and tetratricopeptide repeats, reveals that they belong to the class of helical repeat proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19777061",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 79,
                    "text": "BACKGROUND\nHEAT and ARM repeats occur in a large number of eukaryotic proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9673349",
                    "endSection": "abstract",
                    "offsetInBeginSection": 478,
                    "offsetInEndSection": 652,
                    "text": "The protein contains a conserved positively charged tail and several HEAT repeats, designated after four functionally characterized proteins in which the repeat was detected."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10378263",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 151,
                    "text": "The recently determined crystal structure of the PR65/A subunit of protein phosphatase 2A reveals the architecture of proteins containing HEAT repeats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1266,
                    "offsetInEndSection": 1498,
                    "text": "HEAT repeats also were found in dis1-TOG family and cofactor D family microtubule-associated proteins, which, owing to their roles in microtubule dynamics, perform functions related to mitotic progression and chromosome segregation."
                }
            ]
        },
        {
            "body": "What is the aim of  perfoming a \"cycloheximide chase assay\"?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/5699932",
                "http://www.ncbi.nlm.nih.gov/pubmed/6260193",
                "http://www.ncbi.nlm.nih.gov/pubmed/1814680",
                "http://www.ncbi.nlm.nih.gov/pubmed/29122887",
                "http://www.ncbi.nlm.nih.gov/pubmed/641806",
                "http://www.ncbi.nlm.nih.gov/pubmed/18227081",
                "http://www.ncbi.nlm.nih.gov/pubmed/25742191",
                "http://www.ncbi.nlm.nih.gov/pubmed/27167179",
                "http://www.ncbi.nlm.nih.gov/pubmed/16925598",
                "http://www.ncbi.nlm.nih.gov/pubmed/29082276"
            ],
            "id": "5ac08478d0c506ce46000002",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/5699932",
                    "endSection": "title",
                    "offsetInBeginSection": 79,
                    "offsetInEndSection": 81,
                    "text": "3."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6260193",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1040,
                    "offsetInEndSection": 1042,
                    "text": "3."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1814680",
                    "endSection": "abstract",
                    "offsetInBeginSection": 325,
                    "offsetInEndSection": 327,
                    "text": "3."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6260193",
                    "endSection": "abstract",
                    "offsetInBeginSection": 310,
                    "offsetInEndSection": 312,
                    "text": "2."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1814680",
                    "endSection": "abstract",
                    "offsetInBeginSection": 164,
                    "offsetInEndSection": 166,
                    "text": "2."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6260193",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 2,
                    "text": "1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1814680",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 2,
                    "text": "1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/5699932",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 231,
                    "text": "Experiments have been carried out to determine whether intracellular transport of pancreatic secretory proteins is obligatorily coupled to protein synthesis or whether it is a separable process which can be independently regulated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/5699932",
                    "endSection": "abstract",
                    "offsetInBeginSection": 232,
                    "offsetInEndSection": 469,
                    "text": "To this intent, guinea pig pancreatic slices were pulse labeled with leucine-(3)H for 3 min and incubated post-pulse for 37 min in chase medium containing cycloheximide up to concentrations sufficient to inhibit protein synthesis by 98%."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1814680",
                    "endSection": "abstract",
                    "offsetInBeginSection": 493,
                    "offsetInEndSection": 609,
                    "text": "The stimulation of incorporation into sulfolipids by hyperosmotic culture was completely inhibited by cycloheximide."
                }
            ]
        },
        {
            "body": "What is an exosome?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17174896",
                "http://www.ncbi.nlm.nih.gov/pubmed/26341056",
                "http://www.ncbi.nlm.nih.gov/pubmed/16087368",
                "http://www.ncbi.nlm.nih.gov/pubmed/24462375",
                "http://www.ncbi.nlm.nih.gov/pubmed/26725667",
                "http://www.ncbi.nlm.nih.gov/pubmed/21618876",
                "http://www.ncbi.nlm.nih.gov/pubmed/21713679",
                "http://www.ncbi.nlm.nih.gov/pubmed/22031862",
                "http://www.ncbi.nlm.nih.gov/pubmed/25849885",
                "http://www.ncbi.nlm.nih.gov/pubmed/22956173"
            ],
            "id": "5ac0a36f19833b0d7b000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17174896",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 131,
                    "text": "The RNA exosome is a multisubunit 3' to 5' exoribonuclease complex that participates in degradation and processing of cellular RNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26341056",
                    "endSection": "abstract",
                    "offsetInBeginSection": 580,
                    "offsetInEndSection": 889,
                    "text": "How exosomes target recipient cells in vivo remains largely unknown, however, exosomes are selectively enriched in some transmembrane proteins that can be genetically engineered to display ligands/homing peptides on their surface, which confers exosome targeting capability to cells bearing cognate receptors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16087368",
                    "endSection": "abstract",
                    "offsetInBeginSection": 840,
                    "offsetInEndSection": 1074,
                    "text": "The Exosome Display technology is very versatile since soluble, membrane-bound, trans-membrane or multimeric antigens that are not naturally found on exosomes can now be efficiently expressed at their surface in a native conformation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16087368",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "Exosome Display is a novel methodology enabling the manipulation of exosome protein content."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16087368",
                    "endSection": "abstract",
                    "offsetInBeginSection": 383,
                    "offsetInEndSection": 571,
                    "text": "Exosome Display of soluble antigens and extracellular domains of membrane proteins that are not naturally found on exosomes occurs upon fusion of proteins with the Lactadherin C1C2 domain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26341056",
                    "endSection": "abstract",
                    "offsetInBeginSection": 890,
                    "offsetInEndSection": 1115,
                    "text": "With the discovery of many peptides homing to diseased tissues or organs through phage display and in vivo biopanning technologies, there is ample opportunity to explore the potential use of exosome for targeted gene therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17174896",
                    "endSection": "abstract",
                    "offsetInBeginSection": 335,
                    "offsetInEndSection": 816,
                    "text": "Comparative biochemical analysis between purified subunits and reconstituted exosomes using AU-rich, polyadenylated (poly[A]), generic, and structured RNA substrates reveals processive phosphorolytic activities for human Rrp41/Rrp45 and the 9-subunit human exosome, processive hydrolytic activities for yeast Rrp44 and the yeast 10-subunit exosome, distributive hydrolytic activities for Rrp6, and processive and distributive hydrolytic activities for the yeast 11-subunit exosome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16087368",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1341,
                    "offsetInEndSection": 1465,
                    "text": "The potential of Exosome Display technology for developing a broad range of novel diagnostics and therapeutics is discussed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16087368",
                    "endSection": "abstract",
                    "offsetInBeginSection": 225,
                    "offsetInEndSection": 382,
                    "text": "More particularly, Lactadherin expressed in non-mammary gland tissue has been found to localize to exosomes via binding of its C1C2 domain to exosome lipids."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16087368",
                    "endSection": "abstract",
                    "offsetInBeginSection": 572,
                    "offsetInEndSection": 723,
                    "text": "Exosome Display of native full-length membrane proteins can also be achieved by non-restricted expression or sampling of membrane proteins on exosomes."
                }
            ]
        },
        {
            "body": "Are human enhancers or promoters evolving faster?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21282711",
                "http://www.ncbi.nlm.nih.gov/pubmed/8356050",
                "http://www.ncbi.nlm.nih.gov/pubmed/1668145",
                "http://www.ncbi.nlm.nih.gov/pubmed/17904351",
                "http://www.ncbi.nlm.nih.gov/pubmed/24842994",
                "http://www.ncbi.nlm.nih.gov/pubmed/23652427",
                "http://www.ncbi.nlm.nih.gov/pubmed/28116828",
                "http://www.ncbi.nlm.nih.gov/pubmed/2104960",
                "http://www.ncbi.nlm.nih.gov/pubmed/28803729",
                "http://www.ncbi.nlm.nih.gov/pubmed/20442713"
            ],
            "id": "5ac3699f0340b9f058000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21282711",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1215,
                    "offsetInEndSection": 1328,
                    "text": "Promoters were primarily evolving under purifying selection but with certain categories of genes evolving faster."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8356050",
                    "endSection": "abstract",
                    "offsetInBeginSection": 291,
                    "offsetInEndSection": 418,
                    "text": "Nonetheless, the arrangement of functional elements, such as spacer promoters and enhancers, is thought to be highly conserved."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1668145",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 186,
                    "text": "The promoters and enhancers of cell type-specific genes are often conserved in evolution, and hence one might expect that a given enhancer has evolved to work best with its own promoter."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17904351",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 137,
                    "text": "In eukaryotes, enhancers must often exert their effect over many tens of kilobases of DNA with a choice between many different promoters."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24842994",
                    "endSection": "abstract",
                    "offsetInBeginSection": 465,
                    "offsetInEndSection": 586,
                    "text": "Tyr1P is predominantly found in antisense orientation at promoters but is also specifically enriched at active enhancers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23652427",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1112,
                    "offsetInEndSection": 1259,
                    "text": "I propose that these newly inserted segments may play a role in genome evolution by potentially functioning as novel exons, promoters or enhancers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17904351",
                    "endSection": "abstract",
                    "offsetInBeginSection": 138,
                    "offsetInEndSection": 281,
                    "text": "Given this situation, elements known as chromatin boundaries have evolved to prevent adventitious interactions between enhancers and promoters."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28116828",
                    "endSection": "abstract",
                    "offsetInBeginSection": 461,
                    "offsetInEndSection": 603,
                    "text": "Promoters and enhancers are functionally similar; both can regulate the transcription of distal promoters and both direct local transcription."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1668145",
                    "endSection": "abstract",
                    "offsetInBeginSection": 389,
                    "offsetInEndSection": 595,
                    "text": "We found that the relative efficiency of the enhancers is approximately the same, irrespective of the type of promoter used, i.e., there was no strong preference for any given enhancer/promoter combination."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2104960",
                    "endSection": "abstract",
                    "offsetInBeginSection": 135,
                    "offsetInEndSection": 282,
                    "text": "3), for which binding sites are widely distributed in the promoters and enhancers of the globin gene family, and of other erythroid-specific genes."
                }
            ]
        },
        {
            "body": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21883380",
                "http://www.ncbi.nlm.nih.gov/pubmed/23953907",
                "http://www.ncbi.nlm.nih.gov/pubmed/17762530",
                "http://www.ncbi.nlm.nih.gov/pubmed/25494843",
                "http://www.ncbi.nlm.nih.gov/pubmed/24205696",
                "http://www.ncbi.nlm.nih.gov/pubmed/28198201",
                "http://www.ncbi.nlm.nih.gov/pubmed/23455714",
                "http://www.ncbi.nlm.nih.gov/pubmed/12557411",
                "http://www.ncbi.nlm.nih.gov/pubmed/3896792",
                "http://www.ncbi.nlm.nih.gov/pubmed/26814780"
            ],
            "id": "5ac0f7b919833b0d7b000006",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21883380",
                    "endSection": "abstract",
                    "offsetInBeginSection": 957,
                    "offsetInEndSection": 959,
                    "text": "3."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21883380",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1488,
                    "offsetInEndSection": 1490,
                    "text": "4."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21883380",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 2,
                    "text": "1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21883380",
                    "endSection": "abstract",
                    "offsetInBeginSection": 627,
                    "offsetInEndSection": 629,
                    "text": "2."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21883380",
                    "endSection": "abstract",
                    "offsetInBeginSection": 179,
                    "offsetInEndSection": 376,
                    "text": "The anticoagulant activity of dalteparin can be monitored by measuring anti-factor Xa levels and activated partial thromboplastin time (aPTT); however, aPTT is an unreliable parameter in this case."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21883380",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1491,
                    "offsetInEndSection": 1664,
                    "text": "In conclusion, the results indicate that the thrombelastograph ROTEM(\u00ae) can detect the anticoagulant effects of dalteparin only at supratherapeutic levels of anti-factor Xa."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23953907",
                    "endSection": "abstract",
                    "offsetInBeginSection": 301,
                    "offsetInEndSection": 576,
                    "text": "Specific antidotes for the reversal of the anticoagulant effect of these drugs, such as monoclonal antibodies against the direct thrombin inhibitor dabigatran or recombinant Xa-analog in the case of factor Xa inhibitors, are still being investigated in early clinical trials."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21883380",
                    "endSection": "abstract",
                    "offsetInBeginSection": 630,
                    "offsetInEndSection": 956,
                    "text": "The ROTEM(\u00ae) parameters, namely coagulation time (CT), clot formation time (CFT) and maximum clot firmness (MCF), were measured using the reagents EXTEM and INTEM (Pentapharm, Munich, Germany) at increasing concentrations of dalteparin (0.01-10 \u03bcg/mL, which corresponded to anti-factor Xa levels of 1-1000 U/mL, respectively)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21883380",
                    "endSection": "abstract",
                    "offsetInBeginSection": 377,
                    "offsetInEndSection": 626,
                    "text": "The aim of the present in vitro study was to evaluate the thrombelastograph ROTEM(\u00ae) (Tem International, Munich, Germany) with respect to determining the anticoagulant activity of dalteparin at therapeutic and supratherapeutic plasma concentrations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21883380",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1163,
                    "offsetInEndSection": 1387,
                    "text": "Moreover, the mean CFT value (EXTEM) increased from 97.7 \u00b1 21.5 s at baseline to 187.6 \u00b1 115.2 s (P\u2003=\u20030.0001) at a drug concentration of 10\u2003\u03bcg/mL, which is greater than the therapeutic anti-factor Xa concentrations for LMWH."
                }
            ]
        },
        {
            "body": "Which genes are associated with Epidermolysis Bullosa Simplex?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19797037",
                "http://www.ncbi.nlm.nih.gov/pubmed/12655565",
                "http://www.ncbi.nlm.nih.gov/pubmed/22161089",
                "http://www.ncbi.nlm.nih.gov/pubmed/7561171",
                "http://www.ncbi.nlm.nih.gov/pubmed/9406827",
                "http://www.ncbi.nlm.nih.gov/pubmed/7537032",
                "http://www.ncbi.nlm.nih.gov/pubmed/8757772",
                "http://www.ncbi.nlm.nih.gov/pubmed/7539246",
                "http://www.ncbi.nlm.nih.gov/pubmed/10682398",
                "http://www.ncbi.nlm.nih.gov/pubmed/25354580"
            ],
            "id": "5ace34eb0340b9f058000010",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19797037",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 200,
                    "text": "Epidermolysis bullosa simplex is an autosomal dominant inherited skin blistering disorder caused by mutations in the genes KRT5 or KRT14 coding for the basal epidermal keratins 5 and 14, respectively."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12655565",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 132,
                    "text": "Epidermolysis bullosa simplex is a group of blistering skin disorders caused by defects in one of the keratin genes, KRT5 and KRT14."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22161089",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 127,
                    "text": "[Mutation analysis of keratin 5 and keratin 14 genes in a family with epidermolysis bullosa simplex with mottled pigmentation]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7561171",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 201,
                    "text": "Mutations in genes encoding the keratin intermediate filaments expressed in basal cells have been identified in some families with epidermolysis bullosa simplex as the proximate cause of the fragility."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9406827",
                    "endSection": "abstract",
                    "offsetInBeginSection": 570,
                    "offsetInEndSection": 670,
                    "text": "In this study we sequenced these genes in a family with epidermolysis bullosa simplex Dowling-Meara."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12655565",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 140,
                    "text": "Mutation analysis of the entire keratin 5 and 14 genes in patients with epidermolysis bullosa simplex and identification of novel mutations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7537032",
                    "endSection": "abstract",
                    "offsetInBeginSection": 267,
                    "offsetInEndSection": 392,
                    "text": "The simplex forms of epidermolysis bullosa are caused by mutations in the genes for the basal epidermal keratins, K5 and K14."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9406827",
                    "endSection": "abstract",
                    "offsetInBeginSection": 361,
                    "offsetInEndSection": 569,
                    "text": "The keratin 5 and keratin 14 genes encode proteins that form the primary structural components of the basal epidermal keratinocytes, mutations in either of these genes can cause epidermolysis bullosa simplex."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7537032",
                    "endSection": "abstract",
                    "offsetInBeginSection": 809,
                    "offsetInEndSection": 1075,
                    "text": "Junctional epidermolysis bullosa is caused by mutations in the genes encoding different chains of the novel laminin isoform, nicein/kalinin, also known as laminin 5, which is associated with the anchoring filament-hemidesmosome complex of the basement membrane zone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8757772",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 169,
                    "text": "We examined keratin K14 and K5 genes mutation in a Japanese Dowling-Meara epidermolysis bullosa simplex patient with severe generalized blistering and erosions at birth."
                }
            ]
        },
        {
            "body": "What biologic process in the body is associated with Mast cells?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17485116",
                "http://www.ncbi.nlm.nih.gov/pubmed/9354811",
                "http://www.ncbi.nlm.nih.gov/pubmed/16141514",
                "http://www.ncbi.nlm.nih.gov/pubmed/8629992",
                "http://www.ncbi.nlm.nih.gov/pubmed/18028996",
                "http://www.ncbi.nlm.nih.gov/pubmed/8353280",
                "http://www.ncbi.nlm.nih.gov/pubmed/21185371",
                "http://www.ncbi.nlm.nih.gov/pubmed/28189858",
                "http://www.ncbi.nlm.nih.gov/pubmed/10359893",
                "http://www.ncbi.nlm.nih.gov/pubmed/26840764"
            ],
            "id": "5aac543bfcf4565872000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17485116",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 148,
                    "text": "Mast cells are widely distributed throughout the body and express effector functions in allergic reactions, inflammatory diseases, and host defense."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9354811",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 11,
                    "text": "Mast cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16141514",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 194,
                    "text": "Mast cells are widely distributed throughout the body, predominantly near blood vessels and nerves, and express effector functions in allergic reactions, inflammatory diseases, and host defense."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8629992",
                    "endSection": "abstract",
                    "offsetInBeginSection": 769,
                    "offsetInEndSection": 1091,
                    "text": "These data demonstrate that activated lymphocytes have the ability to induce the promoter of the TCA3 gene in mast cells through a mechanism requiring cell-to-cell contact, and suggest the possibility that activated lymphocytes may effect other biologic processes in mast cells as well through such heterotypic activation."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18028996",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 101,
                    "text": "Human mast cells release oncostatin M on contact with activated T cells: possible biologic relevance."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8353280",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1037,
                    "offsetInEndSection": 1475,
                    "text": "The prolonged biologic half-life of IL-3 was reproducibly associated with a threefold to fivefold increase in splenic mast-cell precursors over levels observed in mice treated with IL-3 alone; increases in the numbers of mature mucosal-type mast cells in the spleen, but not in the jejunum or lung; increases in IL-3-dependent colony-forming unit-cell in the spleen; and an apparent redistribution of mast cells away from the bone marrow."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9354811",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 209,
                    "text": "Mast cells are found resident in tissues throughout the body, particularly in association with structures such as blood vessels and nerves, and in proximity to surfaces that interface the external environment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21185371",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1088,
                    "offsetInEndSection": 1286,
                    "text": "Understanding selective release of mediators could explain how mast cells participate in numerous diverse biologic processes, and how they exert both immunostimulatory and immunosuppressive actions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16141514",
                    "endSection": "abstract",
                    "offsetInBeginSection": 466,
                    "offsetInEndSection": 632,
                    "text": "Mast cells are associated with hypersensitivity reactions, not only in the classical immunoglobulin E (IgE)-dependent mechanism but also in an IgE-independent manner."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18028996",
                    "endSection": "abstract",
                    "offsetInBeginSection": 570,
                    "offsetInEndSection": 736,
                    "text": "Immunocytochemistry was used to localize OSM in human mast cells, and its biologic activity was verified by its effect on the proliferation of human lung fibroblasts."
                }
            ]
        },
        {
            "body": "What are the 3 types of ultraviolet (UV) solar radiation?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17204418",
                "http://www.ncbi.nlm.nih.gov/pubmed/25685424",
                "http://www.ncbi.nlm.nih.gov/pubmed/20858922",
                "http://www.ncbi.nlm.nih.gov/pubmed/9704331",
                "http://www.ncbi.nlm.nih.gov/pubmed/21192130",
                "http://www.ncbi.nlm.nih.gov/pubmed/11920550",
                "http://www.ncbi.nlm.nih.gov/pubmed/21253661",
                "http://www.ncbi.nlm.nih.gov/pubmed/19360745",
                "http://www.ncbi.nlm.nih.gov/pubmed/12821280",
                "http://www.ncbi.nlm.nih.gov/pubmed/9346474"
            ],
            "id": "5aae6a86fcf456587200000e",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17204418",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 259,
                    "text": "Sunlight, skin cancer and vitamin D: What are the conclusions of recent findings that protection against solar ultraviolet (UV) radiation causes 25-hydroxyvitamin D deficiency in solid organ-transplant recipients, xeroderma pigmentosum, and other risk groups?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25685424",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 621,
                    "text": "We present the ambitions of the SWUSV (Space Weather and Ultraviolet Solar Variability) Microsatellite Mission that encompasses three major scientific objectives: (1) Space Weather including the prediction and detection of major eruptions and coronal mass ejections (Lyman-Alpha and Herzberg continuum imaging); (2) solar forcing on the climate through radiation and their interactions with the local stratosphere (UV spectral irradiance from 180 to 400\u00a0nm by bands of 20\u00a0nm, plus Lyman-Alpha and the CN bandhead); (3) simultaneous radiative budget of the Earth, UV to IR, with an accuracy better than 1% in differential."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20858922",
                    "endSection": "abstract",
                    "offsetInBeginSection": 149,
                    "offsetInEndSection": 383,
                    "text": "The film changes from a clear colour to blue colour when exposed to ultraviolet radiation and results have shown that the colour change is reproducible within \u00b110% at 5 kJ m(-2) UV exposure under various conditions of solar radiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25685424",
                    "endSection": "abstract",
                    "offsetInBeginSection": 622,
                    "offsetInEndSection": 1176,
                    "text": "The paper briefly outlines the mission and describes the five proposed instruments of the model payload: SUAVE (Solar Ultraviolet Advanced Variability Experiment), an optimized telescope for FUV (Lyman-Alpha) and MUV (200-220\u00a0nm Herzberg continuum) imaging (sources of variability); UPR (Ultraviolet Passband Radiometers), with 64 UV filter radiometers; a vector magnetometer; thermal plasma measurements and Langmuir probes; and a total and spectral solar irradiance and Earth radiative budget ensemble (SERB, Solar irradiance & Earth Radiative Budget)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9704331",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 232,
                    "text": "BACKGROUND\nTo test the effectiveness of commercially available ultraviolet (UV)-protective eye drops (8-hydroxy-1-methylchinolinium methylsulphate) which are recommended for protection against both solar and artificial UV radiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20858922",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 148,
                    "text": "Ultraviolet radiation dosimetry has been performed with the use of a radiochromic film dosimeter called Gafchromic EBT for solar radiation exposure."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17204418",
                    "endSection": "abstract",
                    "offsetInBeginSection": 126,
                    "offsetInEndSection": 415,
                    "text": "We have shown that patients that have to protect themselves against solar UV radiation for medical reasons, including patients with xeroderma pigmentosum (XP), basal cell nevus syndrome (BCNS), lupus erythematodes (LE) or transplant recipients, are at risk to develop vitamin D deficiency."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21192130",
                    "endSection": "abstract",
                    "offsetInBeginSection": 512,
                    "offsetInEndSection": 1119,
                    "text": "It had two fixed radiation sensors total solar and ultraviolet A radiation sensor manual ultraviolet calibrated according to the erythemal response of skin measuring human ultraviolet index and the maximum exposure timer ecommended for different skin types (Safesun from Optix Tech, Inc.).The aim of this study was to measure the rate and exposure ultraviolet (UV) to evaluate the erythemal effect on most sensitive areas of the face and neck to noon fotoexposici\u00f3n solar in the four annual seasons, and thus promote extending protection regulations to prevent the effects harmful UV non-ionizing radiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17204418",
                    "endSection": "abstract",
                    "offsetInBeginSection": 416,
                    "offsetInEndSection": 610,
                    "text": "We conclude that 25-hydroxyvitamin D serum levels as a measure of vitamin D status have to be analyzed in patients that have to protect themselves against solar UV radiation for medical reasons."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11920550",
                    "endSection": "abstract",
                    "offsetInBeginSection": 389,
                    "offsetInEndSection": 593,
                    "text": "The purpose of the current study was to determine how many types of cancer are affected by solar radiation and how many premature deaths from cancer occur due to insufficient ultraviolet (UV)-B radiation."
                }
            ]
        },
        {
            "body": "Please list 10 conditions which play a role in causing atrial fibrillation.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                "http://www.ncbi.nlm.nih.gov/pubmed/26872434",
                "http://www.ncbi.nlm.nih.gov/pubmed/12693508",
                "http://www.ncbi.nlm.nih.gov/pubmed/12746748",
                "http://www.ncbi.nlm.nih.gov/pubmed/12395678",
                "http://www.ncbi.nlm.nih.gov/pubmed/15851612",
                "http://www.ncbi.nlm.nih.gov/pubmed/9809896",
                "http://www.ncbi.nlm.nih.gov/pubmed/16271942",
                "http://www.ncbi.nlm.nih.gov/pubmed/19450316",
                "http://www.ncbi.nlm.nih.gov/pubmed/12884644"
            ],
            "id": "5aaef38dfcf456587200000f",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 288,
                    "offsetInEndSection": 453,
                    "text": "Of the long list of various cardiac conditions associated with an increased risk of cardioembolic strokes, non-valvular atrial fibrillation is the most common cause."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 963,
                    "offsetInEndSection": 1161,
                    "text": "Apart from atrial fibrillation, there is relatively limited evidence for the role of antithrombotic therapy for other cardiac conditions associated with cardioembolism and how long one should treat."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26872434",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 276,
                    "text": "Cardiac arrhythmias, with, on top of the list, atrial fibrillation, are frequent conditions and any physician might have to get involved at any stage of patient care (from diagnosis to treatment), without always having the opportunity to immediately refer to the cardiologist."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12693508",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 314,
                    "text": "5-Hydroxytryptamine, a recent addition to the list of hormonal triggers for atrial fibrillation (AF), may play a pivotal role in the induction of AF related not only to cardiac surgery but also to acute coronary syndromes, valvular heart disease, cardiomyopathies, alcoholism, aging, and conducting tissue disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 619,
                    "offsetInEndSection": 801,
                    "text": "Treatment with vitamin K-antagonists substantially reduces the long-term complications associated with cardioembolism in some high-risk patients, for example, in atrial fibrillation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12746748",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1012,
                    "offsetInEndSection": 1221,
                    "text": "The most common causes of atrial fibrillation are hypertensive heart disease, coronary artery disease, and heart failure with a miscellany of lesser conditions, with about 10% lacking structural heart disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26872434",
                    "endSection": "abstract",
                    "offsetInBeginSection": 476,
                    "offsetInEndSection": 661,
                    "text": "Supra-ventricular tachycardias (atrial fibrillation and flutter, atrioventricular reciprocating tachycardias) and ventricular tachycardias will be consecutively presented and discussed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12746748",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 98,
                    "text": "Atrial fibrillation is now the most common cardiac arrhythmia for which a patient is hospitalized."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12746748",
                    "endSection": "abstract",
                    "offsetInBeginSection": 723,
                    "offsetInEndSection": 931,
                    "text": "In the United States, 80% of atrial fibrillation occurs in patients over the age of 65 years, and its prevalence tracks that of heart failure, which may be the cause, as well as the result, of the arrhythmia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12746748",
                    "endSection": "abstract",
                    "offsetInBeginSection": 99,
                    "offsetInEndSection": 359,
                    "text": "Clinically, it presents in a form that is paroxysmal, persistent, or permanent and may be symptomatic or asymptomatic, occurring in the setting of either no cardiac disease (\"lone atrial fibrillation\") or, most often, in association with an underlying disease."
                }
            ]
        },
        {
            "body": "Is p53 a transcription factor?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25755280",
                "http://www.ncbi.nlm.nih.gov/pubmed/17237821",
                "http://www.ncbi.nlm.nih.gov/pubmed/16264274",
                "http://www.ncbi.nlm.nih.gov/pubmed/15969767",
                "http://www.ncbi.nlm.nih.gov/pubmed/10514438",
                "http://www.ncbi.nlm.nih.gov/pubmed/8134379",
                "http://www.ncbi.nlm.nih.gov/pubmed/8299938",
                "http://www.ncbi.nlm.nih.gov/pubmed/10446138",
                "http://www.ncbi.nlm.nih.gov/pubmed/17957787",
                "http://www.ncbi.nlm.nih.gov/pubmed/20805247"
            ],
            "id": "5ac0817cd0c506ce46000001",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25755280",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 81,
                    "text": "PATZ1 Is a DNA Damage-Responsive Transcription Factor That Inhibits p53 Function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25755280",
                    "endSection": "abstract",
                    "offsetInBeginSection": 148,
                    "offsetInEndSection": 332,
                    "text": "Here we report that the BTB/POZ domain transcription factor PATZ1 (MAZR), previously known for its transcriptional suppressor functions in T lymphocytes, is a crucial regulator of p53."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17237821",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 70,
                    "text": "Transcription factor TAFII250 promotes Mdm2-dependent turnover of p53."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16264274",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 82,
                    "text": "Transcription repression of a CCAAT-binding transcription factor CBF/HSP70 by p53."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25755280",
                    "endSection": "abstract",
                    "offsetInBeginSection": 779,
                    "offsetInEndSection": 923,
                    "text": "Significantly, treatment with the DNA damage-inducing drug doxorubicin results in the loss of the PATZ1 transcription factor as p53 accumulates."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15969767",
                    "endSection": "abstract",
                    "offsetInBeginSection": 256,
                    "offsetInEndSection": 384,
                    "text": "P53 is a homotetrameric transcription factor known to interact with the ankyrin protein 53BP2 (a fragment of the ASPP2 protein)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25755280",
                    "endSection": "abstract",
                    "offsetInBeginSection": 924,
                    "offsetInEndSection": 1008,
                    "text": "We find that PATZ1 binds to p53 and inhibits p53-dependent transcription activation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16264274",
                    "endSection": "abstract",
                    "offsetInBeginSection": 236,
                    "offsetInEndSection": 410,
                    "text": "CBF/HSP70 was originally identified as a transcription factor binding to the CCAAT box on the hsp70 promoter and mediates transcription repression of hsp70 pro- moter by p53."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16264274",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 136,
                    "text": "NF-Y transcription factor binds to CCAAT boxes on promoters of cell cycle regulatory genes such as cdc2, cyclin B, cdc25C, and cyclin A."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17237821",
                    "endSection": "abstract",
                    "offsetInBeginSection": 313,
                    "offsetInEndSection": 398,
                    "text": "Mdm2 associates with TAFII250, a component of the general transcription factor TFIID."
                }
            ]
        },
        {
            "body": "Is Cystatin D a biomarker?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22350134",
                "http://www.ncbi.nlm.nih.gov/pubmed/23463154",
                "http://www.ncbi.nlm.nih.gov/pubmed/21151566",
                "http://www.ncbi.nlm.nih.gov/pubmed/21918259",
                "http://www.ncbi.nlm.nih.gov/pubmed/19623638",
                "http://www.ncbi.nlm.nih.gov/pubmed/29087712",
                "http://www.ncbi.nlm.nih.gov/pubmed/22795897",
                "http://www.ncbi.nlm.nih.gov/pubmed/21377848",
                "http://www.ncbi.nlm.nih.gov/pubmed/26724852",
                "http://www.ncbi.nlm.nih.gov/pubmed/28282874"
            ],
            "id": "5a9d9ab94e03427e73000003",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22350134",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 60,
                    "text": "Cystatin C is not a good candidate biomarker for HNF1A-MODY."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22350134",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1333,
                    "offsetInEndSection": 1522,
                    "text": "Concluding, we could not confirm our hypothesis (supported by the Polish results) that cystatin C level is altered by HNF1A mutations; thus, it cannot be used as a biomarker for HNF1A-MODY."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23463154",
                    "endSection": "abstract",
                    "offsetInBeginSection": 144,
                    "offsetInEndSection": 256,
                    "text": "Serum cystatin C is a novel biomarker that has emerged as a possible diagnostic alternative to serum creatinine."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21151566",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 68,
                    "text": "Cystatin C: a candidate biomarker for amyotrophic lateral sclerosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21918259",
                    "endSection": "abstract",
                    "offsetInBeginSection": 402,
                    "offsetInEndSection": 528,
                    "text": "Since 1985 cystatin C has been studied mainly in serum/plasma as an alternative biomarker to serum creatinine to estimate GFR."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21918259",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 165,
                    "text": "Cystatin C (cysC) is an endogenous cysteine peptidase (proteinase) inhibitor that has been intensively investigated as a biomarker of kidney function for many years."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19623638",
                    "endSection": "abstract",
                    "offsetInBeginSection": 195,
                    "offsetInEndSection": 356,
                    "text": "Cystatin C, a nonglycosylated protein unaffected by muscle mass, is potentially an ideal biomarker of nephrotoxicity for this population but requires validation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21151566",
                    "endSection": "abstract",
                    "offsetInBeginSection": 382,
                    "offsetInEndSection": 576,
                    "text": "The cysteine protease inhibitor cystatin C has recently gained interest as a candidate diagnostic biomarker for ALS, but further studies are required to fully characterize its biomarker utility."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29087712",
                    "endSection": "abstract",
                    "offsetInBeginSection": 653,
                    "offsetInEndSection": 881,
                    "text": "Because cathepsin D is a biomarker in aggressive forms of breast cancer and linked to poor prognosis, the effects of cathepsin D inhibition by 1 and 3 on the downstream cellular substrates cystatin C and PAI-1 were investigated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22795897",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 80,
                    "text": "Cystatin C, a cysteine protease inhibitor, is a novel biomarker of renal damage."
                }
            ]
        },
        {
            "body": "What causes leishmaniasis?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/18457726",
                "http://www.ncbi.nlm.nih.gov/pubmed/25988048",
                "http://www.ncbi.nlm.nih.gov/pubmed/7602174",
                "http://www.ncbi.nlm.nih.gov/pubmed/23219435",
                "http://www.ncbi.nlm.nih.gov/pubmed/24707415",
                "http://www.ncbi.nlm.nih.gov/pubmed/2670376",
                "http://www.ncbi.nlm.nih.gov/pubmed/17361837",
                "http://www.ncbi.nlm.nih.gov/pubmed/25228325",
                "http://www.ncbi.nlm.nih.gov/pubmed/25768375",
                "http://www.ncbi.nlm.nih.gov/pubmed/25116660"
            ],
            "id": "5abcf0b0fcf4565872000024",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18457726",
                    "endSection": "abstract",
                    "offsetInBeginSection": 80,
                    "offsetInEndSection": 182,
                    "text": "It causes massive mutilating and disfiguring lesions and can lead to destruction of facial structures."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25988048",
                    "endSection": "abstract",
                    "offsetInBeginSection": 332,
                    "offsetInEndSection": 409,
                    "text": "Kala azar is the most aggressive form and if untreated causes high mortality."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25988048",
                    "endSection": "abstract",
                    "offsetInBeginSection": 156,
                    "offsetInEndSection": 331,
                    "text": "The protozoa is obliged intracellularly and causes a wide spectrum of clinical syndromes: VL ('kala azar'), cutaneous leishmaniasis and mucocutaneous leishmaniasis (espundia)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7602174",
                    "endSection": "abstract",
                    "offsetInBeginSection": 243,
                    "offsetInEndSection": 361,
                    "text": "It causes chronic ulceration of the mucous membranes with destruction of the bone and cartilage of the nose and mouth."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23219435",
                    "endSection": "abstract",
                    "offsetInBeginSection": 409,
                    "offsetInEndSection": 520,
                    "text": "However, in Sri Lanka, L. donovani causes mainly cutaneous leishmaniasis, while visceral leishmaniasis is rare."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24707415",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 145,
                    "text": "Leishmaniasis is a tropical infection caused by the protozoan, belonging to the group of Leishmania which causes Old World and New World disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2670376",
                    "endSection": "abstract",
                    "offsetInBeginSection": 356,
                    "offsetInEndSection": 416,
                    "text": "Undiagnosed, it causes considerable morbidity and mortality."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18457726",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1191,
                    "offsetInEndSection": 1294,
                    "text": "Our case is also unusual in that zymodeme MON-80 is only rarely a cause of Mediterranean leishmaniasis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25988048",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 155,
                    "text": "Visceral leishmaniasis (VL) is caused by the protozoan parasite Leishmania donovani and transmitted by the bite of infected sandfly Phlebotomus argentipes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2670376",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 89,
                    "text": "Leishmaniasis is a parasitic infection caused by many species of the protozoa Leishmania."
                }
            ]
        },
        {
            "body": "Please list 7 classes of drugs that interact with Warfarin.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21397772",
                "http://www.ncbi.nlm.nih.gov/pubmed/19587643",
                "http://www.ncbi.nlm.nih.gov/pubmed/8801057",
                "http://www.ncbi.nlm.nih.gov/pubmed/23045839",
                "http://www.ncbi.nlm.nih.gov/pubmed/9707357",
                "http://www.ncbi.nlm.nih.gov/pubmed/8243910",
                "http://www.ncbi.nlm.nih.gov/pubmed/22717419",
                "http://www.ncbi.nlm.nih.gov/pubmed/21359645",
                "http://www.ncbi.nlm.nih.gov/pubmed/3271186",
                "http://www.ncbi.nlm.nih.gov/pubmed/18221095"
            ],
            "id": "5abce6acfcf4565872000022",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1744,
                    "offsetInEndSection": 2026,
                    "text": "CONCLUSION\nThis assessment of official US product labeling for 50 drugs, biologics, and drug classes known to interact with warfarin, comprising 73 distinct agents, found that 15% failed to mention the interaction, even though the interaction was mentioned in the warfarin labeling."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772",
                    "endSection": "abstract",
                    "offsetInBeginSection": 399,
                    "offsetInEndSection": 754,
                    "text": "METHODS\nWe examined the official labeling information approved by the US Food and Drug Administration for the 50 drugs, biologics, and drug classes that were commonly identified by 3 drug information compendia--Clinical Pharmacology, ePocrates(\u00ae), and Micromedex(\u00ae)--and the warfarin US prescribing information (PI) as having an interaction with warfarin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643",
                    "endSection": "abstract",
                    "offsetInBeginSection": 611,
                    "offsetInEndSection": 797,
                    "text": "The types of substances listed as interacting with warfarin were entire classes of drugs, individual drugs, and combinations; biologics; dietary supplements; foods; alcohol; and tobacco."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8801057",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 21,
                    "text": "Warfarin-fluconazole."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1304,
                    "offsetInEndSection": 1404,
                    "text": "Those failing to mention the warfarin interaction were for older generic drugs or influenza vaccine."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 83,
                    "text": "Interactions of warfarin with other drugs or substances can pose a serious problem."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 110,
                    "text": "Evaluation of warfarin drug interaction listings in US product information for warfarin and interacting drugs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643",
                    "endSection": "abstract",
                    "offsetInBeginSection": 84,
                    "offsetInEndSection": 388,
                    "text": "We assessed three drug information compendia-Clinical Pharmacology, ePocrates, and Micromedex-and the warfarin sodium (Coumadin) product label (August 2007) approved by the US Food and Drug Administration for listings of interactions between warfarin and drugs, biologics, foods, and dietary supplements."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 204,
                    "text": "BACKGROUND\nBecause interactions with warfarin represent a serious risk to patients, drug information sources used by clinicians should contain accurate, timely, and practical drug interaction information."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23045839",
                    "endSection": "abstract",
                    "offsetInBeginSection": 403,
                    "offsetInEndSection": 645,
                    "text": "Since the possible interactions between these two classes of drugs have been poorly explored in literature, with a risk to the patients who use them, we reviewed the pharmacology of warfarin and its possible interactions with antidepressants."
                }
            ]
        },
        {
            "body": "What part of the body is affected by mesotheliomia?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19280864",
                "http://www.ncbi.nlm.nih.gov/pubmed/22879850",
                "http://www.ncbi.nlm.nih.gov/pubmed/24980000",
                "http://www.ncbi.nlm.nih.gov/pubmed/11984226",
                "http://www.ncbi.nlm.nih.gov/pubmed/14597380",
                "http://www.ncbi.nlm.nih.gov/pubmed/17957509",
                "http://www.ncbi.nlm.nih.gov/pubmed/22688599",
                "http://www.ncbi.nlm.nih.gov/pubmed/24520350",
                "http://www.ncbi.nlm.nih.gov/pubmed/16051171",
                "http://www.ncbi.nlm.nih.gov/pubmed/21963254"
            ],
            "id": "5a74eaa50384be955100000b",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19280864",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 100,
                    "text": "Dystonia is a common movement disorder characterised by abnormal postures of the affected body part."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22879850",
                    "endSection": "abstract",
                    "offsetInBeginSection": 628,
                    "offsetInEndSection": 764,
                    "text": "Symptoms vary from person to person, and may come and go, depend on what part of the body is affected, can be mild, moderate, or severe."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24980000",
                    "endSection": "abstract",
                    "offsetInBeginSection": 286,
                    "offsetInEndSection": 492,
                    "text": "CRPS is a complex pathophysiological entity characterised by pain, trophic and vasomotoric changes, limited function of affected body part and relatively fast development of osteoporosis of affected region."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22879850",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 131,
                    "text": "Systemic lupus erythematosus (SLE) is a chronic, multifaceted autoimmune inflammatory disease that can affect any part of the body."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11984226",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 218,
                    "text": "Reflex sympathetic dystrophy is a condition characterized by unrelenting pain, swelling, discoloration, temperature, and physical changes in the affected body part that are life-altering for the patient and the family."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14597380",
                    "endSection": "abstract",
                    "offsetInBeginSection": 120,
                    "offsetInEndSection": 220,
                    "text": "Although they may originate from any part of the body head and neck region is occasionally affected."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17957509",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 235,
                    "text": "Blue rubber bleb nevus syndrome (BRBNS) is a rare condition that consists of multiple venous malformations involving several organ systems, particularly the skin and the gastrointestinal tract, but any part of the body may be affected."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22688599",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 266,
                    "text": "OBJECTIVES\nImpaired left/right judgment of the affected body part is regarded as a disruption of the body's representation in cortical and subcortical somatosensory and motor areas and has previously been demonstrated in patients with severe neuropathic pain states."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24520350",
                    "endSection": "abstract",
                    "offsetInBeginSection": 220,
                    "offsetInEndSection": 485,
                    "text": "In isolated focal dystonia, whole putaminal binding of dopamine D2-like receptor radioligands is quantitatively decreased, but it has not been known whether selected parts of the putamen are differentially affected depending upon the body part affected by dystonia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16051171",
                    "endSection": "abstract",
                    "offsetInBeginSection": 240,
                    "offsetInEndSection": 410,
                    "text": "Here, we demonstrate that an intrinsic primary quality of a tactile object, for example its size, is directly affected by the perceived size of the body part touching it."
                }
            ]
        },
        {
            "body": "What is BORSA?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23554199",
                "http://www.ncbi.nlm.nih.gov/pubmed/18819540",
                "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                "http://www.ncbi.nlm.nih.gov/pubmed/20880412",
                "http://www.ncbi.nlm.nih.gov/pubmed/26064878",
                "http://www.ncbi.nlm.nih.gov/pubmed/18630132",
                "http://www.ncbi.nlm.nih.gov/pubmed/10834971",
                "http://www.ncbi.nlm.nih.gov/pubmed/2069374",
                "http://www.ncbi.nlm.nih.gov/pubmed/2261916",
                "http://www.ncbi.nlm.nih.gov/pubmed/1900315"
            ],
            "id": "5aae6499fcf456587200000c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23554199",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1218,
                    "offsetInEndSection": 1410,
                    "text": "Retrospective typing of an MRSA outbreak showed that it is possible to differentiate unrelated MSSA, MRSA, and borderline resistant S. aureus (BORSA) strains isolated from health care workers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18819540",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1786,
                    "offsetInEndSection": 1950,
                    "text": "Because one fourth of our staphylococcus strains are mecA negative BORSA and there is no alternative for vancomycin against mecA positive MRSA and Enterococcus spp."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                    "endSection": "abstract",
                    "offsetInBeginSection": 586,
                    "offsetInEndSection": 692,
                    "text": "BORSA cannot be classified as either truly methicillin-resistant or truly methicillin-susceptible strains."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20880412",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 301,
                    "text": "Since it is unknown whether \u03b2-lactam antimicrobial agents can be used effectively against borderline oxacillin-resistant Staphylococcus aureus (BORSA) with oxacillin MICs \u22654 mg/L, the in vitro bactericidal activity and pharmacodynamic effect of oxacillin against clinical BORSA isolates was evaluated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26064878",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1067,
                    "offsetInEndSection": 1168,
                    "text": "To our knowledge it is also the first report concerning CC398 BORSA isolates from pigs and pork meat."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 159,
                    "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and inadequately defined phenotype of methicillin resistance."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20880412",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1159,
                    "offsetInEndSection": 1301,
                    "text": "Further investigation into \u03b2-lactam dosing strategies against different BORSA strains is warranted in order to avoid possible therapy failure."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18630132",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1981,
                    "offsetInEndSection": 2144,
                    "text": "The frequency of BORSA isolates and production of beta-lactamases were higher among hospital Staphylococcus aureus isolates, but the difference is not significant."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 99,
                    "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) - a more common problem than expected?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                    "endSection": "abstract",
                    "offsetInBeginSection": 160,
                    "offsetInEndSection": 455,
                    "text": "BORSA strains show low, borderline resistance to penicillinase-resistant penicillins (PRPs), with oxacillin MICs typically equal to 1-8\u2009\u00b5g\u2009ml-1, and in contrast to methicillin-resistant S. aureus (MRSA), do not have an altered penicillin-binding protein, PBP2a, encoded by the mecA or mecC gene."
                }
            ]
        },
        {
            "body": "Which gene is responsible for proper speech development?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16497722",
                "http://www.ncbi.nlm.nih.gov/pubmed/19332160",
                "http://www.ncbi.nlm.nih.gov/pubmed/27148578",
                "http://www.ncbi.nlm.nih.gov/pubmed/25269856",
                "http://www.ncbi.nlm.nih.gov/pubmed/26980647",
                "http://www.ncbi.nlm.nih.gov/pubmed/23099646",
                "http://www.ncbi.nlm.nih.gov/pubmed/21108403",
                "http://www.ncbi.nlm.nih.gov/pubmed/23687080",
                "http://www.ncbi.nlm.nih.gov/pubmed/11586359",
                "http://www.ncbi.nlm.nih.gov/pubmed/15685218"
            ],
            "id": "5ace12be0340b9f058000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16497722",
                    "endSection": "abstract",
                    "offsetInBeginSection": 265,
                    "offsetInEndSection": 423,
                    "text": "We have identified the Xq22 gene SRPX2 as being responsible for rolandic seizures (RSs) associated with oral and speech dyspraxia and mental retardation (MR)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19332160",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "A 785kb deletion of 3p14.1p13, including the FOXP1 gene, associated with speech delay, contractures, hypertonia and blepharophimosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27148578",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 116,
                    "text": "Forkhead box protein P2 (FOXP2) is a well-studied gene known to play an essential role in normal speech development."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19332160",
                    "endSection": "abstract",
                    "offsetInBeginSection": 599,
                    "offsetInEndSection": 723,
                    "text": "Identification of the transcriptional targets of FOXP2, a gene linked to speech and language, in developing human brain, Am."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25269856",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 83,
                    "text": "BACKGROUND\nMutations in the human FOXP2 gene cause speech and language impairments."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26980647",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 89,
                    "text": "The FOXP2 gene is important for the development of proper speech motor control in humans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27148578",
                    "endSection": "abstract",
                    "offsetInBeginSection": 117,
                    "offsetInEndSection": 305,
                    "text": "Deletions in the gene have been shown to result in developmental speech disorders and regulatory disruption of downstream gene targets associated with common forms of language impairments."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19332160",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1117,
                    "offsetInEndSection": 1228,
                    "text": "Monaco, A forkhead-domain gene is mutated in a severe speech and language disorder, Nature 413 (2001) 519-523.]"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23099646",
                    "endSection": "abstract",
                    "offsetInBeginSection": 400,
                    "offsetInEndSection": 603,
                    "text": "We have identified a 69 kb deletion including the 5' region of the DYRK1A gene in a patient with growth retardation, primary microcephaly, facial dysmorphism, seizures, ataxic gait, absent speech and ID."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27148578",
                    "endSection": "abstract",
                    "offsetInBeginSection": 306,
                    "offsetInEndSection": 533,
                    "text": "Despite similarities in motor planning and execution between speech development and oral feeding competence, there have been no reports to date linking deletions within the FOXP2 gene to oral feeding impairments in the newborn."
                }
            ]
        },
        {
            "body": "What is PNPPP?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                "http://www.ncbi.nlm.nih.gov/pubmed/24201366",
                "http://www.ncbi.nlm.nih.gov/pubmed/21747892"
            ],
            "id": "5a9da59c4e03427e73000005",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 919,
                    "offsetInEndSection": 1050,
                    "text": "PdeM is a monomer of 29.3 kDa, which exhibits optimum activity at 25\u00b0C and pH 8.5, but low affinity for bis(pNPP) as well as pNPPP."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1827,
                    "offsetInEndSection": 1913,
                    "text": "PdeM, thus, is a novel representative of new subclass of class III phosphodiesterases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1647,
                    "offsetInEndSection": 1826,
                    "text": "Structural comparison of PdeM with its homologs showed that it lacked critical residues required for dimerization, cAMP hydrolysis, and for the high affinity binding of bis(pNPP)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1152,
                    "offsetInEndSection": 1224,
                    "text": "It lacked phosphomonoesterase, phosphotriesterase, and RNAse activities."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 79,
                    "text": "Phosphoesterases are involved in the degradation of organophosphorus compounds."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 196,
                    "text": "OBJECTIVE\nTo study the impact of genetic and lifestyle factors on protein biomarkers and develop personally normalized plasma protein profiles (PNPPP) controlling for non-disease-related variance."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 167,
                    "text": "Effect of genetic and environmental factors on protein biomarkers for common non-communicable disease and use of personally normalized plasma protein profiles (PNPPP)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                    "endSection": "abstract",
                    "offsetInBeginSection": 520,
                    "offsetInEndSection": 722,
                    "text": "CONCLUSION\nPNPPP efficiently controls for non-disease-related variance, allowing both for efficient discovery of novel biomarkers and for covariate-independent linear cut-offs suitable for clinical use."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 80,
                    "offsetInEndSection": 212,
                    "text": "Although phosphomonoesterases and phosphotriesterases have been studied in detail, studies on phosphodiesterases are rather limited."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1225,
                    "offsetInEndSection": 1399,
                    "text": "Overexpression of PdeM in E.coli neither affected catabolite respression nor did the recombinant protein hydrolyzed cAMP in vitro, indicating its inability to hydrolyze cAMP."
                }
            ]
        },
        {
            "body": "What is Mendelian randomization?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20616999",
                "http://www.ncbi.nlm.nih.gov/pubmed/26291580",
                "http://www.ncbi.nlm.nih.gov/pubmed/28960498",
                "http://www.ncbi.nlm.nih.gov/pubmed/17715159",
                "http://www.ncbi.nlm.nih.gov/pubmed/27749700",
                "http://www.ncbi.nlm.nih.gov/pubmed/15321841",
                "http://www.ncbi.nlm.nih.gov/pubmed/27411906",
                "http://www.ncbi.nlm.nih.gov/pubmed/18038153",
                "http://www.ncbi.nlm.nih.gov/pubmed/23934314",
                "http://www.ncbi.nlm.nih.gov/pubmed/26079416"
            ],
            "id": "5a9da37e4e03427e73000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20616999",
                    "endSection": "abstract",
                    "offsetInBeginSection": 263,
                    "offsetInEndSection": 705,
                    "text": "In this review, we recall the principles of a \"Mendelian randomization\" approach in observational epidemiology, which is based on the technique of instrumental variables; we provide simulations and an example based on real data to demonstrate its implications; we present the results of a systematic search on original articles having used this approach; and we discuss some limitations of this approach in view of what has been found so far."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26291580",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1095,
                    "offsetInEndSection": 1262,
                    "text": "CONCLUSION\nWe discuss the role of such investigations (in the style of Mendelian randomization), and what they add to our understanding of potential causal mechanisms."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28960498",
                    "endSection": "abstract",
                    "offsetInBeginSection": 154,
                    "offsetInEndSection": 691,
                    "text": "These include multivariable Mendelian randomization, in which a genetic variant may be associated with multiple risk factors so long as any association with the outcome is via the measured risk factors (measured pleiotropy), and the MR-Egger (Mendelian randomization-Egger) method, in which a genetic variant may be directly associated with the outcome not via the risk factor of interest, so long as the direct effects of the variants on the outcome are uncorrelated with their associations with the risk factor (unmeasured pleiotropy)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20616999",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 99,
                    "text": "Mendelian randomization refers to the random allocation of alleles at the time of gamete formation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17715159",
                    "endSection": "abstract",
                    "offsetInBeginSection": 276,
                    "offsetInEndSection": 525,
                    "text": "However, if we know of a gene closely linked to the phenotype without direct effect on the disease, it can often be reasonably assumed that the gene is not itself associated with any confounding factors - a phenomenon called Mendelian randomization."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26291580",
                    "endSection": "abstract",
                    "offsetInBeginSection": 767,
                    "offsetInEndSection": 984,
                    "text": "We also give a framework for performing and interpreting investigations performed in the style of Mendelian randomization, but where the choice of genetic variants is statistically, rather than biologically motivated."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26291580",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 87,
                    "text": "Beyond Mendelian randomization: how to interpret evidence of shared genetic predictors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26291580",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 121,
                    "text": "OBJECTIVE\nMendelian randomization is a popular technique for assessing and estimating the causal effects of risk factors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26291580",
                    "endSection": "abstract",
                    "offsetInBeginSection": 985,
                    "offsetInEndSection": 1092,
                    "text": "Such analyses should not be assigned the same evidential weight as a Mendelian randomization investigation."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17715159",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 81,
                    "text": "Mendelian randomization as an instrumental variable approach to causal inference."
                }
            ]
        }
    ]
}